<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:dcterms="http://purl.org/dc/terms/"
 xmlns:cc="http://web.resource.org/cc/"
 xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns:admin="http://webns.net/mvcb/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/">
    <channel rdf:about="https://www.mdpi.com/rss/journal/msf">
		<title>Medical Sciences Forum</title>
		<description>Latest open access articles published in Med. Sci. Forum at https://www.mdpi.com/journal/msf</description>
		<link>https://www.mdpi.com/journal/msf</link>
		<admin:generatorAgent rdf:resource="https://www.mdpi.com/journal/msf"/>
		<admin:errorReportsTo rdf:resource="mailto:support@mdpi.com"/>
		<dc:publisher>MDPI</dc:publisher>
		<dc:language>en</dc:language>
		<dc:rights>Creative Commons Attribution (CC-BY)</dc:rights>
						<prism:copyright>MDPI</prism:copyright>
		<prism:rightsAgent>support@mdpi.com</prism:rightsAgent>
		<image rdf:resource="https://pub.mdpi-res.com/img/design/mdpi-pub-logo.png?13cf3b5bd783e021?1779439589"/>
				<items>
			<rdf:Seq>
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/45/1/6" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/39/1/7" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/39/1/6" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/39/1/5" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/40/1/4" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/44/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/43/1/4" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/45/1/5" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/45/1/4" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/45/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/43/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/45/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/43/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/45/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/44/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/41/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/43/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/42/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/41/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/33/1/7" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/38/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/33/1/6" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/40/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/38/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/40/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/39/1/4" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/40/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/39/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/39/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/39/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/38/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/11" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/26" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/10" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/9" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/25" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/24" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/36/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/23" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/20" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/22" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/21" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/18" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/19" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/17" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/16" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/15" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/14" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/8" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/13" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/12" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/11" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/10" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/9" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/8" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/7" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/7" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/5" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/6" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/4" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/37/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/6" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/5" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/4" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/33/1/5" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/33/1/4" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/36/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/33/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/34/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/32/1/5" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/35/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/32/1/4" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/32/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/34/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/34/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/32/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/33/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/30/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/33/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/32/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/31/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/29/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/28/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/25/1/16" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/25/1/15" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/25/1/14" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/28/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/25/1/13" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/23/1/10" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/25/1/12" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/27/1/3" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/27/1/2" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/27/1/1" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/24/1/21" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/24/1/20" />
            				<rdf:li rdf:resource="https://www.mdpi.com/2673-9992/25/1/11" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="https://creativecommons.org/licenses/by/4.0/" />
	</channel>

        <item rdf:about="https://www.mdpi.com/2673-9992/45/1/6">

	<title>Medical Sciences Forum, Vol. 45, Pages 6: A Revolution in Dentistry: An AI-Powered 3D Scanning and Printing System for Custom Prosthetics, Implants, and Orthodontics Using Palano-Enhanced Implants</title>
	<link>https://www.mdpi.com/2673-9992/45/1/6</link>
	<description>This research presents an artificial intelligence (AI)-driven 3D scanning and printing system for the fabrication of personalized dental prosthetics, implants, and orthodontic appliances. The proposed system integrates high-resolution intraoral scanning, AI-based data analysis, and additive manufacturing to enhance precision, customization, and treatment efficiency. Patient-specific anatomical data and medical history are incorporated to optimize implant design, material selection, and functional performance. Nano-enhanced biocompatible materials are utilized to improve mechanical strength, durability, and antibacterial properties. Specifically, these materials demonstrate a 30% increase in overall precision and a 50% improvement in durability compared to traditional dental materials. In addition, the system adopts a zero-waste manufacturing strategy by recycling excess materials, supporting sustainable dental practices. The results demonstrate significant improvements in accuracy, patient comfort, and environmental responsibility in modern digital dentistry.</description>
	<pubDate>2026-04-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 45, Pages 6: A Revolution in Dentistry: An AI-Powered 3D Scanning and Printing System for Custom Prosthetics, Implants, and Orthodontics Using Palano-Enhanced Implants</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/45/1/6">doi: 10.3390/msf2026045006</a></p>
	<p>Authors:
		Mariam Tarek Shawkat
		</p>
	<p>This research presents an artificial intelligence (AI)-driven 3D scanning and printing system for the fabrication of personalized dental prosthetics, implants, and orthodontic appliances. The proposed system integrates high-resolution intraoral scanning, AI-based data analysis, and additive manufacturing to enhance precision, customization, and treatment efficiency. Patient-specific anatomical data and medical history are incorporated to optimize implant design, material selection, and functional performance. Nano-enhanced biocompatible materials are utilized to improve mechanical strength, durability, and antibacterial properties. Specifically, these materials demonstrate a 30% increase in overall precision and a 50% improvement in durability compared to traditional dental materials. In addition, the system adopts a zero-waste manufacturing strategy by recycling excess materials, supporting sustainable dental practices. The results demonstrate significant improvements in accuracy, patient comfort, and environmental responsibility in modern digital dentistry.</p>
	]]></content:encoded>

	<dc:title>A Revolution in Dentistry: An AI-Powered 3D Scanning and Printing System for Custom Prosthetics, Implants, and Orthodontics Using Palano-Enhanced Implants</dc:title>
			<dc:creator>Mariam Tarek Shawkat</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026045006</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-04-24</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-04-24</prism:publicationDate>
	<prism:volume>45</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>6</prism:startingPage>
		<prism:doi>10.3390/msf2026045006</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/45/1/6</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/39/1/7">

	<title>Medical Sciences Forum, Vol. 39, Pages 7: Preface and Statement of Peer Review</title>
	<link>https://www.mdpi.com/2673-9992/39/1/7</link>
	<description>The 2025 International Kidney Cancer Symposium&amp;amp;mdash;Europe (IKCSEU25) was held in Amsterdam, The Netherlands, from 1 to 3 May 2025, organized by the Kidney Cancer Association (KCA) [...]</description>
	<pubDate>2026-04-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 39, Pages 7: Preface and Statement of Peer Review</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/39/1/7">doi: 10.3390/msf2025039007</a></p>
	<p>Authors:
		Axel Bex
		Ignacio Durán
		Salvatore La Rosa
		Lisa Pickering
		</p>
	<p>The 2025 International Kidney Cancer Symposium&amp;amp;mdash;Europe (IKCSEU25) was held in Amsterdam, The Netherlands, from 1 to 3 May 2025, organized by the Kidney Cancer Association (KCA) [...]</p>
	]]></content:encoded>

	<dc:title>Preface and Statement of Peer Review</dc:title>
			<dc:creator>Axel Bex</dc:creator>
			<dc:creator>Ignacio Durán</dc:creator>
			<dc:creator>Salvatore La Rosa</dc:creator>
			<dc:creator>Lisa Pickering</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025039007</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-04-08</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-04-08</prism:publicationDate>
	<prism:volume>39</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Editorial</prism:section>
	<prism:startingPage>7</prism:startingPage>
		<prism:doi>10.3390/msf2025039007</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/39/1/7</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/39/1/6">

	<title>Medical Sciences Forum, Vol. 39, Pages 6: Real-World Usage of Cabozantinib at University Hospitals Plymouth NHS Trust Between 2020 and 2024: Does Dose Reduction Impact Treatment Outcomes?</title>
	<link>https://www.mdpi.com/2673-9992/39/1/6</link>
	<description>Cabozantinib is a commonly prescribed tyrosine kinase inhibitor for metastatic renal cell carcinoma (mRCC). Dose reductions may be required to manage side effects. Data was collected at University Hospitals Plymouth NHS Trust between 2020 and 2024 to investigate the dosing of Cabozantinib and its impact on cancer control. Starting at a reduced dose was common, with only 17% starting at full dose (60 mg). Only 9% completed their Cabozantinib course at 60 mg, with the majority (61%) ending up taking 20 mg. Dose reductions occurred early, with the vast majority ending up on their final dose at cycle two or three. Median progression-free survival was 7&amp;amp;ndash;10 months regardless of dose, and there was no statistically significant difference in PFS or OS according to dose.</description>
	<pubDate>2026-04-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 39, Pages 6: Real-World Usage of Cabozantinib at University Hospitals Plymouth NHS Trust Between 2020 and 2024: Does Dose Reduction Impact Treatment Outcomes?</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/39/1/6">doi: 10.3390/msf2025039006</a></p>
	<p>Authors:
		Dominique Parslow
		Ikenna Ibeanusi
		Jessica Hill
		</p>
	<p>Cabozantinib is a commonly prescribed tyrosine kinase inhibitor for metastatic renal cell carcinoma (mRCC). Dose reductions may be required to manage side effects. Data was collected at University Hospitals Plymouth NHS Trust between 2020 and 2024 to investigate the dosing of Cabozantinib and its impact on cancer control. Starting at a reduced dose was common, with only 17% starting at full dose (60 mg). Only 9% completed their Cabozantinib course at 60 mg, with the majority (61%) ending up taking 20 mg. Dose reductions occurred early, with the vast majority ending up on their final dose at cycle two or three. Median progression-free survival was 7&amp;amp;ndash;10 months regardless of dose, and there was no statistically significant difference in PFS or OS according to dose.</p>
	]]></content:encoded>

	<dc:title>Real-World Usage of Cabozantinib at University Hospitals Plymouth NHS Trust Between 2020 and 2024: Does Dose Reduction Impact Treatment Outcomes?</dc:title>
			<dc:creator>Dominique Parslow</dc:creator>
			<dc:creator>Ikenna Ibeanusi</dc:creator>
			<dc:creator>Jessica Hill</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025039006</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-04-01</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-04-01</prism:publicationDate>
	<prism:volume>39</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>6</prism:startingPage>
		<prism:doi>10.3390/msf2025039006</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/39/1/6</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/39/1/5">

	<title>Medical Sciences Forum, Vol. 39, Pages 5: Relevance of the IMDC Risk Model in a Real World Setting: A Single Institution Experience</title>
	<link>https://www.mdpi.com/2673-9992/39/1/5</link>
	<description>This single-centre retrospective study evaluated outcomes in 112 patients with metastatic renal cell carcinoma (mRCC) treated with first-line VEGF-TKIs or immune checkpoint inhibitor (IO)-based combinations. The primary objective of this study was to evaluate survival outcomes of mRCC patients according to IMDC risk stratification in the modern systemic treatment era. A secondary aim was to assess whether prior nephrectomy provides an independent prognostic advantage when adjusted for an IMDC risk category. This study highlights that the IMDC risk classification remains a strong and reliable prognostic tool for predicting survival outcomes in mRCC patients treated with modern VEGF TKI and IO-based therapies, with median overall survival (OS) of 87, 36, and 9 months in favourable-, intermediate-, and poor-risk patients, respectively. Prior nephrectomy appeared to improve OS (55 vs. 21 months) and progression-free survival (29 vs. 10.9 months) on unadjusted analysis; however, this association was attenuated and no longer statistically significant after adjusting for IMDC risk groups, reflecting strong baseline imbalances and indicating that any true independent benefit is uncertain and requires confirmation in larger cohorts.</description>
	<pubDate>2026-03-31</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 39, Pages 5: Relevance of the IMDC Risk Model in a Real World Setting: A Single Institution Experience</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/39/1/5">doi: 10.3390/msf2025039005</a></p>
	<p>Authors:
		Kyaw Kyaw Tun
		Loaie Elhelw
		Salil Vengalil
		</p>
	<p>This single-centre retrospective study evaluated outcomes in 112 patients with metastatic renal cell carcinoma (mRCC) treated with first-line VEGF-TKIs or immune checkpoint inhibitor (IO)-based combinations. The primary objective of this study was to evaluate survival outcomes of mRCC patients according to IMDC risk stratification in the modern systemic treatment era. A secondary aim was to assess whether prior nephrectomy provides an independent prognostic advantage when adjusted for an IMDC risk category. This study highlights that the IMDC risk classification remains a strong and reliable prognostic tool for predicting survival outcomes in mRCC patients treated with modern VEGF TKI and IO-based therapies, with median overall survival (OS) of 87, 36, and 9 months in favourable-, intermediate-, and poor-risk patients, respectively. Prior nephrectomy appeared to improve OS (55 vs. 21 months) and progression-free survival (29 vs. 10.9 months) on unadjusted analysis; however, this association was attenuated and no longer statistically significant after adjusting for IMDC risk groups, reflecting strong baseline imbalances and indicating that any true independent benefit is uncertain and requires confirmation in larger cohorts.</p>
	]]></content:encoded>

	<dc:title>Relevance of the IMDC Risk Model in a Real World Setting: A Single Institution Experience</dc:title>
			<dc:creator>Kyaw Kyaw Tun</dc:creator>
			<dc:creator>Loaie Elhelw</dc:creator>
			<dc:creator>Salil Vengalil</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025039005</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-03-31</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-03-31</prism:publicationDate>
	<prism:volume>39</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>5</prism:startingPage>
		<prism:doi>10.3390/msf2025039005</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/39/1/5</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/40/1/4">

	<title>Medical Sciences Forum, Vol. 40, Pages 4: Detection of Anti-HEV IgM and IgG Antibodies Among Antenatal Women Attending a Tertiary Care Center</title>
	<link>https://www.mdpi.com/2673-9992/40/1/4</link>
	<description>Hepatitis E virus (HEV) is recognized as one of the leading causes of acute viral hepatitis (AVH) in developing countries, where it is primarily transmitted through the consumption of contaminated food and water. Although often self-limiting, HEV infection poses a significant public health concern, particularly among pregnant women, due to its potential complications. The present study aimed to determine the seroprevalence of HEV infection in asymptomatic antenatal women attending a tertiary care center in South Punjab, Pakistan. A total of 100 asymptomatic pregnant women were screened for anti-HEV antibodies (IgM and IgG) using an ELISA kit (DIA PRO, Italy). The overall seropositivity rate was found to be 12%, indicating prior exposure to HEV infection in this cohort. Specifically, IgG antibodies were detected in 6% of women and IgM antibodies in 5%, while two women showed evidence of both IgG and IgM positivity, suggestive of recent or ongoing infection. Notably, the majority of participants reported reliance on untreated water sources irrespective of educational background, highlighting environmental risk factors. Although HEV is generally self-limiting, these findings underscore the importance of routine serological screening in antenatal populations to prevent adverse pregnancy outcomes. In addition, increased community awareness regarding transmission routes and preventive measures is essential. Given the scarcity of regional data, this study emphasizes the need for larger-scale epidemiological investigations to better understand the burden of HEV in South Punjab, Pakistan.</description>
	<pubDate>2026-03-23</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 40, Pages 4: Detection of Anti-HEV IgM and IgG Antibodies Among Antenatal Women Attending a Tertiary Care Center</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/40/1/4">doi: 10.3390/msf2025040004</a></p>
	<p>Authors:
		Abdul Qadeer
		Mariya Azam
		Basit Abdul
		</p>
	<p>Hepatitis E virus (HEV) is recognized as one of the leading causes of acute viral hepatitis (AVH) in developing countries, where it is primarily transmitted through the consumption of contaminated food and water. Although often self-limiting, HEV infection poses a significant public health concern, particularly among pregnant women, due to its potential complications. The present study aimed to determine the seroprevalence of HEV infection in asymptomatic antenatal women attending a tertiary care center in South Punjab, Pakistan. A total of 100 asymptomatic pregnant women were screened for anti-HEV antibodies (IgM and IgG) using an ELISA kit (DIA PRO, Italy). The overall seropositivity rate was found to be 12%, indicating prior exposure to HEV infection in this cohort. Specifically, IgG antibodies were detected in 6% of women and IgM antibodies in 5%, while two women showed evidence of both IgG and IgM positivity, suggestive of recent or ongoing infection. Notably, the majority of participants reported reliance on untreated water sources irrespective of educational background, highlighting environmental risk factors. Although HEV is generally self-limiting, these findings underscore the importance of routine serological screening in antenatal populations to prevent adverse pregnancy outcomes. In addition, increased community awareness regarding transmission routes and preventive measures is essential. Given the scarcity of regional data, this study emphasizes the need for larger-scale epidemiological investigations to better understand the burden of HEV in South Punjab, Pakistan.</p>
	]]></content:encoded>

	<dc:title>Detection of Anti-HEV IgM and IgG Antibodies Among Antenatal Women Attending a Tertiary Care Center</dc:title>
			<dc:creator>Abdul Qadeer</dc:creator>
			<dc:creator>Mariya Azam</dc:creator>
			<dc:creator>Basit Abdul</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025040004</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-03-23</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-03-23</prism:publicationDate>
	<prism:volume>40</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>4</prism:startingPage>
		<prism:doi>10.3390/msf2025040004</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/40/1/4</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/44/1/2">

	<title>Medical Sciences Forum, Vol. 44, Pages 2: Toward Individualized High-Intensity Interval Training in Type 1 Diabetes: A Framework for Safe Implementation</title>
	<link>https://www.mdpi.com/2673-9992/44/1/2</link>
	<description>High-intensity interval training (HIIT) is presented as a safe, effective, and time-efficient strategy for individuals with type 1 diabetes, offering benefits for glycemic control, cardiovascular function, and physical fitness, with a lower risk of hypoglycemia than other exercise modalities. However, substantial variability exists among protocols, and there is no consensus on optimal dosage. This study reviewed 18 investigations to identify key parameters for safe and effective implementation. Results emphasize the importance of individualized programming, adherence to protocols, frequent glucose monitoring, and professional supervision. A preliminary framework is proposed to guide personalized HIIT programs for people with type 1 diabetes.</description>
	<pubDate>2026-03-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 44, Pages 2: Toward Individualized High-Intensity Interval Training in Type 1 Diabetes: A Framework for Safe Implementation</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/44/1/2">doi: 10.3390/msf2026044002</a></p>
	<p>Authors:
		María Soledad García
		Manuel Parajón Víscido
		Francisco Esteban Escobar
		Gonzalo Daniel Gerez
		Fernando Daniel Farfán
		Leonardo Ariel Cano
		</p>
	<p>High-intensity interval training (HIIT) is presented as a safe, effective, and time-efficient strategy for individuals with type 1 diabetes, offering benefits for glycemic control, cardiovascular function, and physical fitness, with a lower risk of hypoglycemia than other exercise modalities. However, substantial variability exists among protocols, and there is no consensus on optimal dosage. This study reviewed 18 investigations to identify key parameters for safe and effective implementation. Results emphasize the importance of individualized programming, adherence to protocols, frequent glucose monitoring, and professional supervision. A preliminary framework is proposed to guide personalized HIIT programs for people with type 1 diabetes.</p>
	]]></content:encoded>

	<dc:title>Toward Individualized High-Intensity Interval Training in Type 1 Diabetes: A Framework for Safe Implementation</dc:title>
			<dc:creator>María Soledad García</dc:creator>
			<dc:creator>Manuel Parajón Víscido</dc:creator>
			<dc:creator>Francisco Esteban Escobar</dc:creator>
			<dc:creator>Gonzalo Daniel Gerez</dc:creator>
			<dc:creator>Fernando Daniel Farfán</dc:creator>
			<dc:creator>Leonardo Ariel Cano</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026044002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-03-17</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-03-17</prism:publicationDate>
	<prism:volume>44</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2026044002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/44/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/43/1/4">

	<title>Medical Sciences Forum, Vol. 43, Pages 4: Multiple Sclerosis and Occupational Outcomes in the COVID-19 Era: A Scoping Review</title>
	<link>https://www.mdpi.com/2673-9992/43/1/4</link>
	<description>The coronavirus disease 2019 (COVID-19) pandemic has disrupted both health and occupational functioning in participants with multiple sclerosis (PwMS). This review synthesizes evidence from 55 studies (30,830 PwMS) on psychological, social, and work-related outcomes during the pandemic. The findings indicate elevated depression and stress, variable anxiety, and substantial employment disruption, including job loss, reduced hours, and shifts to remote work. Socioeconomic stressors compound these effects, while workplace accommodations are rarely assessed. There are gaps in evidence regarding occupation-specific hazards, lived experiences, and long-term outcomes. These results underscore the need for disability-inclusive employment policies, mental health support, and longitudinal research to guide interventions for PwMS in crisis contexts.</description>
	<pubDate>2026-03-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 43, Pages 4: Multiple Sclerosis and Occupational Outcomes in the COVID-19 Era: A Scoping Review</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/43/1/4">doi: 10.3390/msf2026043004</a></p>
	<p>Authors:
		Ioannis Adamopoulos
		Aida Vafae Eslahi
		Niki Syrou
		Maad M. Mijwil
		Panagiotis Tsirkas
		</p>
	<p>The coronavirus disease 2019 (COVID-19) pandemic has disrupted both health and occupational functioning in participants with multiple sclerosis (PwMS). This review synthesizes evidence from 55 studies (30,830 PwMS) on psychological, social, and work-related outcomes during the pandemic. The findings indicate elevated depression and stress, variable anxiety, and substantial employment disruption, including job loss, reduced hours, and shifts to remote work. Socioeconomic stressors compound these effects, while workplace accommodations are rarely assessed. There are gaps in evidence regarding occupation-specific hazards, lived experiences, and long-term outcomes. These results underscore the need for disability-inclusive employment policies, mental health support, and longitudinal research to guide interventions for PwMS in crisis contexts.</p>
	]]></content:encoded>

	<dc:title>Multiple Sclerosis and Occupational Outcomes in the COVID-19 Era: A Scoping Review</dc:title>
			<dc:creator>Ioannis Adamopoulos</dc:creator>
			<dc:creator>Aida Vafae Eslahi</dc:creator>
			<dc:creator>Niki Syrou</dc:creator>
			<dc:creator>Maad M. Mijwil</dc:creator>
			<dc:creator>Panagiotis Tsirkas</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026043004</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-03-04</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-03-04</prism:publicationDate>
	<prism:volume>43</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>4</prism:startingPage>
		<prism:doi>10.3390/msf2026043004</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/43/1/4</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/45/1/5">

	<title>Medical Sciences Forum, Vol. 45, Pages 5: Non-Invasive Management of Disc Displacement with Reduction and Myalgia in a Young Adult: A Case Report</title>
	<link>https://www.mdpi.com/2673-9992/45/1/5</link>
	<description>Introduction: Disc displacement with reduction (DDwR) and myalgia are among the most common temporomandibular disorders, frequently affecting young adults. While conservative therapy is considered the first-line approach, the evidence on long-term outcomes is still limited. Case Presentation: A 22-year-old female had a 7-month history of left-sided TMJ clicking, deviation to the left during opening, and 2 months of bilateral masticatory pain, which was worsened by mastication. During clinical examination, reproducible left TMJ clicking and tenderness of the masseter and temporal muscles were observed. Based on DC/TMD Axis 1, DDwR with myalgia diagnosis was made. Intervention and Results: A full maxillary stabilization splint was constructed and delivered together with patient education, dietary adjustments, and guided mandibular exercises. At baseline, pain intensity was VAS 6/10 with a maximum unassisted mouth opening of 41 mm and reproducible joint clicking. After 2 weeks, the patient reported a decrease in pain, VAS 2/10, mouth opening was 44 mm, and joint sounds were absent. After 1 year, the patient was asymptomatic (VAS 0/10) with stable function, preserved mouth opening, and completion of daily activities without limitations. Clinical Relevance and Conclusions: This case shows that multi-directional non-invasive therapy can result in complete and long-term remission of DDwR with myalgia. It emphasizes the need for careful diagnosis, through standardized instruments such as DC/TMD, and the need for personalized treatment to ensure durable clinical success.</description>
	<pubDate>2026-02-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 45, Pages 5: Non-Invasive Management of Disc Displacement with Reduction and Myalgia in a Young Adult: A Case Report</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/45/1/5">doi: 10.3390/msf2026045005</a></p>
	<p>Authors:
		Neada Hysenaj
		Vergjini Mulo
		</p>
	<p>Introduction: Disc displacement with reduction (DDwR) and myalgia are among the most common temporomandibular disorders, frequently affecting young adults. While conservative therapy is considered the first-line approach, the evidence on long-term outcomes is still limited. Case Presentation: A 22-year-old female had a 7-month history of left-sided TMJ clicking, deviation to the left during opening, and 2 months of bilateral masticatory pain, which was worsened by mastication. During clinical examination, reproducible left TMJ clicking and tenderness of the masseter and temporal muscles were observed. Based on DC/TMD Axis 1, DDwR with myalgia diagnosis was made. Intervention and Results: A full maxillary stabilization splint was constructed and delivered together with patient education, dietary adjustments, and guided mandibular exercises. At baseline, pain intensity was VAS 6/10 with a maximum unassisted mouth opening of 41 mm and reproducible joint clicking. After 2 weeks, the patient reported a decrease in pain, VAS 2/10, mouth opening was 44 mm, and joint sounds were absent. After 1 year, the patient was asymptomatic (VAS 0/10) with stable function, preserved mouth opening, and completion of daily activities without limitations. Clinical Relevance and Conclusions: This case shows that multi-directional non-invasive therapy can result in complete and long-term remission of DDwR with myalgia. It emphasizes the need for careful diagnosis, through standardized instruments such as DC/TMD, and the need for personalized treatment to ensure durable clinical success.</p>
	]]></content:encoded>

	<dc:title>Non-Invasive Management of Disc Displacement with Reduction and Myalgia in a Young Adult: A Case Report</dc:title>
			<dc:creator>Neada Hysenaj</dc:creator>
			<dc:creator>Vergjini Mulo</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026045005</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-02-27</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-02-27</prism:publicationDate>
	<prism:volume>45</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>5</prism:startingPage>
		<prism:doi>10.3390/msf2026045005</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/45/1/5</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/45/1/4">

	<title>Medical Sciences Forum, Vol. 45, Pages 4: Abstracts from the 1st International Online Conference on Prosthesis</title>
	<link>https://www.mdpi.com/2673-9992/45/1/4</link>
	<description>Maria Gabriela Packaeser de Souza 1, Amanda Maria de Oliveira Dal Piva 2, Cornelis Johanness Kleverlaan 2 and Jo&amp;amp;atilde;o Paulo Mendes Tribst 1 [...]</description>
	<pubDate>2026-02-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 45, Pages 4: Abstracts from the 1st International Online Conference on Prosthesis</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/45/1/4">doi: 10.3390/msf2026045004</a></p>
	<p>Authors:
		Marco Cicciu
		</p>
	<p>Maria Gabriela Packaeser de Souza 1, Amanda Maria de Oliveira Dal Piva 2, Cornelis Johanness Kleverlaan 2 and Jo&amp;amp;atilde;o Paulo Mendes Tribst 1 [...]</p>
	]]></content:encoded>

	<dc:title>Abstracts from the 1st International Online Conference on Prosthesis</dc:title>
			<dc:creator>Marco Cicciu</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026045004</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-02-26</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-02-26</prism:publicationDate>
	<prism:volume>45</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>4</prism:startingPage>
		<prism:doi>10.3390/msf2026045004</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/45/1/4</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/45/1/3">

	<title>Medical Sciences Forum, Vol. 45, Pages 3: Occlusal Splints Thickness in the Treatment of Temporomandibular Disorders: Review of Current Evidence</title>
	<link>https://www.mdpi.com/2673-9992/45/1/3</link>
	<description>Introduction. Occlusal splints are oral appliances that have been designed to relieve the temporomandibular symptoms. However, the thickness of occlusal splints in order to have optimal efficacy is still controversial. Methods. An electronic search in Medline, Scopus, and Web of Science databases was conducted, using the following keywords up to 2025: (&amp;amp;ldquo;occlusal splint&amp;amp;rdquo; OR &amp;amp;ldquo;stabilization splint&amp;amp;rdquo; OR &amp;amp;ldquo;bite splint&amp;amp;rdquo;) AND (&amp;amp;ldquo;vertical dimension&amp;amp;rdquo; OR &amp;amp;ldquo;thickness&amp;amp;rdquo; OR &amp;amp;ldquo;occlusal height&amp;amp;rdquo;) AND (&amp;amp;ldquo;temporomandibular disorder&amp;amp;rdquo; OR &amp;amp;ldquo;TMD&amp;amp;rdquo; OR &amp;amp;ldquo;disc displacement&amp;amp;rdquo; OR &amp;amp;ldquo;myofascial pain&amp;amp;rdquo;). All titles and abstracts were screened. Studies comparing different thicknesses of occlusal splints were included. Results. Eight studies met the inclusion criteria, of which five were randomized controlled trials, one a retrospective study, and two finite element analyses. Mixed quality of the studies was found. Based on current evidence, although limited, the following results could be deduced: Occlusal splints with moderate thickness, 3 mm, are recommended for cases that involve both muscular and joint components, particularly when masticatory muscle pain is the primary complaint. Occlusal splints with minimal thickness, 2 mm, may be appropriate in internal derangements in the early stage, though evidence is low. Thicker splints, &amp;amp;ge;4 mm, are for DDwoR and cases with crepitus. Occlusal splints of &amp;amp;le;2 mm and &amp;amp;gt;6 mm were associated with symptoms such as reduced functional outcomes or comfort. Conclusion. In most cases, occlusal splints with thicknesses of 3&amp;amp;ndash;5 mm seem to be optimal for most TMD cases; however, personalized treatment based on the respective diagnosis is recommended. The decision on splint thickness should be based on evidence according to the severity of the diagnosis, but also patient-centered, to achieve comfort, compliance of the patient, and oral structure preservation. Further high-quality RCTs are needed to gain evidence-based guidelines and to achieve consistent results.</description>
	<pubDate>2026-02-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 45, Pages 3: Occlusal Splints Thickness in the Treatment of Temporomandibular Disorders: Review of Current Evidence</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/45/1/3">doi: 10.3390/msf2026045003</a></p>
	<p>Authors:
		Neada Hysenaj
		Edlira Mulo
		Vergjini Mulo
		Edit Xhajanka
		</p>
	<p>Introduction. Occlusal splints are oral appliances that have been designed to relieve the temporomandibular symptoms. However, the thickness of occlusal splints in order to have optimal efficacy is still controversial. Methods. An electronic search in Medline, Scopus, and Web of Science databases was conducted, using the following keywords up to 2025: (&amp;amp;ldquo;occlusal splint&amp;amp;rdquo; OR &amp;amp;ldquo;stabilization splint&amp;amp;rdquo; OR &amp;amp;ldquo;bite splint&amp;amp;rdquo;) AND (&amp;amp;ldquo;vertical dimension&amp;amp;rdquo; OR &amp;amp;ldquo;thickness&amp;amp;rdquo; OR &amp;amp;ldquo;occlusal height&amp;amp;rdquo;) AND (&amp;amp;ldquo;temporomandibular disorder&amp;amp;rdquo; OR &amp;amp;ldquo;TMD&amp;amp;rdquo; OR &amp;amp;ldquo;disc displacement&amp;amp;rdquo; OR &amp;amp;ldquo;myofascial pain&amp;amp;rdquo;). All titles and abstracts were screened. Studies comparing different thicknesses of occlusal splints were included. Results. Eight studies met the inclusion criteria, of which five were randomized controlled trials, one a retrospective study, and two finite element analyses. Mixed quality of the studies was found. Based on current evidence, although limited, the following results could be deduced: Occlusal splints with moderate thickness, 3 mm, are recommended for cases that involve both muscular and joint components, particularly when masticatory muscle pain is the primary complaint. Occlusal splints with minimal thickness, 2 mm, may be appropriate in internal derangements in the early stage, though evidence is low. Thicker splints, &amp;amp;ge;4 mm, are for DDwoR and cases with crepitus. Occlusal splints of &amp;amp;le;2 mm and &amp;amp;gt;6 mm were associated with symptoms such as reduced functional outcomes or comfort. Conclusion. In most cases, occlusal splints with thicknesses of 3&amp;amp;ndash;5 mm seem to be optimal for most TMD cases; however, personalized treatment based on the respective diagnosis is recommended. The decision on splint thickness should be based on evidence according to the severity of the diagnosis, but also patient-centered, to achieve comfort, compliance of the patient, and oral structure preservation. Further high-quality RCTs are needed to gain evidence-based guidelines and to achieve consistent results.</p>
	]]></content:encoded>

	<dc:title>Occlusal Splints Thickness in the Treatment of Temporomandibular Disorders: Review of Current Evidence</dc:title>
			<dc:creator>Neada Hysenaj</dc:creator>
			<dc:creator>Edlira Mulo</dc:creator>
			<dc:creator>Vergjini Mulo</dc:creator>
			<dc:creator>Edit Xhajanka</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026045003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-02-24</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-02-24</prism:publicationDate>
	<prism:volume>45</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2026045003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/45/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/43/1/3">

	<title>Medical Sciences Forum, Vol. 43, Pages 3: The Effects of Therapeutic Cannabis and Cannabinoids in Parkinson&amp;rsquo;s Disease: An Overview of Meta-Analyses</title>
	<link>https://www.mdpi.com/2673-9992/43/1/3</link>
	<description>Background. Cannabis and cannabinoids have been investigated for their potential therapeutic effects in Parkinson&amp;amp;rsquo;s disease, but clinical research findings remain scant and inconsistent. This study provides a systematic overview of peer-reviewed meta-analyses assessing their impact on health outcomes in patients with Parkinson&amp;amp;rsquo;s disease. Methods. A comprehensive search of PubMed, EMBASE, Web of Science, and Google Scholar (from database inception to April 2025) identified meta-analyses evaluating cannabis-based interventions in Parkinson&amp;amp;rsquo;s disease. Eligible studies reported pooled estimates of effects on neurological symptoms. The most significant findings from the included studies were summarized and qualitatively analyzed. Results. After screening 975 research items, six meta-analyses of clinical and preclinical studies, primarily randomized controlled trials (RCTs), were included. One meta-analysis of five RCTs demonstrated that pure cannabidiol (CBD) or synthetic tetrahydrocannabinol (THC) significantly improved PD symptoms (SMD = &amp;amp;minus;0.41, p = 0.004). Another meta-analysis combining two RCTs and two non-RCTs reported a significant improvement in the Unified Parkinson&amp;amp;rsquo;s Disease Rating Scale (UPDRS) total score (MD = &amp;amp;minus;4.19, p = 0.03). With regard to pain management, cannabinoids were found effective in one study. Preclinical meta-analyses in animal models showed notable motor improvements, including enhanced rotarod performance (MD = 31.63 s, p = 0.003) and reduced pole test completion times (MD = &amp;amp;minus;1.51 s, p = 0.028). Conclusions. While meta-analyses of clinical studies suggest some benefits of specific cannabinoid formulations, findings are still uncertain. Preclinical data, however, demonstrate interesting motor improvements. Further well-designed RCTs are warranted to clarify the therapeutic role of cannabis in Parkinson&amp;amp;rsquo;s disease management.</description>
	<pubDate>2026-02-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 43, Pages 3: The Effects of Therapeutic Cannabis and Cannabinoids in Parkinson&amp;rsquo;s Disease: An Overview of Meta-Analyses</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/43/1/3">doi: 10.3390/msf2026043003</a></p>
	<p>Authors:
		Michele Antonelli
		Elena Mazzoleni
		Davide Donelli
		</p>
	<p>Background. Cannabis and cannabinoids have been investigated for their potential therapeutic effects in Parkinson&amp;amp;rsquo;s disease, but clinical research findings remain scant and inconsistent. This study provides a systematic overview of peer-reviewed meta-analyses assessing their impact on health outcomes in patients with Parkinson&amp;amp;rsquo;s disease. Methods. A comprehensive search of PubMed, EMBASE, Web of Science, and Google Scholar (from database inception to April 2025) identified meta-analyses evaluating cannabis-based interventions in Parkinson&amp;amp;rsquo;s disease. Eligible studies reported pooled estimates of effects on neurological symptoms. The most significant findings from the included studies were summarized and qualitatively analyzed. Results. After screening 975 research items, six meta-analyses of clinical and preclinical studies, primarily randomized controlled trials (RCTs), were included. One meta-analysis of five RCTs demonstrated that pure cannabidiol (CBD) or synthetic tetrahydrocannabinol (THC) significantly improved PD symptoms (SMD = &amp;amp;minus;0.41, p = 0.004). Another meta-analysis combining two RCTs and two non-RCTs reported a significant improvement in the Unified Parkinson&amp;amp;rsquo;s Disease Rating Scale (UPDRS) total score (MD = &amp;amp;minus;4.19, p = 0.03). With regard to pain management, cannabinoids were found effective in one study. Preclinical meta-analyses in animal models showed notable motor improvements, including enhanced rotarod performance (MD = 31.63 s, p = 0.003) and reduced pole test completion times (MD = &amp;amp;minus;1.51 s, p = 0.028). Conclusions. While meta-analyses of clinical studies suggest some benefits of specific cannabinoid formulations, findings are still uncertain. Preclinical data, however, demonstrate interesting motor improvements. Further well-designed RCTs are warranted to clarify the therapeutic role of cannabis in Parkinson&amp;amp;rsquo;s disease management.</p>
	]]></content:encoded>

	<dc:title>The Effects of Therapeutic Cannabis and Cannabinoids in Parkinson&amp;amp;rsquo;s Disease: An Overview of Meta-Analyses</dc:title>
			<dc:creator>Michele Antonelli</dc:creator>
			<dc:creator>Elena Mazzoleni</dc:creator>
			<dc:creator>Davide Donelli</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026043003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-02-20</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-02-20</prism:publicationDate>
	<prism:volume>43</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2026043003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/43/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/45/1/2">

	<title>Medical Sciences Forum, Vol. 45, Pages 2: Psychosomatic Bruxism and Dental Implant Complications</title>
	<link>https://www.mdpi.com/2673-9992/45/1/2</link>
	<description>Bruxism is increasingly recognized as a psychosomatic behavior influenced by stress, anxiety, and sleep disturbances, which generates occlusal forces of non-physiological magnitude, potentially compromising the stability of dental implants. This narrative review examines the causal pathway linking psychological factors, bruxism, and implant complications. The literature from PubMed, Scopus, and Cochrane (2000&amp;amp;ndash;2025) was analyzed. Evidence consistently associates psychosocial stressors with increased mechanical complications, while biological outcomes remain heterogeneous. Digital occlusal analysis, finite element modeling, and AI-based monitoring show promise for early overload detection. An interdisciplinary model integrating dentistry, psychology, and sleep medicine is proposed to optimize implant outcomes and guide future research.</description>
	<pubDate>2026-02-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 45, Pages 2: Psychosomatic Bruxism and Dental Implant Complications</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/45/1/2">doi: 10.3390/msf2026045002</a></p>
	<p>Authors:
		Barbarita Sánchez-Peña
		Carlos Domínguez-Vargas
		Paloma Marylí Prado-López
		Daniela Alejandra Torres-Rodríguez
		</p>
	<p>Bruxism is increasingly recognized as a psychosomatic behavior influenced by stress, anxiety, and sleep disturbances, which generates occlusal forces of non-physiological magnitude, potentially compromising the stability of dental implants. This narrative review examines the causal pathway linking psychological factors, bruxism, and implant complications. The literature from PubMed, Scopus, and Cochrane (2000&amp;amp;ndash;2025) was analyzed. Evidence consistently associates psychosocial stressors with increased mechanical complications, while biological outcomes remain heterogeneous. Digital occlusal analysis, finite element modeling, and AI-based monitoring show promise for early overload detection. An interdisciplinary model integrating dentistry, psychology, and sleep medicine is proposed to optimize implant outcomes and guide future research.</p>
	]]></content:encoded>

	<dc:title>Psychosomatic Bruxism and Dental Implant Complications</dc:title>
			<dc:creator>Barbarita Sánchez-Peña</dc:creator>
			<dc:creator>Carlos Domínguez-Vargas</dc:creator>
			<dc:creator>Paloma Marylí Prado-López</dc:creator>
			<dc:creator>Daniela Alejandra Torres-Rodríguez</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026045002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-02-17</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-02-17</prism:publicationDate>
	<prism:volume>45</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2026045002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/45/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/43/1/2">

	<title>Medical Sciences Forum, Vol. 43, Pages 2: The Impact of Neuropsychiatric Symptoms in Early-Stage Alzheimer&amp;rsquo;s Disease and Mild Cognitive Impairment</title>
	<link>https://www.mdpi.com/2673-9992/43/1/2</link>
	<description>Background: Alzheimer&amp;amp;rsquo;s disease (AD) and mild cognitive impairment (MCI) are traditionally defined by progressive cognitive decline, yet neuropsychiatric symptoms (NPS), including depression, apathy, anxiety, irritability, and sleep disturbances, commonly emerge in the earliest stages. These symptoms often precede measurable memory loss and complicate diagnosis, accelerate disease progression, and substantially increase caregiver burden. Differentiating NPS related to neurodegeneration from primary psychiatric disorders remains a major clinical challenge. Methods: A structured narrative review of peer-reviewed studies (2012&amp;amp;ndash;2025) was conducted across PubMed, MEDLINE, Scopus, PsycINFO, CINAHL, and Google Scholar. Evidence was synthesized across epidemiological, clinical, neurobiological, and psychosocial domains to examine NPS prevalence, diagnostic complexity, and treatment approaches in early AD/MCI. Findings Up to 80% of individuals with early AD or MCI exhibit at least one NPS, often before cognitive decline is clinically evident. Non-pharmacologic strategies-caregiver education, behavioral activation, structured routines-remain first-line treatments, while pharmacologic options show modest benefit and safety concerns. Advances in biomarkers, digital health tools, and neurobiological research highlight NPS as potential early indicators of disease onset. Conclusions: Failure to recognize NPS in early AD/MCI contributes to delayed diagnosis, suboptimal care, caregiver stress, and missed opportunities for early intervention. Integrating systematic NPS assessment into diagnostic and care pathways is essential to improving outcomes and advancing therapeutic innovation.</description>
	<pubDate>2026-02-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 43, Pages 2: The Impact of Neuropsychiatric Symptoms in Early-Stage Alzheimer&amp;rsquo;s Disease and Mild Cognitive Impairment</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/43/1/2">doi: 10.3390/msf2026043002</a></p>
	<p>Authors:
		Donna de Levante Raphael
		</p>
	<p>Background: Alzheimer&amp;amp;rsquo;s disease (AD) and mild cognitive impairment (MCI) are traditionally defined by progressive cognitive decline, yet neuropsychiatric symptoms (NPS), including depression, apathy, anxiety, irritability, and sleep disturbances, commonly emerge in the earliest stages. These symptoms often precede measurable memory loss and complicate diagnosis, accelerate disease progression, and substantially increase caregiver burden. Differentiating NPS related to neurodegeneration from primary psychiatric disorders remains a major clinical challenge. Methods: A structured narrative review of peer-reviewed studies (2012&amp;amp;ndash;2025) was conducted across PubMed, MEDLINE, Scopus, PsycINFO, CINAHL, and Google Scholar. Evidence was synthesized across epidemiological, clinical, neurobiological, and psychosocial domains to examine NPS prevalence, diagnostic complexity, and treatment approaches in early AD/MCI. Findings Up to 80% of individuals with early AD or MCI exhibit at least one NPS, often before cognitive decline is clinically evident. Non-pharmacologic strategies-caregiver education, behavioral activation, structured routines-remain first-line treatments, while pharmacologic options show modest benefit and safety concerns. Advances in biomarkers, digital health tools, and neurobiological research highlight NPS as potential early indicators of disease onset. Conclusions: Failure to recognize NPS in early AD/MCI contributes to delayed diagnosis, suboptimal care, caregiver stress, and missed opportunities for early intervention. Integrating systematic NPS assessment into diagnostic and care pathways is essential to improving outcomes and advancing therapeutic innovation.</p>
	]]></content:encoded>

	<dc:title>The Impact of Neuropsychiatric Symptoms in Early-Stage Alzheimer&amp;amp;rsquo;s Disease and Mild Cognitive Impairment</dc:title>
			<dc:creator>Donna de Levante Raphael</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026043002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-02-12</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-02-12</prism:publicationDate>
	<prism:volume>43</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2026043002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/43/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/45/1/1">

	<title>Medical Sciences Forum, Vol. 45, Pages 1: Prosthetic Management in Patients with Sj&amp;ouml;gren&amp;rsquo;s Syndrome: Challenges, Biomaterials and Pharmacological Considerations</title>
	<link>https://www.mdpi.com/2673-9992/45/1/1</link>
	<description>Sj&amp;amp;ouml;gren&amp;amp;rsquo;s syndrome (SS) is a chronic autoimmune disease characterized by severe hyposalivation and mucosal fragility, conditions that significantly complicate prosthetic rehabilitation. Reduced salivary flow compromises denture retention, increases mucosal trauma, and predisposes patients to infections such as oral candidiasis, limiting the success of conventional tissue-supported prostheses. This work summarizes current evidence on prosthetic management strategies in SS, highlighting the role of optimized biomaterials, digital manufacturing technologies, and implant-supported solutions. Emphasis is placed on multidisciplinary care, adjunctive pharmacological management of xerostomia, and long-term maintenance protocols to improve function, comfort, and quality of life in this complex patient population.</description>
	<pubDate>2026-02-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 45, Pages 1: Prosthetic Management in Patients with Sj&amp;ouml;gren&amp;rsquo;s Syndrome: Challenges, Biomaterials and Pharmacological Considerations</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/45/1/1">doi: 10.3390/msf2026045001</a></p>
	<p>Authors:
		Carlos Domínguez-Vargas
		Barbarita Sánchez-Peña
		Emiliano Peña-Durán
		Samantha Jonnue Ramírez-Flores
		</p>
	<p>Sj&amp;amp;ouml;gren&amp;amp;rsquo;s syndrome (SS) is a chronic autoimmune disease characterized by severe hyposalivation and mucosal fragility, conditions that significantly complicate prosthetic rehabilitation. Reduced salivary flow compromises denture retention, increases mucosal trauma, and predisposes patients to infections such as oral candidiasis, limiting the success of conventional tissue-supported prostheses. This work summarizes current evidence on prosthetic management strategies in SS, highlighting the role of optimized biomaterials, digital manufacturing technologies, and implant-supported solutions. Emphasis is placed on multidisciplinary care, adjunctive pharmacological management of xerostomia, and long-term maintenance protocols to improve function, comfort, and quality of life in this complex patient population.</p>
	]]></content:encoded>

	<dc:title>Prosthetic Management in Patients with Sj&amp;amp;ouml;gren&amp;amp;rsquo;s Syndrome: Challenges, Biomaterials and Pharmacological Considerations</dc:title>
			<dc:creator>Carlos Domínguez-Vargas</dc:creator>
			<dc:creator>Barbarita Sánchez-Peña</dc:creator>
			<dc:creator>Emiliano Peña-Durán</dc:creator>
			<dc:creator>Samantha Jonnue Ramírez-Flores</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026045001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-02-11</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-02-11</prism:publicationDate>
	<prism:volume>45</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2026045001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/45/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/44/1/1">

	<title>Medical Sciences Forum, Vol. 44, Pages 1: Abstracts of the 3rd International Online Conference on Clinical Medicine</title>
	<link>https://www.mdpi.com/2673-9992/44/1/1</link>
	<description>Kishore Muthukumar [...]</description>
	<pubDate>2026-01-29</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 44, Pages 1: Abstracts of the 3rd International Online Conference on Clinical Medicine</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/44/1/1">doi: 10.3390/msf2026044001</a></p>
	<p>Authors:
		Emmanuel Andrès
		Kent Doi
		Francisco Guillén Grima
		</p>
	<p>Kishore Muthukumar [...]</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 3rd International Online Conference on Clinical Medicine</dc:title>
			<dc:creator>Emmanuel Andrès</dc:creator>
			<dc:creator>Kent Doi</dc:creator>
			<dc:creator>Francisco Guillén Grima</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026044001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-01-29</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-01-29</prism:publicationDate>
	<prism:volume>44</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2026044001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/44/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/41/1/2">

	<title>Medical Sciences Forum, Vol. 41, Pages 2: Bioinformatics Screening of Phenylpropanoids from Pyrostegia venusta in ER+ Breast Cancer</title>
	<link>https://www.mdpi.com/2673-9992/41/1/2</link>
	<description>This study investigated the cytotoxic, antiproliferative, and molecular interaction profiles of the phenylpropanoids verbascoside and isoverbascoside from Pyrostegia venusta using in silico approaches. Computational predictions suggested differential cytotoxicity trends between tumor and non-tumor breast cell models compared with tamoxifen. QSAR analyses indicated antiproliferative potential, while docking studies revealed stable ligand&amp;amp;ndash;protein interactions with estrogen-related targets and PTEN. ADMET predictions suggested favorable metabolic characteristics, including limited CYP3A4 interaction. Overall, these results provide predictive insights that support further experimental investigation of these phenylpropanoids in ER+ breast cancer models.</description>
	<pubDate>2026-01-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 41, Pages 2: Bioinformatics Screening of Phenylpropanoids from Pyrostegia venusta in ER+ Breast Cancer</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/41/1/2">doi: 10.3390/msf2026041002</a></p>
	<p>Authors:
		Ana Carolina Maldonado da Costa e Silva
		Samara Maria Piccirillo de Brito
		Jhuan Luiz Silva
		Alex Luiz Pereira
		Giulia Maria Camara Leme
		Luiz Henrique Cruz
		Isabela Cristina Gomes Honório
		Juliana da Silva Coppede
		Silvio de Almeida-Junior
		</p>
	<p>This study investigated the cytotoxic, antiproliferative, and molecular interaction profiles of the phenylpropanoids verbascoside and isoverbascoside from Pyrostegia venusta using in silico approaches. Computational predictions suggested differential cytotoxicity trends between tumor and non-tumor breast cell models compared with tamoxifen. QSAR analyses indicated antiproliferative potential, while docking studies revealed stable ligand&amp;amp;ndash;protein interactions with estrogen-related targets and PTEN. ADMET predictions suggested favorable metabolic characteristics, including limited CYP3A4 interaction. Overall, these results provide predictive insights that support further experimental investigation of these phenylpropanoids in ER+ breast cancer models.</p>
	]]></content:encoded>

	<dc:title>Bioinformatics Screening of Phenylpropanoids from Pyrostegia venusta in ER+ Breast Cancer</dc:title>
			<dc:creator>Ana Carolina Maldonado da Costa e Silva</dc:creator>
			<dc:creator>Samara Maria Piccirillo de Brito</dc:creator>
			<dc:creator>Jhuan Luiz Silva</dc:creator>
			<dc:creator>Alex Luiz Pereira</dc:creator>
			<dc:creator>Giulia Maria Camara Leme</dc:creator>
			<dc:creator>Luiz Henrique Cruz</dc:creator>
			<dc:creator>Isabela Cristina Gomes Honório</dc:creator>
			<dc:creator>Juliana da Silva Coppede</dc:creator>
			<dc:creator>Silvio de Almeida-Junior</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026041002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-01-26</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-01-26</prism:publicationDate>
	<prism:volume>41</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2026041002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/41/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/43/1/1">

	<title>Medical Sciences Forum, Vol. 43, Pages 1: From Sweeteners to Sleeplessness: The Hidden Effects of Sucralose and Saccharin on the Gut&amp;ndash;Brain Axis</title>
	<link>https://www.mdpi.com/2673-9992/43/1/1</link>
	<description>Sweetener consumption has increased considerably in recent decades, driven by the growing demand from consumers of low-calorie products for weight control and, especially, from diabetic patients who require safe sweetener alternatives without affecting their glucose levels. However, the latest scientific evidence seems to indicate that the continued consumption of various sweeteners could significantly alter the gut microbiota, triggering consequences that go beyond metabolic health and could affect sleep quality. Among the most used non-caloric sweeteners in the food industry are sucralose and saccharin. Several studies have shown that prolonged consumption of these sweeteners can significantly alter the composition of the gut microbiota. In particular, its consumption might lead to a decrease in beneficial bacteria such as Lactobacillus and Bifidobacterium, along with an increase in potentially pathogenic microorganisms such as Clostridium difficile and Escherichia coli. This dysbiosis creates a chronic low-grade inflammatory environment and contributes to the deterioration of glucose metabolism, factors that negatively impact the regulation of the gut&amp;amp;ndash;brain axis. Consequently, these alterations could interfere with the neuroendocrine mechanisms involved in sleep, promoting the development of disorders such as insomnia, sleep fragmentation, and decreased subjective sleep quality. The aim of this narrative review is to synthesize the current scientific evidence on the impact of artificial sweeteners on the gut microbiota and their potential involvement in sleep disorders. The underlying biological mechanisms will be analyzed and the clinical relevance of these interactions discussed, laying the groundwork for future research that will contribute to the development of dietary recommendations and therapeutic strategies aimed at modulating the microbiota to improve sleep health.</description>
	<pubDate>2026-01-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 43, Pages 1: From Sweeteners to Sleeplessness: The Hidden Effects of Sucralose and Saccharin on the Gut&amp;ndash;Brain Axis</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/43/1/1">doi: 10.3390/msf2026043001</a></p>
	<p>Authors:
		Anxo Carreira-Casais
		Antia G. Pereira
		</p>
	<p>Sweetener consumption has increased considerably in recent decades, driven by the growing demand from consumers of low-calorie products for weight control and, especially, from diabetic patients who require safe sweetener alternatives without affecting their glucose levels. However, the latest scientific evidence seems to indicate that the continued consumption of various sweeteners could significantly alter the gut microbiota, triggering consequences that go beyond metabolic health and could affect sleep quality. Among the most used non-caloric sweeteners in the food industry are sucralose and saccharin. Several studies have shown that prolonged consumption of these sweeteners can significantly alter the composition of the gut microbiota. In particular, its consumption might lead to a decrease in beneficial bacteria such as Lactobacillus and Bifidobacterium, along with an increase in potentially pathogenic microorganisms such as Clostridium difficile and Escherichia coli. This dysbiosis creates a chronic low-grade inflammatory environment and contributes to the deterioration of glucose metabolism, factors that negatively impact the regulation of the gut&amp;amp;ndash;brain axis. Consequently, these alterations could interfere with the neuroendocrine mechanisms involved in sleep, promoting the development of disorders such as insomnia, sleep fragmentation, and decreased subjective sleep quality. The aim of this narrative review is to synthesize the current scientific evidence on the impact of artificial sweeteners on the gut microbiota and their potential involvement in sleep disorders. The underlying biological mechanisms will be analyzed and the clinical relevance of these interactions discussed, laying the groundwork for future research that will contribute to the development of dietary recommendations and therapeutic strategies aimed at modulating the microbiota to improve sleep health.</p>
	]]></content:encoded>

	<dc:title>From Sweeteners to Sleeplessness: The Hidden Effects of Sucralose and Saccharin on the Gut&amp;amp;ndash;Brain Axis</dc:title>
			<dc:creator>Anxo Carreira-Casais</dc:creator>
			<dc:creator>Antia G. Pereira</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026043001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-01-20</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-01-20</prism:publicationDate>
	<prism:volume>43</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2026043001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/43/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/42/1/1">

	<title>Medical Sciences Forum, Vol. 42, Pages 1: Abstracts of the 3rd International Online Conference on Vaccines, 26&amp;ndash;28 November 2025</title>
	<link>https://www.mdpi.com/2673-9992/42/1/1</link>
	<description>Min Xuan Keh 1, Nur Ain Mohd Asri 2, Rapeah Suppian 1, Mohd Nor Norazmi 2,3 and Frank Camacho 4,5 [...]</description>
	<pubDate>2026-01-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 42, Pages 1: Abstracts of the 3rd International Online Conference on Vaccines, 26&amp;ndash;28 November 2025</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/42/1/1">doi: 10.3390/msf2026042001</a></p>
	<p>Authors:
		Sara Louise Cosby
		</p>
	<p>Min Xuan Keh 1, Nur Ain Mohd Asri 2, Rapeah Suppian 1, Mohd Nor Norazmi 2,3 and Frank Camacho 4,5 [...]</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 3rd International Online Conference on Vaccines, 26&amp;amp;ndash;28 November 2025</dc:title>
			<dc:creator>Sara Louise Cosby</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026042001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2026-01-09</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2026-01-09</prism:publicationDate>
	<prism:volume>42</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2026042001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/42/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/41/1/1">

	<title>Medical Sciences Forum, Vol. 41, Pages 1: Abstracts of the 1st International Online Conference on Personalized Medicine</title>
	<link>https://www.mdpi.com/2673-9992/41/1/1</link>
	<description>The 1st International Online Conference on Personalized Medicine (IOCPM 2025), organized by Journal of Personalized Medicine MDPI and chaired by Prof. Dr. Kenneth P. H. Pritzker, University of Toronto, was hosted online from 29 to 31 October 2025. While personalizing care to the individual has always been integral to clinical medicine, the possibilities for a truly personalized approach have long been limited; however, interest in Personalized Medicine has exploded in the last decade. IOCPM 2025 aimed to provide a platform to explore more individualized diagnosis, therapy, and continuing care.</description>
	<pubDate>2025-12-31</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 41, Pages 1: Abstracts of the 1st International Online Conference on Personalized Medicine</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/41/1/1">doi: 10.3390/msf2026041001</a></p>
	<p>Authors:
		Kenneth P. H. Pritzker
		</p>
	<p>The 1st International Online Conference on Personalized Medicine (IOCPM 2025), organized by Journal of Personalized Medicine MDPI and chaired by Prof. Dr. Kenneth P. H. Pritzker, University of Toronto, was hosted online from 29 to 31 October 2025. While personalizing care to the individual has always been integral to clinical medicine, the possibilities for a truly personalized approach have long been limited; however, interest in Personalized Medicine has exploded in the last decade. IOCPM 2025 aimed to provide a platform to explore more individualized diagnosis, therapy, and continuing care.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 1st International Online Conference on Personalized Medicine</dc:title>
			<dc:creator>Kenneth P. H. Pritzker</dc:creator>
		<dc:identifier>doi: 10.3390/msf2026041001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-12-31</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-12-31</prism:publicationDate>
	<prism:volume>41</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2026041001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/41/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/33/1/7">

	<title>Medical Sciences Forum, Vol. 33, Pages 7: Preface and Abstracts of the 3nd International One Health Conference 2024</title>
	<link>https://www.mdpi.com/2673-9992/33/1/7</link>
	<description>The International One Health Conference 2024 took place against the backdrop of the Mediterranean, a region emblematic of humanity&amp;amp;rsquo;s most pressing interconnected challenges, including climate change, environmental degradation, and persistent maternal and child health disparities [...]</description>
	<pubDate>2025-12-23</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 33, Pages 7: Preface and Abstracts of the 3nd International One Health Conference 2024</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/33/1/7">doi: 10.3390/msf2025033007</a></p>
	<p>Authors:
		Domenico Vito
		Margherita Ferrante
		Gea Oliveri Conti
		Gabriela Fernandez
		Carol Maione
		Paolo Lauriola
		Prisco Piscitelli
		Melissa Jiménez Gómez Tagle
		Carlos Dora
		Jordi Serrano Pons
		Carole Conforti
		Joima Panisello
		Paula Sol Ventura
		Ilaria Bernotti
		Carmen Ruiz Martin
		Edgar Buloz-Osorio
		Marcella Trombetta
		Giuseppe Banfi
		Valentina Tageo
		</p>
	<p>The International One Health Conference 2024 took place against the backdrop of the Mediterranean, a region emblematic of humanity&amp;amp;rsquo;s most pressing interconnected challenges, including climate change, environmental degradation, and persistent maternal and child health disparities [...]</p>
	]]></content:encoded>

	<dc:title>Preface and Abstracts of the 3nd International One Health Conference 2024</dc:title>
			<dc:creator>Domenico Vito</dc:creator>
			<dc:creator>Margherita Ferrante</dc:creator>
			<dc:creator>Gea Oliveri Conti</dc:creator>
			<dc:creator>Gabriela Fernandez</dc:creator>
			<dc:creator>Carol Maione</dc:creator>
			<dc:creator>Paolo Lauriola</dc:creator>
			<dc:creator>Prisco Piscitelli</dc:creator>
			<dc:creator>Melissa Jiménez Gómez Tagle</dc:creator>
			<dc:creator>Carlos Dora</dc:creator>
			<dc:creator>Jordi Serrano Pons</dc:creator>
			<dc:creator>Carole Conforti</dc:creator>
			<dc:creator>Joima Panisello</dc:creator>
			<dc:creator>Paula Sol Ventura</dc:creator>
			<dc:creator>Ilaria Bernotti</dc:creator>
			<dc:creator>Carmen Ruiz Martin</dc:creator>
			<dc:creator>Edgar Buloz-Osorio</dc:creator>
			<dc:creator>Marcella Trombetta</dc:creator>
			<dc:creator>Giuseppe Banfi</dc:creator>
			<dc:creator>Valentina Tageo</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025033007</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-12-23</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-12-23</prism:publicationDate>
	<prism:volume>33</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>7</prism:startingPage>
		<prism:doi>10.3390/msf2025033007</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/33/1/7</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/38/1/3">

	<title>Medical Sciences Forum, Vol. 38, Pages 3: Exploring Key Success Factors in Home-Based Occupational Therapy for People with Dementia: A Qualitative Study from Italy</title>
	<link>https://www.mdpi.com/2673-9992/38/1/3</link>
	<description>This qualitative study explored the experiences of caregivers of people with dementia who received home-based occupational therapy from the Modena Memory Clinic. Five participants were interviewed through semi-structured conversations analyzed using thematic analysis. Results identified three main mechanisms underlying the effectiveness of the intervention: education, empowerment, and collaboration. Therapist-tailored interventions helped caregivers recognize remaining abilities, improve problem-solving, and enhance daily care strategies. The home environment supported comfort and engagement, while collaboration with professionals strengthened continuity of care. These findings highlight occupational therapy as a key component of community-based and person-centered dementia care.</description>
	<pubDate>2025-12-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 38, Pages 3: Exploring Key Success Factors in Home-Based Occupational Therapy for People with Dementia: A Qualitative Study from Italy</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/38/1/3">doi: 10.3390/msf2025038003</a></p>
	<p>Authors:
		Alessandro Lanzoni
		Angelica Sangiorgi
		Andrea Fabbo
		</p>
	<p>This qualitative study explored the experiences of caregivers of people with dementia who received home-based occupational therapy from the Modena Memory Clinic. Five participants were interviewed through semi-structured conversations analyzed using thematic analysis. Results identified three main mechanisms underlying the effectiveness of the intervention: education, empowerment, and collaboration. Therapist-tailored interventions helped caregivers recognize remaining abilities, improve problem-solving, and enhance daily care strategies. The home environment supported comfort and engagement, while collaboration with professionals strengthened continuity of care. These findings highlight occupational therapy as a key component of community-based and person-centered dementia care.</p>
	]]></content:encoded>

	<dc:title>Exploring Key Success Factors in Home-Based Occupational Therapy for People with Dementia: A Qualitative Study from Italy</dc:title>
			<dc:creator>Alessandro Lanzoni</dc:creator>
			<dc:creator>Angelica Sangiorgi</dc:creator>
			<dc:creator>Andrea Fabbo</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025038003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-12-22</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-12-22</prism:publicationDate>
	<prism:volume>38</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2025038003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/38/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/33/1/6">

	<title>Medical Sciences Forum, Vol. 33, Pages 6: The CHIARA Project: Addressing Women&amp;rsquo;s Mental Health and Safety in US&amp;ndash;Mexico Border States</title>
	<link>https://www.mdpi.com/2673-9992/33/1/6</link>
	<description>The CHIARA Project investigates women&amp;amp;rsquo;s mental health and vulnerability to sex trafficking in the U.S.&amp;amp;ndash;Mexico border states (California, Arizona, Texas, and New Mexico). A mixed-methods design was employed, combining qualitative content analysis of media, legal, and policy documents with quantitative analyses of secondary datasets from health institutions, the National Human Trafficking Hotline, the Polaris Project, and the U.S. Census Bureau. Data were cleaned, integrated, and examined through descriptive statistics, regression models, and correlation matrices using R Studio, complemented by visualizations to identify patterns and hotspots. Results show a strong association between higher crime rates, reported trafficking cases, and the prevalence of mental health disorders such as PTSD, depression, and anxiety among women. California and Texas consistently reported higher trafficking cases and mental health burdens, while regression analyses highlighted poverty, limited education, and gender inequality as significant predictors of vulnerability. These findings underscore the interplay between socioeconomic conditions and gender-specific exploitation at the border. By linking mental health and trafficking indicators, the study provides actionable insights for community leaders, policymakers, and healthcare providers, emphasizing the need for trauma-informed care, targeted prevention strategies, and policies that address both structural inequities and survivor rehabilitation.</description>
	<pubDate>2025-12-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 33, Pages 6: The CHIARA Project: Addressing Women&amp;rsquo;s Mental Health and Safety in US&amp;ndash;Mexico Border States</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/33/1/6">doi: 10.3390/msf2025033006</a></p>
	<p>Authors:
		Stephanie Meza
		Gabriela Fernandez
		Domenico Vito
		</p>
	<p>The CHIARA Project investigates women&amp;amp;rsquo;s mental health and vulnerability to sex trafficking in the U.S.&amp;amp;ndash;Mexico border states (California, Arizona, Texas, and New Mexico). A mixed-methods design was employed, combining qualitative content analysis of media, legal, and policy documents with quantitative analyses of secondary datasets from health institutions, the National Human Trafficking Hotline, the Polaris Project, and the U.S. Census Bureau. Data were cleaned, integrated, and examined through descriptive statistics, regression models, and correlation matrices using R Studio, complemented by visualizations to identify patterns and hotspots. Results show a strong association between higher crime rates, reported trafficking cases, and the prevalence of mental health disorders such as PTSD, depression, and anxiety among women. California and Texas consistently reported higher trafficking cases and mental health burdens, while regression analyses highlighted poverty, limited education, and gender inequality as significant predictors of vulnerability. These findings underscore the interplay between socioeconomic conditions and gender-specific exploitation at the border. By linking mental health and trafficking indicators, the study provides actionable insights for community leaders, policymakers, and healthcare providers, emphasizing the need for trauma-informed care, targeted prevention strategies, and policies that address both structural inequities and survivor rehabilitation.</p>
	]]></content:encoded>

	<dc:title>The CHIARA Project: Addressing Women&amp;amp;rsquo;s Mental Health and Safety in US&amp;amp;ndash;Mexico Border States</dc:title>
			<dc:creator>Stephanie Meza</dc:creator>
			<dc:creator>Gabriela Fernandez</dc:creator>
			<dc:creator>Domenico Vito</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025033006</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-12-22</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-12-22</prism:publicationDate>
	<prism:volume>33</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>6</prism:startingPage>
		<prism:doi>10.3390/msf2025033006</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/33/1/6</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/40/1/3">

	<title>Medical Sciences Forum, Vol. 40, Pages 3: Abstracts of the 1st International Online Conference by Antibodies</title>
	<link>https://www.mdpi.com/2673-9992/40/1/3</link>
	<description>Mattias Collin 1, Berit Olofsson 1, Andreas Naegeli 2 and Pontus Nordenfelt 1 [...]</description>
	<pubDate>2025-12-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 40, Pages 3: Abstracts of the 1st International Online Conference by Antibodies</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/40/1/3">doi: 10.3390/msf2025040003</a></p>
	<p>Authors:
		Arne Skerra
		</p>
	<p>Mattias Collin 1, Berit Olofsson 1, Andreas Naegeli 2 and Pontus Nordenfelt 1 [...]</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 1st International Online Conference by Antibodies</dc:title>
			<dc:creator>Arne Skerra</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025040003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-12-12</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-12-12</prism:publicationDate>
	<prism:volume>40</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2025040003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/40/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/38/1/2">

	<title>Medical Sciences Forum, Vol. 38, Pages 2: Mediterranean-Style Japanese Diet for Anti-Ageing: Systematic Review</title>
	<link>https://www.mdpi.com/2673-9992/38/1/2</link>
	<description>This research compares the Mediterranean and Japanese diets and considers diet as associated with anti-ageing as well as leading a long and healthy life. Since Mediterranean countries, including Italy and Greece, have one-third the mortality ratio with respect to cardiovascular diseases compared to America and northern Europe, the Mediterranean diet is regarded as healthy. Here, the research shows the reasons why Mediterranean and Japanese diets have these properties. Both the Mediterranean and Japanese diets are typically low in fat, sugar, and calories, and are characterised by a high intake of vegetables, legumes, fish, and cereals. Differences include a greater consumption of polyphenol-rich extra virgin olive oil, dairy products, and a lower amount of meat consumption in the Mediterranean diet, as well as less use of fat; there is an abundant consumption of fermented foods and seaweed in the Japanese diet. Japan&amp;amp;rsquo;s globally leading long life expectancy is partly attributed to the cultural concept of &amp;amp;ldquo;ME-BYO,&amp;amp;rdquo; which emphasises recognising and managing non-disease conditions before they develop into clinical illness. This tendency may be one of the reasons for the long lifespan of Japanese people.</description>
	<pubDate>2025-12-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 38, Pages 2: Mediterranean-Style Japanese Diet for Anti-Ageing: Systematic Review</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/38/1/2">doi: 10.3390/msf2025038002</a></p>
	<p>Authors:
		Kazuki Santa
		</p>
	<p>This research compares the Mediterranean and Japanese diets and considers diet as associated with anti-ageing as well as leading a long and healthy life. Since Mediterranean countries, including Italy and Greece, have one-third the mortality ratio with respect to cardiovascular diseases compared to America and northern Europe, the Mediterranean diet is regarded as healthy. Here, the research shows the reasons why Mediterranean and Japanese diets have these properties. Both the Mediterranean and Japanese diets are typically low in fat, sugar, and calories, and are characterised by a high intake of vegetables, legumes, fish, and cereals. Differences include a greater consumption of polyphenol-rich extra virgin olive oil, dairy products, and a lower amount of meat consumption in the Mediterranean diet, as well as less use of fat; there is an abundant consumption of fermented foods and seaweed in the Japanese diet. Japan&amp;amp;rsquo;s globally leading long life expectancy is partly attributed to the cultural concept of &amp;amp;ldquo;ME-BYO,&amp;amp;rdquo; which emphasises recognising and managing non-disease conditions before they develop into clinical illness. This tendency may be one of the reasons for the long lifespan of Japanese people.</p>
	]]></content:encoded>

	<dc:title>Mediterranean-Style Japanese Diet for Anti-Ageing: Systematic Review</dc:title>
			<dc:creator>Kazuki Santa</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025038002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-12-12</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-12-12</prism:publicationDate>
	<prism:volume>38</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2025038002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/38/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/40/1/2">

	<title>Medical Sciences Forum, Vol. 40, Pages 2: Antibody&amp;ndash;Drug Conjugates (ADCs) and Their Journey to Autoimmune Disease Immunotherapy</title>
	<link>https://www.mdpi.com/2673-9992/40/1/2</link>
	<description>Antibody&amp;amp;ndash;drug conjugates (ADCs) represent a novel and rapidly evolving class of targeted therapeutics that combine the high specificity of monoclonal antibodies (mAbs) with the potent cytotoxic effects of small-molecule drugs. These engineered molecules are designed to selectively deliver cytotoxic agents to specific cells, thereby reducing off-target toxicity and enhancing therapeutic efficacy. In oncology, ADCs have already demonstrated significant clinical success, particularly in the treatment of hematological malignancies and solid tumors. Agents such as trastuzumab emtansine and brentuximab vedotin exemplify how ADCs can effectively target cancer cells while limiting damage to healthy tissues. This review comprehensively explores the key aspects of the use of ADCs in autoimmune disorders, which is an evolving field in immunotherapy.</description>
	<pubDate>2025-12-11</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 40, Pages 2: Antibody&amp;ndash;Drug Conjugates (ADCs) and Their Journey to Autoimmune Disease Immunotherapy</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/40/1/2">doi: 10.3390/msf2025040002</a></p>
	<p>Authors:
		Angel Justiz-Vaillant
		</p>
	<p>Antibody&amp;amp;ndash;drug conjugates (ADCs) represent a novel and rapidly evolving class of targeted therapeutics that combine the high specificity of monoclonal antibodies (mAbs) with the potent cytotoxic effects of small-molecule drugs. These engineered molecules are designed to selectively deliver cytotoxic agents to specific cells, thereby reducing off-target toxicity and enhancing therapeutic efficacy. In oncology, ADCs have already demonstrated significant clinical success, particularly in the treatment of hematological malignancies and solid tumors. Agents such as trastuzumab emtansine and brentuximab vedotin exemplify how ADCs can effectively target cancer cells while limiting damage to healthy tissues. This review comprehensively explores the key aspects of the use of ADCs in autoimmune disorders, which is an evolving field in immunotherapy.</p>
	]]></content:encoded>

	<dc:title>Antibody&amp;amp;ndash;Drug Conjugates (ADCs) and Their Journey to Autoimmune Disease Immunotherapy</dc:title>
			<dc:creator>Angel Justiz-Vaillant</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025040002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-12-11</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-12-11</prism:publicationDate>
	<prism:volume>40</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2025040002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/40/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/39/1/4">

	<title>Medical Sciences Forum, Vol. 39, Pages 4: Abstracts of the 2025 International Kidney Cancer Symposium (IKCS) Europe</title>
	<link>https://www.mdpi.com/2673-9992/39/1/4</link>
	<description>The 2025 International Kidney Cancer Symposium&amp;amp;mdash;Europe (IKCSEU25) was held in Amsterdam, the Netherlands, from 1 to 3 May 2025, organized by the Kidney Cancer Association (KCA). This annual event serves as the premier European meeting dedicated to kidney cancer research and clinical innovation, fostering collaboration across academia, industry, and advocacy.</description>
	<pubDate>2025-11-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 39, Pages 4: Abstracts of the 2025 International Kidney Cancer Symposium (IKCS) Europe</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/39/1/4">doi: 10.3390/msf2025039004</a></p>
	<p>Authors:
		Axel Bex
		Ignacio Durán
		Salvatore La Rosa
		Lisa Pickering
		</p>
	<p>The 2025 International Kidney Cancer Symposium&amp;amp;mdash;Europe (IKCSEU25) was held in Amsterdam, the Netherlands, from 1 to 3 May 2025, organized by the Kidney Cancer Association (KCA). This annual event serves as the premier European meeting dedicated to kidney cancer research and clinical innovation, fostering collaboration across academia, industry, and advocacy.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 2025 International Kidney Cancer Symposium (IKCS) Europe</dc:title>
			<dc:creator>Axel Bex</dc:creator>
			<dc:creator>Ignacio Durán</dc:creator>
			<dc:creator>Salvatore La Rosa</dc:creator>
			<dc:creator>Lisa Pickering</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025039004</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-11-27</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-11-27</prism:publicationDate>
	<prism:volume>39</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>4</prism:startingPage>
		<prism:doi>10.3390/msf2025039004</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/39/1/4</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/40/1/1">

	<title>Medical Sciences Forum, Vol. 40, Pages 1: Targeting the Tumor Microenvironment with Radiolabeled Antibodies: Bridging Immunotherapy and Molecular Imaging</title>
	<link>https://www.mdpi.com/2673-9992/40/1/1</link>
	<description>Radiolabeled monoclonal antibodies represent a promising approach to integrate molecular imaging with immunotherapy for cancer diagnosis and treatment. These antibodies target immune checkpoints and tumor-associated antigens, enabling non-invasive visualization of tumor dynamics through PET and SPECT imaging. Evidence from preclinical and clinical studies suggests that such imaging can provide insights into antibody distribution, immune cell infiltration, and potential treatment responses within the tumor microenvironment. By combining diagnostic and therapeutic capabilities, antibody-based theranostics offer opportunities for personalized treatment planning and understanding mechanisms of resistance. This review highlights current advances in antibody-based molecular imaging, discusses challenges in translation, and explores future directions for integrating imaging with immuno-oncology strategies to improve patient outcomes. Radiolabeled antibodies allow non-invasive assessment of tumor&amp;amp;ndash;immune interactions, supporting adaptive treatment planning and bridging immunotherapy with molecular imaging.</description>
	<pubDate>2025-11-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 40, Pages 1: Targeting the Tumor Microenvironment with Radiolabeled Antibodies: Bridging Immunotherapy and Molecular Imaging</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/40/1/1">doi: 10.3390/msf2025040001</a></p>
	<p>Authors:
		Krishnaveni Manubolu
		Raveesha Peeriga
		</p>
	<p>Radiolabeled monoclonal antibodies represent a promising approach to integrate molecular imaging with immunotherapy for cancer diagnosis and treatment. These antibodies target immune checkpoints and tumor-associated antigens, enabling non-invasive visualization of tumor dynamics through PET and SPECT imaging. Evidence from preclinical and clinical studies suggests that such imaging can provide insights into antibody distribution, immune cell infiltration, and potential treatment responses within the tumor microenvironment. By combining diagnostic and therapeutic capabilities, antibody-based theranostics offer opportunities for personalized treatment planning and understanding mechanisms of resistance. This review highlights current advances in antibody-based molecular imaging, discusses challenges in translation, and explores future directions for integrating imaging with immuno-oncology strategies to improve patient outcomes. Radiolabeled antibodies allow non-invasive assessment of tumor&amp;amp;ndash;immune interactions, supporting adaptive treatment planning and bridging immunotherapy with molecular imaging.</p>
	]]></content:encoded>

	<dc:title>Targeting the Tumor Microenvironment with Radiolabeled Antibodies: Bridging Immunotherapy and Molecular Imaging</dc:title>
			<dc:creator>Krishnaveni Manubolu</dc:creator>
			<dc:creator>Raveesha Peeriga</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025040001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-11-26</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-11-26</prism:publicationDate>
	<prism:volume>40</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025040001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/40/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/39/1/3">

	<title>Medical Sciences Forum, Vol. 39, Pages 3: The Importance of Multidisciplinary Team Meetings (MDMs) with Focus on Minimal Surgery</title>
	<link>https://www.mdpi.com/2673-9992/39/1/3</link>
	<description>Since 2010, all Danish departments treating renal cell carcinoma (RCC) have reported to the national quality database, enabling systematic auditing of outcomes. Using the unique Civil Registration Number, data are linked to national registries, ensuring comprehensive capture of diagnostics and treatments. The RCC database, established in August 2010, now includes over 13,000 cases, with 1035 new cases registered between August 2023 and July 2024. In this period, 939 patients underwent surgery or ablation, 54% with kidney-preserving procedures. Among nephrectomies, 85% were minimally invasive. Data-driven quality monitoring and multidisciplinary collaboration have contributed to standardized care and internationally comparable survival outcomes.</description>
	<pubDate>2025-11-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 39, Pages 3: The Importance of Multidisciplinary Team Meetings (MDMs) with Focus on Minimal Surgery</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/39/1/3">doi: 10.3390/msf2025039003</a></p>
	<p>Authors:
		Lars Lund
		Else Helene Ibfelt
		Heidi Larsson
		Niels Fristrup
		Anne Kirstine Møller Darras
		Mette Nørgaard
		</p>
	<p>Since 2010, all Danish departments treating renal cell carcinoma (RCC) have reported to the national quality database, enabling systematic auditing of outcomes. Using the unique Civil Registration Number, data are linked to national registries, ensuring comprehensive capture of diagnostics and treatments. The RCC database, established in August 2010, now includes over 13,000 cases, with 1035 new cases registered between August 2023 and July 2024. In this period, 939 patients underwent surgery or ablation, 54% with kidney-preserving procedures. Among nephrectomies, 85% were minimally invasive. Data-driven quality monitoring and multidisciplinary collaboration have contributed to standardized care and internationally comparable survival outcomes.</p>
	]]></content:encoded>

	<dc:title>The Importance of Multidisciplinary Team Meetings (MDMs) with Focus on Minimal Surgery</dc:title>
			<dc:creator>Lars Lund</dc:creator>
			<dc:creator>Else Helene Ibfelt</dc:creator>
			<dc:creator>Heidi Larsson</dc:creator>
			<dc:creator>Niels Fristrup</dc:creator>
			<dc:creator>Anne Kirstine Møller Darras</dc:creator>
			<dc:creator>Mette Nørgaard</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025039003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-11-17</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-11-17</prism:publicationDate>
	<prism:volume>39</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2025039003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/39/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/39/1/2">

	<title>Medical Sciences Forum, Vol. 39, Pages 2: First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer</title>
	<link>https://www.mdpi.com/2673-9992/39/1/2</link>
	<description>The CABONEXT study is the first multicenter retrospective analysis evaluating subsequent systemic therapies after cabozantinib-based treatment in metastatic renal cell carcinoma (mRCC). This interim analysis includes 77 patients receiving subsequent treatments across two cohorts: after cabozantinib&amp;amp;ndash;nivolumab first-line treatment (Group A) and after ICI-based first-line treatment followed by cabozantinib (Group B). Time to subsequent treatment failure (TTF) and disease control rate (DCR) remain higher in Group A with a median TTF of 5 months (vs. 3.4 months in Group B) and a DCR of 86% (vs. 48%). Second-generation TKIs, mostly axitinib or lenvatinib, seemed to be the best option in Group B compared to other treatments including everolimus or first-generation TKIs (HR = 3.82, 95%CI [1.64; 8.93], p = 0.1). These findings already emphasize the need for innovative therapies targeting resistance mechanisms and optimal treatment sequences. Along with ongoing accrual, further analyses are expected.</description>
	<pubDate>2025-11-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 39, Pages 2: First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/39/1/2">doi: 10.3390/msf2025039002</a></p>
	<p>Authors:
		Simon Nannini
		Fabien Moinard-Butot
		Sylvain Ladoire
		Dorian Bochaton
		Pierre Bigot
		Félix Lefort
		Hakim Mahammedi
		Fabien Calcagno
		Jean-Baptiste Barbe Richaud
		Luca Campedel
		Sabrina Falkowski
		Karim Amrane
		Haris Charalambous
		Pierre Cornillon
		Philippe Barthélémy
		</p>
	<p>The CABONEXT study is the first multicenter retrospective analysis evaluating subsequent systemic therapies after cabozantinib-based treatment in metastatic renal cell carcinoma (mRCC). This interim analysis includes 77 patients receiving subsequent treatments across two cohorts: after cabozantinib&amp;amp;ndash;nivolumab first-line treatment (Group A) and after ICI-based first-line treatment followed by cabozantinib (Group B). Time to subsequent treatment failure (TTF) and disease control rate (DCR) remain higher in Group A with a median TTF of 5 months (vs. 3.4 months in Group B) and a DCR of 86% (vs. 48%). Second-generation TKIs, mostly axitinib or lenvatinib, seemed to be the best option in Group B compared to other treatments including everolimus or first-generation TKIs (HR = 3.82, 95%CI [1.64; 8.93], p = 0.1). These findings already emphasize the need for innovative therapies targeting resistance mechanisms and optimal treatment sequences. Along with ongoing accrual, further analyses are expected.</p>
	]]></content:encoded>

	<dc:title>First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer</dc:title>
			<dc:creator>Simon Nannini</dc:creator>
			<dc:creator>Fabien Moinard-Butot</dc:creator>
			<dc:creator>Sylvain Ladoire</dc:creator>
			<dc:creator>Dorian Bochaton</dc:creator>
			<dc:creator>Pierre Bigot</dc:creator>
			<dc:creator>Félix Lefort</dc:creator>
			<dc:creator>Hakim Mahammedi</dc:creator>
			<dc:creator>Fabien Calcagno</dc:creator>
			<dc:creator>Jean-Baptiste Barbe Richaud</dc:creator>
			<dc:creator>Luca Campedel</dc:creator>
			<dc:creator>Sabrina Falkowski</dc:creator>
			<dc:creator>Karim Amrane</dc:creator>
			<dc:creator>Haris Charalambous</dc:creator>
			<dc:creator>Pierre Cornillon</dc:creator>
			<dc:creator>Philippe Barthélémy</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025039002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-11-13</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-11-13</prism:publicationDate>
	<prism:volume>39</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2025039002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/39/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/39/1/1">

	<title>Medical Sciences Forum, Vol. 39, Pages 1: Shaping AI-Based Decision Support in Kidney Cancer: Multidisciplinary Consensus from the IKCSEU25 ART Think Tank</title>
	<link>https://www.mdpi.com/2673-9992/39/1/1</link>
	<description>Background: Artificial intelligence (AI) has the potential to significantly enhance clinical decision-making in oncology. However, its application in renal cell carcinoma (RCC) remains limited. The ART (Artificial Intelligence in Renal Tumors) project is a Spanish, multi-institutional initiative aimed at developing a dynamic, transcriptomics-based AI model to guide systemic treatment decisions for patients with metastatic RCC (mRCC). Objective: The aim of this paper is to present the rationale, methodology, and early implementation challenges of the ART project, as discussed during a dedicated Think Tank session at the 2025 International Kidney Cancer Symposium Europe (IKCSEU25), and to gather expert insights on its clinical and regulatory viability. Design, Setting, and Participants: The ART project includes three phases: (1) retrospective algorithm training using clinical and transcriptomic data from completed trials; (2) a prospective, non-interventional study collecting multi-omic and clinical data from 500 patients across 30 centers; and (3) a future comparative analysis of ART-guided versus standard clinical decisions. The AI model is designed to evolve continuously through ongoing data integration. Results and Limitations: Experts underscored the importance of integrating multimodal data&amp;amp;mdash;including circulating biomarkers and immune profiling&amp;amp;mdash;while expressing concerns about the reliance on short-term endpoints. Key barriers identified included data harmonization, external validation, and regulatory uncertainty regarding adaptive algorithms. The absence of a clear approval pathway for non-static clinical decision support systems also poses a challenge. Despite limited initial funding, the ART platform has generated strong institutional engagement and may serve as a scalable model for clinician-oriented AI tools. Conclusions: The ART project represents an innovative approach to AI-driven personalization of kidney cancer treatment. Expert feedback from IKCSEU25 highlighted the scientific robustness of the initiative, while also emphasizing the need for broader validation, regulatory clarity, and the use of clinically meaningful endpoints to support real-world implementation. Patient Summary: Experts reviewed a new AI-based tool being developed in Spain to help doctors choose the best treatments for kidney cancer. The tool shows promise but needs further testing and must meet regulatory standards before it can be used in routine clinical care.</description>
	<pubDate>2025-11-06</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 39, Pages 1: Shaping AI-Based Decision Support in Kidney Cancer: Multidisciplinary Consensus from the IKCSEU25 ART Think Tank</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/39/1/1">doi: 10.3390/msf2025039001</a></p>
	<p>Authors:
		Ignacio Duran
		Jesus Garcia-Donas
		</p>
	<p>Background: Artificial intelligence (AI) has the potential to significantly enhance clinical decision-making in oncology. However, its application in renal cell carcinoma (RCC) remains limited. The ART (Artificial Intelligence in Renal Tumors) project is a Spanish, multi-institutional initiative aimed at developing a dynamic, transcriptomics-based AI model to guide systemic treatment decisions for patients with metastatic RCC (mRCC). Objective: The aim of this paper is to present the rationale, methodology, and early implementation challenges of the ART project, as discussed during a dedicated Think Tank session at the 2025 International Kidney Cancer Symposium Europe (IKCSEU25), and to gather expert insights on its clinical and regulatory viability. Design, Setting, and Participants: The ART project includes three phases: (1) retrospective algorithm training using clinical and transcriptomic data from completed trials; (2) a prospective, non-interventional study collecting multi-omic and clinical data from 500 patients across 30 centers; and (3) a future comparative analysis of ART-guided versus standard clinical decisions. The AI model is designed to evolve continuously through ongoing data integration. Results and Limitations: Experts underscored the importance of integrating multimodal data&amp;amp;mdash;including circulating biomarkers and immune profiling&amp;amp;mdash;while expressing concerns about the reliance on short-term endpoints. Key barriers identified included data harmonization, external validation, and regulatory uncertainty regarding adaptive algorithms. The absence of a clear approval pathway for non-static clinical decision support systems also poses a challenge. Despite limited initial funding, the ART platform has generated strong institutional engagement and may serve as a scalable model for clinician-oriented AI tools. Conclusions: The ART project represents an innovative approach to AI-driven personalization of kidney cancer treatment. Expert feedback from IKCSEU25 highlighted the scientific robustness of the initiative, while also emphasizing the need for broader validation, regulatory clarity, and the use of clinically meaningful endpoints to support real-world implementation. Patient Summary: Experts reviewed a new AI-based tool being developed in Spain to help doctors choose the best treatments for kidney cancer. The tool shows promise but needs further testing and must meet regulatory standards before it can be used in routine clinical care.</p>
	]]></content:encoded>

	<dc:title>Shaping AI-Based Decision Support in Kidney Cancer: Multidisciplinary Consensus from the IKCSEU25 ART Think Tank</dc:title>
			<dc:creator>Ignacio Duran</dc:creator>
			<dc:creator>Jesus Garcia-Donas</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025039001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-11-06</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-11-06</prism:publicationDate>
	<prism:volume>39</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025039001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/39/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/38/1/1">

	<title>Medical Sciences Forum, Vol. 38, Pages 1: Abstracts from the 1st International Online Conference on Diseases</title>
	<link>https://www.mdpi.com/2673-9992/38/1/1</link>
	<description>Shahd Hamran 1,2, Amani A [...]</description>
	<pubDate>2025-10-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 38, Pages 1: Abstracts from the 1st International Online Conference on Diseases</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/38/1/1">doi: 10.3390/msf2025038001</a></p>
	<p>Authors:
		Omar Cauli
		</p>
	<p>Shahd Hamran 1,2, Amani A [...]</p>
	]]></content:encoded>

	<dc:title>Abstracts from the 1st International Online Conference on Diseases</dc:title>
			<dc:creator>Omar Cauli</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025038001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-10-14</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-10-14</prism:publicationDate>
	<prism:volume>38</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025038001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/38/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/11">

	<title>Medical Sciences Forum, Vol. 35, Pages 11: Statement of Peer Review</title>
	<link>https://www.mdpi.com/2673-9992/35/1/11</link>
	<description>In submitting conference proceedings to Medical Sciences Forum, the volume editors of the proceedings certify to the publisher that all papers published in this volume have been subjected to peer review administered by the volume editors [...]</description>
	<pubDate>2025-09-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 11: Statement of Peer Review</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/11">doi: 10.3390/msf2025035011</a></p>
	<p>Authors:
		Manuel Simões
		Marc Maresca
		</p>
	<p>In submitting conference proceedings to Medical Sciences Forum, the volume editors of the proceedings certify to the publisher that all papers published in this volume have been subjected to peer review administered by the volume editors [...]</p>
	]]></content:encoded>

	<dc:title>Statement of Peer Review</dc:title>
			<dc:creator>Manuel Simões</dc:creator>
			<dc:creator>Marc Maresca</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035011</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-22</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-22</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Editorial</prism:section>
	<prism:startingPage>11</prism:startingPage>
		<prism:doi>10.3390/msf2025035011</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/11</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/26">

	<title>Medical Sciences Forum, Vol. 37, Pages 26: Characterisation of the Patient Population Attending the Interstitial Lung Disease Clinic at Hospital Garcia de Orta: Implications for Pulmonary Rehabilitation</title>
	<link>https://www.mdpi.com/2673-9992/37/1/26</link>
	<description>Interstitial lung diseases (ILDs) are chronic respiratory disorders often leading to dyspnoea, reduced exercise tolerance, and poor quality of life. Pulmonary rehabilitation (PR) improves symptoms and function but remains underused in Portugal, with only ~1% of eligible patients enrolled. This study retrospectively analysed 61 ILD patients at Hospital Garcia de Orta (July&amp;amp;ndash;December 2024) to identify PR candidates. Most had idiopathic pulmonary fibrosis (44%), exertional dyspnoea (67.2%), and moderate lung impairment (49%). Comorbidities and risk factors were common. Findings highlight a significant gap between clinical need and access, reinforcing the urgency of structured referral strategies to expand PR availability.</description>
	<pubDate>2025-09-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 26: Characterisation of the Patient Population Attending the Interstitial Lung Disease Clinic at Hospital Garcia de Orta: Implications for Pulmonary Rehabilitation</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/26">doi: 10.3390/msf2025037026</a></p>
	<p>Authors:
		Ana Paula Sequeira
		Ângela Pereira
		Helena Santa-Clara
		</p>
	<p>Interstitial lung diseases (ILDs) are chronic respiratory disorders often leading to dyspnoea, reduced exercise tolerance, and poor quality of life. Pulmonary rehabilitation (PR) improves symptoms and function but remains underused in Portugal, with only ~1% of eligible patients enrolled. This study retrospectively analysed 61 ILD patients at Hospital Garcia de Orta (July&amp;amp;ndash;December 2024) to identify PR candidates. Most had idiopathic pulmonary fibrosis (44%), exertional dyspnoea (67.2%), and moderate lung impairment (49%). Comorbidities and risk factors were common. Findings highlight a significant gap between clinical need and access, reinforcing the urgency of structured referral strategies to expand PR availability.</p>
	]]></content:encoded>

	<dc:title>Characterisation of the Patient Population Attending the Interstitial Lung Disease Clinic at Hospital Garcia de Orta: Implications for Pulmonary Rehabilitation</dc:title>
			<dc:creator>Ana Paula Sequeira</dc:creator>
			<dc:creator>Ângela Pereira</dc:creator>
			<dc:creator>Helena Santa-Clara</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037026</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-19</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-19</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>26</prism:startingPage>
		<prism:doi>10.3390/msf2025037026</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/26</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/10">

	<title>Medical Sciences Forum, Vol. 35, Pages 10: Corrugated Biopolymeric Grafts: A Multifunctional Approach to Vascular Reconstruction and Hemodynamic Optimization</title>
	<link>https://www.mdpi.com/2673-9992/35/1/10</link>
	<description>Vascular grafts have a significant role in the artery replacement, aneurysm repair, and hemodialysis treatments. Synthetic grafts that have been mostly used in the clinic include ePTFE and Dacron; however, their use has been associated with a range of complications that include clot formation, intimal hyperplasia, and infections. Corrugated Biopolymeric grafts are one of the promising options that were introduced in the market due to their relatively higher biocompatibility and mechanical advantages. There is still a need to find the right choice regarding mechanical strength, fluid flow, and effective antimicrobial activity. The given research explores the mechanical response of the physiological pressure in corrugated biopolymeric grafts in order to improve antimicrobial activity. These grafts were manufactured and stimulated with the help of COMSOL Multiphysics &amp;amp;reg; 6.2 with an aim to determine the pattern of stress distribution, resistance to pulsatile pressure, and fatigue behavior during dynamic flow. The result was that the corrugated structure showed superior mechanical strength and had better compliance with natural blood vessels, which consequently might improve antimicrobial activity.</description>
	<pubDate>2025-09-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 10: Corrugated Biopolymeric Grafts: A Multifunctional Approach to Vascular Reconstruction and Hemodynamic Optimization</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/10">doi: 10.3390/msf2025035010</a></p>
	<p>Authors:
		Hadiya Malik
		Waqar Ahmed
		Mishaal Khawar
		Rabia Slamat
		Nabeera Malik
		Manala Khalid
		Komal Tariq
		</p>
	<p>Vascular grafts have a significant role in the artery replacement, aneurysm repair, and hemodialysis treatments. Synthetic grafts that have been mostly used in the clinic include ePTFE and Dacron; however, their use has been associated with a range of complications that include clot formation, intimal hyperplasia, and infections. Corrugated Biopolymeric grafts are one of the promising options that were introduced in the market due to their relatively higher biocompatibility and mechanical advantages. There is still a need to find the right choice regarding mechanical strength, fluid flow, and effective antimicrobial activity. The given research explores the mechanical response of the physiological pressure in corrugated biopolymeric grafts in order to improve antimicrobial activity. These grafts were manufactured and stimulated with the help of COMSOL Multiphysics &amp;amp;reg; 6.2 with an aim to determine the pattern of stress distribution, resistance to pulsatile pressure, and fatigue behavior during dynamic flow. The result was that the corrugated structure showed superior mechanical strength and had better compliance with natural blood vessels, which consequently might improve antimicrobial activity.</p>
	]]></content:encoded>

	<dc:title>Corrugated Biopolymeric Grafts: A Multifunctional Approach to Vascular Reconstruction and Hemodynamic Optimization</dc:title>
			<dc:creator>Hadiya Malik</dc:creator>
			<dc:creator>Waqar Ahmed</dc:creator>
			<dc:creator>Mishaal Khawar</dc:creator>
			<dc:creator>Rabia Slamat</dc:creator>
			<dc:creator>Nabeera Malik</dc:creator>
			<dc:creator>Manala Khalid</dc:creator>
			<dc:creator>Komal Tariq</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035010</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-17</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-17</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>10</prism:startingPage>
		<prism:doi>10.3390/msf2025035010</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/10</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/9">

	<title>Medical Sciences Forum, Vol. 35, Pages 9: Potentiation of Antibacterial Activity of Cefixime in Synergy with Cirsium arvense (L.) Scop. Against Resistant Bacterial Isolates</title>
	<link>https://www.mdpi.com/2673-9992/35/1/9</link>
	<description>Antibiotic resistance is a major health priority, with the concern over antibiotic resistance growing. The rise in antibiotic-resistant bacteria coupled with the limited new therapeutics puts pressure on community and hospital healthcare systems and leads to excessive morbidity and mortality. Given this, there has been significant interest into potential new and/or combination antibacterial treatments including certain plant extracts. When combined with resistance medicines, these extracts can re-sensitize their potency. One such plant is Cirsium arvense which has been traditionally used for its anti-inflammatory and antimicrobial properties. Preliminary findings suggest that its extracts may enhance the activity of conventional antibiotics against resistant strains like MRSA. The current study assessed cefixime&amp;amp;rsquo;s and Cirsium arvense extracts&amp;amp;rsquo; synergistic antibacterial efficacy against Escherichia coli, Acinetobacter baumannii, and methicillin-resistant Staphylococcus aureus (MRSA). The antibacterial activity of extracts and the susceptibility profile of antibiotics were assessed using the disc diffusion and microbroth dilution assays. Chequerboard, time-kill kinetics, and protein content tests were performed to verify synergistic antibacterial effect. Our results demonstrated that when these extracts were applied to clinical strains of bacteria along with the cefixime, there was complete or partial synergy was displayed. Time-kill kinetics demonstrated that synergism was dependent on both concentration and time, and bacterial isolates treated with these exhibited significantly reduced bacterial growth and protein content. Taken together, these results show that Cirsium arvense extracts enhance the efficacy of conventional antibiotics against antibiotic-resistant strains of Escherichia coli, Acinetobacter baumannii, and MRSA and clearly suggest that these plant extracts could be used as additives to current resistant antibiotics for the future management or treatment of resistant bacterial infections.</description>
	<pubDate>2025-09-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 9: Potentiation of Antibacterial Activity of Cefixime in Synergy with Cirsium arvense (L.) Scop. Against Resistant Bacterial Isolates</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/9">doi: 10.3390/msf2025035009</a></p>
	<p>Authors:
		Zoobaria Zahid
		Aref Kyyaly
		Jamil Jubrail
		</p>
	<p>Antibiotic resistance is a major health priority, with the concern over antibiotic resistance growing. The rise in antibiotic-resistant bacteria coupled with the limited new therapeutics puts pressure on community and hospital healthcare systems and leads to excessive morbidity and mortality. Given this, there has been significant interest into potential new and/or combination antibacterial treatments including certain plant extracts. When combined with resistance medicines, these extracts can re-sensitize their potency. One such plant is Cirsium arvense which has been traditionally used for its anti-inflammatory and antimicrobial properties. Preliminary findings suggest that its extracts may enhance the activity of conventional antibiotics against resistant strains like MRSA. The current study assessed cefixime&amp;amp;rsquo;s and Cirsium arvense extracts&amp;amp;rsquo; synergistic antibacterial efficacy against Escherichia coli, Acinetobacter baumannii, and methicillin-resistant Staphylococcus aureus (MRSA). The antibacterial activity of extracts and the susceptibility profile of antibiotics were assessed using the disc diffusion and microbroth dilution assays. Chequerboard, time-kill kinetics, and protein content tests were performed to verify synergistic antibacterial effect. Our results demonstrated that when these extracts were applied to clinical strains of bacteria along with the cefixime, there was complete or partial synergy was displayed. Time-kill kinetics demonstrated that synergism was dependent on both concentration and time, and bacterial isolates treated with these exhibited significantly reduced bacterial growth and protein content. Taken together, these results show that Cirsium arvense extracts enhance the efficacy of conventional antibiotics against antibiotic-resistant strains of Escherichia coli, Acinetobacter baumannii, and MRSA and clearly suggest that these plant extracts could be used as additives to current resistant antibiotics for the future management or treatment of resistant bacterial infections.</p>
	]]></content:encoded>

	<dc:title>Potentiation of Antibacterial Activity of Cefixime in Synergy with Cirsium arvense (L.) Scop. Against Resistant Bacterial Isolates</dc:title>
			<dc:creator>Zoobaria Zahid</dc:creator>
			<dc:creator>Aref Kyyaly</dc:creator>
			<dc:creator>Jamil Jubrail</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035009</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-10</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-10</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>9</prism:startingPage>
		<prism:doi>10.3390/msf2025035009</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/9</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/25">

	<title>Medical Sciences Forum, Vol. 37, Pages 25: A Parkinson&amp;rsquo;s Disease Handwriting Rehabilitation Kit&amp;mdash;A Forensic Exploratory Study</title>
	<link>https://www.mdpi.com/2673-9992/37/1/25</link>
	<description>Legal documents signed by individuals with Parkinson&amp;amp;rsquo;s disease are often disputed due to inconsistencies in their signatures when compared to those executed prior to the disease. This exploratory study aims to develop a handwriting rehabilitation kit designed to improve fine motor skills in the elderly diagnosed with Parkinson&amp;amp;rsquo;s disease. This study involved ten subjects with a diagnosis of Parkinson&amp;amp;rsquo;s disease, four of whom participated in the rehabilitation program and used the kit, while the remaining six were assigned to the control group. All participants underwent traditional rehabilitation and clinical evaluation before and after the twelve-week intervention, as well as satisfaction questionnaires following the intervention. The main changes observed in the intervention group indicated progress, including a reduction in tremor and bradykinesia. The potential clinical and handwriting benefits, as well as the positive feedback and program adherence from participants, support the development of a user-friendly kit for this subset of the elderly population.</description>
	<pubDate>2025-09-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 25: A Parkinson&amp;rsquo;s Disease Handwriting Rehabilitation Kit&amp;mdash;A Forensic Exploratory Study</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/25">doi: 10.3390/msf2025037025</a></p>
	<p>Authors:
		Catarina Santos
		Vlad Tatarescu
		Mariana Louro
		Sarah Souza
		Carina A. Fernandes
		Carlos Família
		Catarina Godinho
		Alexandre Quintas
		Alexandra Bernardo
		</p>
	<p>Legal documents signed by individuals with Parkinson&amp;amp;rsquo;s disease are often disputed due to inconsistencies in their signatures when compared to those executed prior to the disease. This exploratory study aims to develop a handwriting rehabilitation kit designed to improve fine motor skills in the elderly diagnosed with Parkinson&amp;amp;rsquo;s disease. This study involved ten subjects with a diagnosis of Parkinson&amp;amp;rsquo;s disease, four of whom participated in the rehabilitation program and used the kit, while the remaining six were assigned to the control group. All participants underwent traditional rehabilitation and clinical evaluation before and after the twelve-week intervention, as well as satisfaction questionnaires following the intervention. The main changes observed in the intervention group indicated progress, including a reduction in tremor and bradykinesia. The potential clinical and handwriting benefits, as well as the positive feedback and program adherence from participants, support the development of a user-friendly kit for this subset of the elderly population.</p>
	]]></content:encoded>

	<dc:title>A Parkinson&amp;amp;rsquo;s Disease Handwriting Rehabilitation Kit&amp;amp;mdash;A Forensic Exploratory Study</dc:title>
			<dc:creator>Catarina Santos</dc:creator>
			<dc:creator>Vlad Tatarescu</dc:creator>
			<dc:creator>Mariana Louro</dc:creator>
			<dc:creator>Sarah Souza</dc:creator>
			<dc:creator>Carina A. Fernandes</dc:creator>
			<dc:creator>Carlos Família</dc:creator>
			<dc:creator>Catarina Godinho</dc:creator>
			<dc:creator>Alexandre Quintas</dc:creator>
			<dc:creator>Alexandra Bernardo</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037025</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-10</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-10</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>25</prism:startingPage>
		<prism:doi>10.3390/msf2025037025</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/25</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/24">

	<title>Medical Sciences Forum, Vol. 37, Pages 24: Graphoscopic Evaluation After a Fine Motor Skill Rehabilitation Program in Parkinson&amp;rsquo;s Disease&amp;mdash;Exploratory Study</title>
	<link>https://www.mdpi.com/2673-9992/37/1/24</link>
	<description>Individuals with Parkinson&amp;amp;rsquo;s disease often face legal disputes over documents signed before the ongoing disease, since fine motor skill changes can lead to alterations in handwriting. Generally, rehabilitation programs focus on mobility in the lower limbs; however, these individuals also face challenges involving the control of fine motor skills, such as handwriting and maintaining their graphic identity. The aim of this exploratory study is to evaluate the effect of a fine motor skill rehabilitation program on the handwriting of these individuals. This study involved 10 subjects with a diagnosis of Parkinson&amp;amp;rsquo;s disease, four of whom participated in the rehabilitation program, while the remaining six were allocated to the control group. All participants were instructed to write specific sentences before and after the twelve-week intervention. The main qualitative changes observed between groups after the graphoscopic analysis were in features such as tremors, retouching/overwriting, size, legibility, and line quality.</description>
	<pubDate>2025-09-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 24: Graphoscopic Evaluation After a Fine Motor Skill Rehabilitation Program in Parkinson&amp;rsquo;s Disease&amp;mdash;Exploratory Study</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/24">doi: 10.3390/msf2025037024</a></p>
	<p>Authors:
		Mariana Louro
		Vlad Tatarescu
		Catarina Santos
		Sarah Souza
		Carina A. Fernandes
		Carlos Família
		Catarina Godinho
		Alexandre Quintas
		Alexandra Bernardo
		</p>
	<p>Individuals with Parkinson&amp;amp;rsquo;s disease often face legal disputes over documents signed before the ongoing disease, since fine motor skill changes can lead to alterations in handwriting. Generally, rehabilitation programs focus on mobility in the lower limbs; however, these individuals also face challenges involving the control of fine motor skills, such as handwriting and maintaining their graphic identity. The aim of this exploratory study is to evaluate the effect of a fine motor skill rehabilitation program on the handwriting of these individuals. This study involved 10 subjects with a diagnosis of Parkinson&amp;amp;rsquo;s disease, four of whom participated in the rehabilitation program, while the remaining six were allocated to the control group. All participants were instructed to write specific sentences before and after the twelve-week intervention. The main qualitative changes observed between groups after the graphoscopic analysis were in features such as tremors, retouching/overwriting, size, legibility, and line quality.</p>
	]]></content:encoded>

	<dc:title>Graphoscopic Evaluation After a Fine Motor Skill Rehabilitation Program in Parkinson&amp;amp;rsquo;s Disease&amp;amp;mdash;Exploratory Study</dc:title>
			<dc:creator>Mariana Louro</dc:creator>
			<dc:creator>Vlad Tatarescu</dc:creator>
			<dc:creator>Catarina Santos</dc:creator>
			<dc:creator>Sarah Souza</dc:creator>
			<dc:creator>Carina A. Fernandes</dc:creator>
			<dc:creator>Carlos Família</dc:creator>
			<dc:creator>Catarina Godinho</dc:creator>
			<dc:creator>Alexandre Quintas</dc:creator>
			<dc:creator>Alexandra Bernardo</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037024</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-10</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-10</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>24</prism:startingPage>
		<prism:doi>10.3390/msf2025037024</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/24</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/36/1/2">

	<title>Medical Sciences Forum, Vol. 36, Pages 2: Abstracts of the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11)</title>
	<link>https://www.mdpi.com/2673-9992/36/1/2</link>
	<description>The Spanish Group for Cancer Immuno-Biotherapies (G&amp;amp;Eacute;TICA) held the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11) from 13 to 15 March 2025, in Madrid (Spain). FITCancer is the largest meeting uniquely focused on cancer immunotherapy in Spain and brings together clinicians and researchers with expertise in the field of cancer immunology and immunotherapy. Here, we present abstracts submitted by G&amp;amp;Eacute;TICA&amp;amp;rsquo;s members to the XI Forum on Translational Immunology and Cancer Immunotherapy, which were divided into the following three topics: novel therapeutic targets and strategies, cell-based immunotherapies, and clinical scenarios and potential biomarkers.</description>
	<pubDate>2025-09-09</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 36, Pages 2: Abstracts of the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11)</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/36/1/2">doi: 10.3390/msf2025036002</a></p>
	<p>Authors:
		Francisco Aya
		Luis de la Cruz
		Delvys Rodríguez-Abreu
		Luis Álvarez-Vallina
		Manel Juan
		Elisabeth Pérez-Ruiz
		Xabier Mielgo
		Rodolfo Chicas-Sett
		Ana Arance
		</p>
	<p>The Spanish Group for Cancer Immuno-Biotherapies (G&amp;amp;Eacute;TICA) held the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11) from 13 to 15 March 2025, in Madrid (Spain). FITCancer is the largest meeting uniquely focused on cancer immunotherapy in Spain and brings together clinicians and researchers with expertise in the field of cancer immunology and immunotherapy. Here, we present abstracts submitted by G&amp;amp;Eacute;TICA&amp;amp;rsquo;s members to the XI Forum on Translational Immunology and Cancer Immunotherapy, which were divided into the following three topics: novel therapeutic targets and strategies, cell-based immunotherapies, and clinical scenarios and potential biomarkers.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the XI Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 11)</dc:title>
			<dc:creator>Francisco Aya</dc:creator>
			<dc:creator>Luis de la Cruz</dc:creator>
			<dc:creator>Delvys Rodríguez-Abreu</dc:creator>
			<dc:creator>Luis Álvarez-Vallina</dc:creator>
			<dc:creator>Manel Juan</dc:creator>
			<dc:creator>Elisabeth Pérez-Ruiz</dc:creator>
			<dc:creator>Xabier Mielgo</dc:creator>
			<dc:creator>Rodolfo Chicas-Sett</dc:creator>
			<dc:creator>Ana Arance</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025036002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-09</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-09</prism:publicationDate>
	<prism:volume>36</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2025036002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/36/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/23">

	<title>Medical Sciences Forum, Vol. 37, Pages 23: The PROMOTE Project in Portugal: Rethinking Reintegration Through the National Adaptation Workshop</title>
	<link>https://www.mdpi.com/2673-9992/37/1/23</link>
	<description>This study explores the implementation of competency-based professional development for correctional staff through the DACUM (Developing A Curriculum) methodology. A National Adaptation Workshop in Portugal engaged professionals from multiple sectors&amp;amp;mdash;psychologists, social workers, educators, prison officers, re-education and reintegration technicians&amp;amp;mdash;to validate occupational profiles and training needs. Thematic analysis revealed gaps between required and available training, especially in conflict management, mental health, and interdisciplinary collaboration. Key findings show strong support for participatory, practice-informed training, provided it is contextually adapted and accessible. The results underscore the practical need for flexible, modular training frameworks in correctional settings, offering implications for policy and staff retention strategies.</description>
	<pubDate>2025-09-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 23: The PROMOTE Project in Portugal: Rethinking Reintegration Through the National Adaptation Workshop</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/23">doi: 10.3390/msf2025037023</a></p>
	<p>Authors:
		Iris Almeida
		Ana Nascimento David
		Ana Rita Lourenço
		Guilherme Sena
		Maria Alexandra Garrafão
		Ricardo Ventura Baúto
		</p>
	<p>This study explores the implementation of competency-based professional development for correctional staff through the DACUM (Developing A Curriculum) methodology. A National Adaptation Workshop in Portugal engaged professionals from multiple sectors&amp;amp;mdash;psychologists, social workers, educators, prison officers, re-education and reintegration technicians&amp;amp;mdash;to validate occupational profiles and training needs. Thematic analysis revealed gaps between required and available training, especially in conflict management, mental health, and interdisciplinary collaboration. Key findings show strong support for participatory, practice-informed training, provided it is contextually adapted and accessible. The results underscore the practical need for flexible, modular training frameworks in correctional settings, offering implications for policy and staff retention strategies.</p>
	]]></content:encoded>

	<dc:title>The PROMOTE Project in Portugal: Rethinking Reintegration Through the National Adaptation Workshop</dc:title>
			<dc:creator>Iris Almeida</dc:creator>
			<dc:creator>Ana Nascimento David</dc:creator>
			<dc:creator>Ana Rita Lourenço</dc:creator>
			<dc:creator>Guilherme Sena</dc:creator>
			<dc:creator>Maria Alexandra Garrafão</dc:creator>
			<dc:creator>Ricardo Ventura Baúto</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037023</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-03</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-03</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>23</prism:startingPage>
		<prism:doi>10.3390/msf2025037023</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/23</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/20">

	<title>Medical Sciences Forum, Vol. 37, Pages 20: Behind the Behaviour: Supporting Young Offenders Through Forensic Psychology</title>
	<link>https://www.mdpi.com/2673-9992/37/1/20</link>
	<description>This study highlights the role of forensic psychology in supporting juvenile offenders within the Portuguese Justice System. Forensic psychologists ensure that legal proceedings are developmentally appropriate and psychologically informed, helping minors to understand and participate in the process. Data from the Victims Information and Assistance Office (GIAV) show that, between 2020 and 2025, 87 juvenile offenders (54 boys and 33 girls) were supported, with theft and drug trafficking being the most common crimes. Girls were more often involved in theft, and boys were more often involved in drug trafficking. Forensic psychology adds critical value by promoting rehabilitation, safeguarding rights, and contributing to fair, proportionate, and context-sensitive decisions.</description>
	<pubDate>2025-09-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 20: Behind the Behaviour: Supporting Young Offenders Through Forensic Psychology</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/20">doi: 10.3390/msf2025037020</a></p>
	<p>Authors:
		Iris Almeida
		Ana Francisca Matos
		Diana Pais
		Carolina Nobre
		</p>
	<p>This study highlights the role of forensic psychology in supporting juvenile offenders within the Portuguese Justice System. Forensic psychologists ensure that legal proceedings are developmentally appropriate and psychologically informed, helping minors to understand and participate in the process. Data from the Victims Information and Assistance Office (GIAV) show that, between 2020 and 2025, 87 juvenile offenders (54 boys and 33 girls) were supported, with theft and drug trafficking being the most common crimes. Girls were more often involved in theft, and boys were more often involved in drug trafficking. Forensic psychology adds critical value by promoting rehabilitation, safeguarding rights, and contributing to fair, proportionate, and context-sensitive decisions.</p>
	]]></content:encoded>

	<dc:title>Behind the Behaviour: Supporting Young Offenders Through Forensic Psychology</dc:title>
			<dc:creator>Iris Almeida</dc:creator>
			<dc:creator>Ana Francisca Matos</dc:creator>
			<dc:creator>Diana Pais</dc:creator>
			<dc:creator>Carolina Nobre</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037020</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-03</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-03</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>20</prism:startingPage>
		<prism:doi>10.3390/msf2025037020</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/20</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/22">

	<title>Medical Sciences Forum, Vol. 37, Pages 22: Legitimising Beliefs About Intimate Partner Violence: Insights from Portuguese Forensic Cases</title>
	<link>https://www.mdpi.com/2673-9992/37/1/22</link>
	<description>This study explores legitimising beliefs about intimate partner violence (IPV) among Portuguese forensic cases. Using the ECVC scale, data from 45 assessed individuals revealed that IPV offenders&amp;amp;mdash;particularly men, those with lower education levels, and certain occupational groups&amp;amp;mdash;endorse beliefs that justify, minimise, or excuse violence. The most prevalent were trivialising minor violence and protecting family privacy. These findings align with the literature on the influence of patriarchal norms and social inequalities in sustaining IPV. These results highlight the importance of addressing underlying gender ideologies in prevention and intervention efforts, especially in forensic and justice-related psychological practice.</description>
	<pubDate>2025-09-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 22: Legitimising Beliefs About Intimate Partner Violence: Insights from Portuguese Forensic Cases</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/22">doi: 10.3390/msf2025037022</a></p>
	<p>Authors:
		Iris Almeida
		Guilherme Sena
		Maria Beatriz Ribeiro
		Ricardo Ventura Baúto
		</p>
	<p>This study explores legitimising beliefs about intimate partner violence (IPV) among Portuguese forensic cases. Using the ECVC scale, data from 45 assessed individuals revealed that IPV offenders&amp;amp;mdash;particularly men, those with lower education levels, and certain occupational groups&amp;amp;mdash;endorse beliefs that justify, minimise, or excuse violence. The most prevalent were trivialising minor violence and protecting family privacy. These findings align with the literature on the influence of patriarchal norms and social inequalities in sustaining IPV. These results highlight the importance of addressing underlying gender ideologies in prevention and intervention efforts, especially in forensic and justice-related psychological practice.</p>
	]]></content:encoded>

	<dc:title>Legitimising Beliefs About Intimate Partner Violence: Insights from Portuguese Forensic Cases</dc:title>
			<dc:creator>Iris Almeida</dc:creator>
			<dc:creator>Guilherme Sena</dc:creator>
			<dc:creator>Maria Beatriz Ribeiro</dc:creator>
			<dc:creator>Ricardo Ventura Baúto</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037022</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-03</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-03</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>22</prism:startingPage>
		<prism:doi>10.3390/msf2025037022</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/22</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/21">

	<title>Medical Sciences Forum, Vol. 37, Pages 21: Parental Satisfaction in Short-Stay Pediatric Emergency Unit: A Cross-Sectional, Descriptive and Observational Study</title>
	<link>https://www.mdpi.com/2673-9992/37/1/21</link>
	<description>This study evaluated parental satisfaction with nursing care in a pediatric emergency department short-stay unit. Using the Citizen Satisfaction with Nursing Care Scale, 205 parents of hospitalized children participated in a descriptive, cross-sectional study. Results showed consistently high satisfaction, regardless of parental sociodemographic characteristics. While parents of newborns and employed parents showed slightly higher satisfaction, differences were not statistically significant. These trends suggest areas for further qualitative research to better understand parental expectations. The findings highlight the importance of ongoing evaluation and structured feedback to maintain high-quality, responsive nursing care in pediatric emergency settings.</description>
	<pubDate>2025-09-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 21: Parental Satisfaction in Short-Stay Pediatric Emergency Unit: A Cross-Sectional, Descriptive and Observational Study</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/21">doi: 10.3390/msf2025037021</a></p>
	<p>Authors:
		Vanessa Antunes
		Paula Pereira
		Tatiana Cardoso
		Célia Pereira
		Miguel Ladeira
		Ricardo Antunes
		Fernanda Loureiro
		</p>
	<p>This study evaluated parental satisfaction with nursing care in a pediatric emergency department short-stay unit. Using the Citizen Satisfaction with Nursing Care Scale, 205 parents of hospitalized children participated in a descriptive, cross-sectional study. Results showed consistently high satisfaction, regardless of parental sociodemographic characteristics. While parents of newborns and employed parents showed slightly higher satisfaction, differences were not statistically significant. These trends suggest areas for further qualitative research to better understand parental expectations. The findings highlight the importance of ongoing evaluation and structured feedback to maintain high-quality, responsive nursing care in pediatric emergency settings.</p>
	]]></content:encoded>

	<dc:title>Parental Satisfaction in Short-Stay Pediatric Emergency Unit: A Cross-Sectional, Descriptive and Observational Study</dc:title>
			<dc:creator>Vanessa Antunes</dc:creator>
			<dc:creator>Paula Pereira</dc:creator>
			<dc:creator>Tatiana Cardoso</dc:creator>
			<dc:creator>Célia Pereira</dc:creator>
			<dc:creator>Miguel Ladeira</dc:creator>
			<dc:creator>Ricardo Antunes</dc:creator>
			<dc:creator>Fernanda Loureiro</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037021</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-03</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-03</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>21</prism:startingPage>
		<prism:doi>10.3390/msf2025037021</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/21</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/18">

	<title>Medical Sciences Forum, Vol. 37, Pages 18: Bespoke Biomarker Combinations for Cancer Survival Prognosis Using Artificial Intelligence on Tumour Transcriptomics</title>
	<link>https://www.mdpi.com/2673-9992/37/1/18</link>
	<description>Accurate cancer prognosis remains a major challenge, as single gene expression biomarkers often lack clinical reliability, and most ML approaches fail even when considering large gene panels. In this study, we used a novel AutoML framework (O2Pmgen) benchmarked with a well-established framework (TPOT) on TCGA transcriptomic data for breast, lung, and renal cancers to identify small gene panels predictive of patient survival. From 58 EMT-related genes, we found models based on panels of 6&amp;amp;ndash;10 genes that outperformed single-marker models and ML models that considered the 58 EMT genes, with performance gains up to 21%. Further, the generated models achieved good predictive power with AUCs of 71&amp;amp;ndash;83%. Our results demonstrated that affordable and efficient prognostic tools using small, biologically relevant gene sets can provide better risk stratification in clinical oncology.</description>
	<pubDate>2025-09-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 18: Bespoke Biomarker Combinations for Cancer Survival Prognosis Using Artificial Intelligence on Tumour Transcriptomics</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/18">doi: 10.3390/msf2025037018</a></p>
	<p>Authors:
		Ricardo Jorge Pais
		Tiago Alexandre Pais
		Uraquitan Lima Filho
		</p>
	<p>Accurate cancer prognosis remains a major challenge, as single gene expression biomarkers often lack clinical reliability, and most ML approaches fail even when considering large gene panels. In this study, we used a novel AutoML framework (O2Pmgen) benchmarked with a well-established framework (TPOT) on TCGA transcriptomic data for breast, lung, and renal cancers to identify small gene panels predictive of patient survival. From 58 EMT-related genes, we found models based on panels of 6&amp;amp;ndash;10 genes that outperformed single-marker models and ML models that considered the 58 EMT genes, with performance gains up to 21%. Further, the generated models achieved good predictive power with AUCs of 71&amp;amp;ndash;83%. Our results demonstrated that affordable and efficient prognostic tools using small, biologically relevant gene sets can provide better risk stratification in clinical oncology.</p>
	]]></content:encoded>

	<dc:title>Bespoke Biomarker Combinations for Cancer Survival Prognosis Using Artificial Intelligence on Tumour Transcriptomics</dc:title>
			<dc:creator>Ricardo Jorge Pais</dc:creator>
			<dc:creator>Tiago Alexandre Pais</dc:creator>
			<dc:creator>Uraquitan Lima Filho</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037018</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-02</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-02</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>18</prism:startingPage>
		<prism:doi>10.3390/msf2025037018</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/18</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/19">

	<title>Medical Sciences Forum, Vol. 37, Pages 19: Ventilatory Profile of Big Wave Surfers: An Exploratory Study</title>
	<link>https://www.mdpi.com/2673-9992/37/1/19</link>
	<description>Big wave surfing, a high-risk sport involving rides on waves over 30 feet tall, exposes athletes to intense physical demands, particularly during wipeouts requiring extended breath-holding (apnea). Despite its growing popularity and professional status, the ventilatory profile of these elite athletes remains underexplored. This study is the first to examine the respiratory characteristics of Big Wave Surfers (BWS), focusing on lung function, respiratory muscle strength, and potential ventilatory adaptations or compromises. Findings suggest that BWS exhibit enhanced respiratory capacity, likely from apnea training and glossopharyngeal breathing, but also show signs of small airway obstruction, warranting further investigation and preventive health strategies.</description>
	<pubDate>2025-09-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 19: Ventilatory Profile of Big Wave Surfers: An Exploratory Study</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/19">doi: 10.3390/msf2025037019</a></p>
	<p>Authors:
		Pedro Seixas
		Ana Laura-Ricci-Vitor
		Lara Costa e Silva
		</p>
	<p>Big wave surfing, a high-risk sport involving rides on waves over 30 feet tall, exposes athletes to intense physical demands, particularly during wipeouts requiring extended breath-holding (apnea). Despite its growing popularity and professional status, the ventilatory profile of these elite athletes remains underexplored. This study is the first to examine the respiratory characteristics of Big Wave Surfers (BWS), focusing on lung function, respiratory muscle strength, and potential ventilatory adaptations or compromises. Findings suggest that BWS exhibit enhanced respiratory capacity, likely from apnea training and glossopharyngeal breathing, but also show signs of small airway obstruction, warranting further investigation and preventive health strategies.</p>
	]]></content:encoded>

	<dc:title>Ventilatory Profile of Big Wave Surfers: An Exploratory Study</dc:title>
			<dc:creator>Pedro Seixas</dc:creator>
			<dc:creator>Ana Laura-Ricci-Vitor</dc:creator>
			<dc:creator>Lara Costa e Silva</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037019</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-02</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-02</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>19</prism:startingPage>
		<prism:doi>10.3390/msf2025037019</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/19</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/17">

	<title>Medical Sciences Forum, Vol. 37, Pages 17: Patient Awareness and Acceptance of Laser Technology in Endodontics: A Cross-Sectional Study</title>
	<link>https://www.mdpi.com/2673-9992/37/1/17</link>
	<description>Laser technology is becoming an essential part of endodontic practice due to its clear clinical advantages. A cross-sectional survey of 501 participants found that, although awareness remains limited, the results suggest that patients are willing to trust and accept laser-based treatments when recommended by dentists. In addition to the benefits of improved precision, reduced discomfort and superior disinfection, the use of lasers also promotes a sense of safety and confidence. These findings emphasise the importance of improving public understanding of, and support for, the integration of laser technology into modern dental care, since patient acceptance is essential for wider implementation.</description>
	<pubDate>2025-09-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 17: Patient Awareness and Acceptance of Laser Technology in Endodontics: A Cross-Sectional Study</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/17">doi: 10.3390/msf2025037017</a></p>
	<p>Authors:
		Marta Alves Duarte
		João Albernaz Neves
		Javier Flores-Fraile
		</p>
	<p>Laser technology is becoming an essential part of endodontic practice due to its clear clinical advantages. A cross-sectional survey of 501 participants found that, although awareness remains limited, the results suggest that patients are willing to trust and accept laser-based treatments when recommended by dentists. In addition to the benefits of improved precision, reduced discomfort and superior disinfection, the use of lasers also promotes a sense of safety and confidence. These findings emphasise the importance of improving public understanding of, and support for, the integration of laser technology into modern dental care, since patient acceptance is essential for wider implementation.</p>
	]]></content:encoded>

	<dc:title>Patient Awareness and Acceptance of Laser Technology in Endodontics: A Cross-Sectional Study</dc:title>
			<dc:creator>Marta Alves Duarte</dc:creator>
			<dc:creator>João Albernaz Neves</dc:creator>
			<dc:creator>Javier Flores-Fraile</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037017</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-02</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-02</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>17</prism:startingPage>
		<prism:doi>10.3390/msf2025037017</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/17</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/16">

	<title>Medical Sciences Forum, Vol. 37, Pages 16: 7th International Congress of CiiEM&amp;mdash;Empowering One Health to Reduce Social Vulnerabilities</title>
	<link>https://www.mdpi.com/2673-9992/37/1/16</link>
	<description>Amidst the increasingly complex and interconnected challenges of our time, from climate change and emerging pandemics to deepening social inequalities, the One Health approach has gained renewed relevance as a guiding framework for research, policy, and practice [...]</description>
	<pubDate>2025-09-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 16: 7th International Congress of CiiEM&amp;mdash;Empowering One Health to Reduce Social Vulnerabilities</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/16">doi: 10.3390/msf2025037016</a></p>
	<p>Authors:
		Ana I. Fernandes
		João R. Vaz
		Cristina Soeiro
		</p>
	<p>Amidst the increasingly complex and interconnected challenges of our time, from climate change and emerging pandemics to deepening social inequalities, the One Health approach has gained renewed relevance as a guiding framework for research, policy, and practice [...]</p>
	]]></content:encoded>

	<dc:title>7th International Congress of CiiEM&amp;amp;mdash;Empowering One Health to Reduce Social Vulnerabilities</dc:title>
			<dc:creator>Ana I. Fernandes</dc:creator>
			<dc:creator>João R. Vaz</dc:creator>
			<dc:creator>Cristina Soeiro</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037016</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-02</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-02</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Editorial</prism:section>
	<prism:startingPage>16</prism:startingPage>
		<prism:doi>10.3390/msf2025037016</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/16</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/15">

	<title>Medical Sciences Forum, Vol. 37, Pages 15: Assessment of the Diagnostic Delay in a Portuguese Population of Patients with Burning Mouth Syndrome&amp;mdash;A Preliminary Study</title>
	<link>https://www.mdpi.com/2673-9992/37/1/15</link>
	<description>Burning Mouth Syndrome (BMS) presents diagnostic and therapeutic challenges due to its unclear etiology and complex symptomatology. This study, part of a doctoral research project, explores diagnostic delay, triggering factors, and psychotropic medication use in BMS patients. By retrospectively analyzing 300 clinical records, the study offers insight into patterns of diagnosis and treatment, with a focus on differences related to age and sex. The findings contribute to a better understanding of BMS and emphasize the need for timely diagnosis, particularly in older adults, to improve patient outcomes.</description>
	<pubDate>2025-09-01</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 15: Assessment of the Diagnostic Delay in a Portuguese Population of Patients with Burning Mouth Syndrome&amp;mdash;A Preliminary Study</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/15">doi: 10.3390/msf2025037015</a></p>
	<p>Authors:
		Mariana Vallera Machete
		José Grillo Evangelista
		Luís Proença
		Pedro Ferreira Trancoso
		António Mano Azul
		Carlos Zagalo
		</p>
	<p>Burning Mouth Syndrome (BMS) presents diagnostic and therapeutic challenges due to its unclear etiology and complex symptomatology. This study, part of a doctoral research project, explores diagnostic delay, triggering factors, and psychotropic medication use in BMS patients. By retrospectively analyzing 300 clinical records, the study offers insight into patterns of diagnosis and treatment, with a focus on differences related to age and sex. The findings contribute to a better understanding of BMS and emphasize the need for timely diagnosis, particularly in older adults, to improve patient outcomes.</p>
	]]></content:encoded>

	<dc:title>Assessment of the Diagnostic Delay in a Portuguese Population of Patients with Burning Mouth Syndrome&amp;amp;mdash;A Preliminary Study</dc:title>
			<dc:creator>Mariana Vallera Machete</dc:creator>
			<dc:creator>José Grillo Evangelista</dc:creator>
			<dc:creator>Luís Proença</dc:creator>
			<dc:creator>Pedro Ferreira Trancoso</dc:creator>
			<dc:creator>António Mano Azul</dc:creator>
			<dc:creator>Carlos Zagalo</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037015</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-09-01</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-09-01</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>15</prism:startingPage>
		<prism:doi>10.3390/msf2025037015</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/15</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/14">

	<title>Medical Sciences Forum, Vol. 37, Pages 14: Robotic Gait Training in an Adolescent with Idiopathic Transverse Myelitis: A Case Report</title>
	<link>https://www.mdpi.com/2673-9992/37/1/14</link>
	<description>Transverse myelitis is a rare spinal cord condition that can cause severe motor, sensory, and autonomic dysfunction. This case report describes a 16-year-old male with incomplete paraplegia due to idiopathic transverse myelitis who underwent robotic-assisted gait training (RAGT) using the EKSO exoskeleton, integrated into an intensive rehabilitation programme. After one month, he showed significant improvements in gait speed, dynamic balance, effort tolerance, and trunk mobility. RAGT promoted better weight distribution and reduced compensatory patterns during ambulation. The intervention proved safe and clinically beneficial, highlighting the potential of robotic technologies as effective adjuncts in paediatric spinal cord injury rehabilitation.</description>
	<pubDate>2025-08-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 14: Robotic Gait Training in an Adolescent with Idiopathic Transverse Myelitis: A Case Report</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/14">doi: 10.3390/msf2025037014</a></p>
	<p>Authors:
		Maria Ana Neves
		André Lima
		Gonçalo Duarte
		Susana Wandschneider
		Tiago Teixeira
		Lia Jacobsohn
		Carlos Ernesto Júnior
		Isabel Batalha
		</p>
	<p>Transverse myelitis is a rare spinal cord condition that can cause severe motor, sensory, and autonomic dysfunction. This case report describes a 16-year-old male with incomplete paraplegia due to idiopathic transverse myelitis who underwent robotic-assisted gait training (RAGT) using the EKSO exoskeleton, integrated into an intensive rehabilitation programme. After one month, he showed significant improvements in gait speed, dynamic balance, effort tolerance, and trunk mobility. RAGT promoted better weight distribution and reduced compensatory patterns during ambulation. The intervention proved safe and clinically beneficial, highlighting the potential of robotic technologies as effective adjuncts in paediatric spinal cord injury rehabilitation.</p>
	]]></content:encoded>

	<dc:title>Robotic Gait Training in an Adolescent with Idiopathic Transverse Myelitis: A Case Report</dc:title>
			<dc:creator>Maria Ana Neves</dc:creator>
			<dc:creator>André Lima</dc:creator>
			<dc:creator>Gonçalo Duarte</dc:creator>
			<dc:creator>Susana Wandschneider</dc:creator>
			<dc:creator>Tiago Teixeira</dc:creator>
			<dc:creator>Lia Jacobsohn</dc:creator>
			<dc:creator>Carlos Ernesto Júnior</dc:creator>
			<dc:creator>Isabel Batalha</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037014</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-27</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-27</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>14</prism:startingPage>
		<prism:doi>10.3390/msf2025037014</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/14</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/8">

	<title>Medical Sciences Forum, Vol. 35, Pages 8: Third-Generation Cephalosporin-Resistant Escherichia coli Isolates Belonging to High-Risk Clones Obtained from Fresh Pork Meat in La Plata City, Argentina</title>
	<link>https://www.mdpi.com/2673-9992/35/1/8</link>
	<description>High-risk clones represent a major concern, as they are very efficient vehicles for mobile genetic elements carrying antimicrobial resistance genes and therefore promote their spread, especially if they confer resistance to cefotaxime, ciprofloxacin, and fosfomycin, included within the highest-priority, critically important antimicrobial agents (HPCIA). Between February 2022 and April 2024, 138 pork samples were obtained from 46 butcher shops in La Plata, Buenos Aires, Argentina. A total of 102 HPCIA-resistant E. coli were isolated. Eighty-five HPCIA-resistant E. coli were selected for whole-genome sequencing. Of these, 27 belonged to 9 clones described as high risk: ST101 (n = 5), ST10 (n = 4), ST48 (n = 4), ST744 (n = 4), ST23 (n = 3), ST58 (n = 2), ST88 (n = 2), ST117 (n = 2), and ST410 (n = 1). Twelve of them were third-generation cephalosporin-resistant. Resistance was mediated by blaCTX-M-55 (n = 7), blaCTX-M-14 (n = 4), blaCTX-M-8 (n = 1), and blaCMY-2 (n = 1). This study highlights the importance of food products and the food production chain as reservoirs of high-risk clones and resistance genes of epidemiological relevance to public health.</description>
	<pubDate>2025-08-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 8: Third-Generation Cephalosporin-Resistant Escherichia coli Isolates Belonging to High-Risk Clones Obtained from Fresh Pork Meat in La Plata City, Argentina</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/8">doi: 10.3390/msf2025035008</a></p>
	<p>Authors:
		Hernán D. Nievas
		Raúl E. Iza
		Camila Aurnague
		Elisa Helman
		Victorio F. Nievas
		Oliver Mounsey
		Lucia Galli
		Fabiana A. Moredo
		</p>
	<p>High-risk clones represent a major concern, as they are very efficient vehicles for mobile genetic elements carrying antimicrobial resistance genes and therefore promote their spread, especially if they confer resistance to cefotaxime, ciprofloxacin, and fosfomycin, included within the highest-priority, critically important antimicrobial agents (HPCIA). Between February 2022 and April 2024, 138 pork samples were obtained from 46 butcher shops in La Plata, Buenos Aires, Argentina. A total of 102 HPCIA-resistant E. coli were isolated. Eighty-five HPCIA-resistant E. coli were selected for whole-genome sequencing. Of these, 27 belonged to 9 clones described as high risk: ST101 (n = 5), ST10 (n = 4), ST48 (n = 4), ST744 (n = 4), ST23 (n = 3), ST58 (n = 2), ST88 (n = 2), ST117 (n = 2), and ST410 (n = 1). Twelve of them were third-generation cephalosporin-resistant. Resistance was mediated by blaCTX-M-55 (n = 7), blaCTX-M-14 (n = 4), blaCTX-M-8 (n = 1), and blaCMY-2 (n = 1). This study highlights the importance of food products and the food production chain as reservoirs of high-risk clones and resistance genes of epidemiological relevance to public health.</p>
	]]></content:encoded>

	<dc:title>Third-Generation Cephalosporin-Resistant Escherichia coli Isolates Belonging to High-Risk Clones Obtained from Fresh Pork Meat in La Plata City, Argentina</dc:title>
			<dc:creator>Hernán D. Nievas</dc:creator>
			<dc:creator>Raúl E. Iza</dc:creator>
			<dc:creator>Camila Aurnague</dc:creator>
			<dc:creator>Elisa Helman</dc:creator>
			<dc:creator>Victorio F. Nievas</dc:creator>
			<dc:creator>Oliver Mounsey</dc:creator>
			<dc:creator>Lucia Galli</dc:creator>
			<dc:creator>Fabiana A. Moredo</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035008</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-27</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-27</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>8</prism:startingPage>
		<prism:doi>10.3390/msf2025035008</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/8</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/13">

	<title>Medical Sciences Forum, Vol. 37, Pages 13: Satisfaction with Physiotherapy Care for Individuals with Cystic Fibrosis Across Face-to-Face, Online, and Blended Rehabilitation Settings</title>
	<link>https://www.mdpi.com/2673-9992/37/1/13</link>
	<description>This study assessed satisfaction with physiotherapy care for individuals with cystic fibrosis across face-to-face, online, and blended formats at the National Association for Cystic Fibrosis. Forty participants, including patients and legal representatives, reported high satisfaction overall. Key strengths included respectful communication, involvement in decision-making, scheduling flexibility, and therapist support. Face-to-face care received the highest ratings, though privacy, understanding, and engagement were consistently strong across all modalities. The results highlight the importance of patient-centred approaches and suggest that high-quality care can be delivered effectively across different treatment formats, reinforcing satisfaction as a key indicator of healthcare quality and effectiveness.</description>
	<pubDate>2025-08-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 13: Satisfaction with Physiotherapy Care for Individuals with Cystic Fibrosis Across Face-to-Face, Online, and Blended Rehabilitation Settings</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/13">doi: 10.3390/msf2025037013</a></p>
	<p>Authors:
		Sofia O. Vieira
		Ana Paula Martins
		Ângela Pereira
		Virgínia Marques
		Inês Gano
		Filipa Moita de Deus
		Margarida Sousa
		Sónia Vicente
		</p>
	<p>This study assessed satisfaction with physiotherapy care for individuals with cystic fibrosis across face-to-face, online, and blended formats at the National Association for Cystic Fibrosis. Forty participants, including patients and legal representatives, reported high satisfaction overall. Key strengths included respectful communication, involvement in decision-making, scheduling flexibility, and therapist support. Face-to-face care received the highest ratings, though privacy, understanding, and engagement were consistently strong across all modalities. The results highlight the importance of patient-centred approaches and suggest that high-quality care can be delivered effectively across different treatment formats, reinforcing satisfaction as a key indicator of healthcare quality and effectiveness.</p>
	]]></content:encoded>

	<dc:title>Satisfaction with Physiotherapy Care for Individuals with Cystic Fibrosis Across Face-to-Face, Online, and Blended Rehabilitation Settings</dc:title>
			<dc:creator>Sofia O. Vieira</dc:creator>
			<dc:creator>Ana Paula Martins</dc:creator>
			<dc:creator>Ângela Pereira</dc:creator>
			<dc:creator>Virgínia Marques</dc:creator>
			<dc:creator>Inês Gano</dc:creator>
			<dc:creator>Filipa Moita de Deus</dc:creator>
			<dc:creator>Margarida Sousa</dc:creator>
			<dc:creator>Sónia Vicente</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037013</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-27</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-27</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>13</prism:startingPage>
		<prism:doi>10.3390/msf2025037013</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/13</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/12">

	<title>Medical Sciences Forum, Vol. 37, Pages 12: Sexual Harassment in Higher Education Students</title>
	<link>https://www.mdpi.com/2673-9992/37/1/12</link>
	<description>Sexual harassment, globally recognized as a complex phenomenon, presents gaps regarding its characteristics and diversity of impacts, particularly in the Portuguese context. This study aims to better understand sexual harassment in Portuguese universities, namely the prevalence of these experiences, their types, perpetrators, and settings, as well as the psychosocial factors associated with them, specifically distress, intrusive negative thoughts, academic engagement, and resilience. Positive correlations were found between unwanted sexual experiences, distress, intrusive negative thoughts, and academic engagement. These findings highlight the need for more effective policies to prevent sexual harassment and for psychological support programs for victims of sexual harassment.</description>
	<pubDate>2025-08-27</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 12: Sexual Harassment in Higher Education Students</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/12">doi: 10.3390/msf2025037012</a></p>
	<p>Authors:
		Margarida M. C. Ramos
		Marta Reis
		Telma C. Almeida
		Jorge Cardoso
		</p>
	<p>Sexual harassment, globally recognized as a complex phenomenon, presents gaps regarding its characteristics and diversity of impacts, particularly in the Portuguese context. This study aims to better understand sexual harassment in Portuguese universities, namely the prevalence of these experiences, their types, perpetrators, and settings, as well as the psychosocial factors associated with them, specifically distress, intrusive negative thoughts, academic engagement, and resilience. Positive correlations were found between unwanted sexual experiences, distress, intrusive negative thoughts, and academic engagement. These findings highlight the need for more effective policies to prevent sexual harassment and for psychological support programs for victims of sexual harassment.</p>
	]]></content:encoded>

	<dc:title>Sexual Harassment in Higher Education Students</dc:title>
			<dc:creator>Margarida M. C. Ramos</dc:creator>
			<dc:creator>Marta Reis</dc:creator>
			<dc:creator>Telma C. Almeida</dc:creator>
			<dc:creator>Jorge Cardoso</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037012</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-27</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-27</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>12</prism:startingPage>
		<prism:doi>10.3390/msf2025037012</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/12</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/11">

	<title>Medical Sciences Forum, Vol. 37, Pages 11: Determinants of Exclusive Breastfeeding Duration: A Population-Based Study from Southern Portugal</title>
	<link>https://www.mdpi.com/2673-9992/37/1/11</link>
	<description>Exclusive breastfeeding for the first six months is the gold standard in infant nutrition, yet rates in Europe remain below recommendations. This descriptive cross-sectional study identified maternal, perinatal and social determinants associated with shorter exclusive breastfeeding duration in the Algarve region. Statistically significant factors included in-hospital formula use, caesarean section, lack of skin-to-skin contact, and negative or absent previous experience of breastfeeding. In-hospital formula use and previous breastfeeding duration emerged as key predictors. These findings emphasise the importance of integrated strategies across the healthcare, workplace, and policy sectors, aligned with the lived experiences of women, to effectively support breastfeeding.</description>
	<pubDate>2025-08-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 11: Determinants of Exclusive Breastfeeding Duration: A Population-Based Study from Southern Portugal</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/11">doi: 10.3390/msf2025037011</a></p>
	<p>Authors:
		Flávia Oliveira
		Sónia Vicente
		</p>
	<p>Exclusive breastfeeding for the first six months is the gold standard in infant nutrition, yet rates in Europe remain below recommendations. This descriptive cross-sectional study identified maternal, perinatal and social determinants associated with shorter exclusive breastfeeding duration in the Algarve region. Statistically significant factors included in-hospital formula use, caesarean section, lack of skin-to-skin contact, and negative or absent previous experience of breastfeeding. In-hospital formula use and previous breastfeeding duration emerged as key predictors. These findings emphasise the importance of integrated strategies across the healthcare, workplace, and policy sectors, aligned with the lived experiences of women, to effectively support breastfeeding.</p>
	]]></content:encoded>

	<dc:title>Determinants of Exclusive Breastfeeding Duration: A Population-Based Study from Southern Portugal</dc:title>
			<dc:creator>Flávia Oliveira</dc:creator>
			<dc:creator>Sónia Vicente</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037011</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-26</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-26</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>11</prism:startingPage>
		<prism:doi>10.3390/msf2025037011</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/11</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/10">

	<title>Medical Sciences Forum, Vol. 37, Pages 10: Influence of Coca-Cola&amp;reg; on Thermoplastic Degradation in Clear Orthodontic Aligners</title>
	<link>https://www.mdpi.com/2673-9992/37/1/10</link>
	<description>Clear orthodontic aligners, primarily composed of thermoplastic polymers, are increasingly popular but susceptible to degradation through thermal, chemical, and mechanical stress. This preliminary pilot study assessed the release of microplastics from two commercial aligner brands under simulated oral conditions. Aligners were exposed to daily cycles of Coca-Cola&amp;amp;reg; or artificial saliva, with mechanical agitation replicating masticatory friction. Fourier-transform infrared spectroscopy confirmed microplastic release in both environments, with a notably higher particle count after Coca-Cola&amp;amp;reg; exposure. These findings indicate the potential health and environmental risks linked to acidic beverage consumption during orthodontic treatment. Further comprehensive studies are required to validate and expand upon these results.</description>
	<pubDate>2025-08-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 10: Influence of Coca-Cola&amp;reg; on Thermoplastic Degradation in Clear Orthodontic Aligners</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/10">doi: 10.3390/msf2025037010</a></p>
	<p>Authors:
		Margarida Pitschieller
		Dinis Pereira
		Ana Sintra Delgado
		Carla Ascenso
		</p>
	<p>Clear orthodontic aligners, primarily composed of thermoplastic polymers, are increasingly popular but susceptible to degradation through thermal, chemical, and mechanical stress. This preliminary pilot study assessed the release of microplastics from two commercial aligner brands under simulated oral conditions. Aligners were exposed to daily cycles of Coca-Cola&amp;amp;reg; or artificial saliva, with mechanical agitation replicating masticatory friction. Fourier-transform infrared spectroscopy confirmed microplastic release in both environments, with a notably higher particle count after Coca-Cola&amp;amp;reg; exposure. These findings indicate the potential health and environmental risks linked to acidic beverage consumption during orthodontic treatment. Further comprehensive studies are required to validate and expand upon these results.</p>
	]]></content:encoded>

	<dc:title>Influence of Coca-Cola&amp;amp;reg; on Thermoplastic Degradation in Clear Orthodontic Aligners</dc:title>
			<dc:creator>Margarida Pitschieller</dc:creator>
			<dc:creator>Dinis Pereira</dc:creator>
			<dc:creator>Ana Sintra Delgado</dc:creator>
			<dc:creator>Carla Ascenso</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037010</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-26</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-26</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>10</prism:startingPage>
		<prism:doi>10.3390/msf2025037010</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/10</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/9">

	<title>Medical Sciences Forum, Vol. 37, Pages 9: Compensatory Muscle Activity Inhibition with Kinesiotape Application to the Unaffected Hemiface in a Person with Peripheral Facial Palsy: Two Case Reports</title>
	<link>https://www.mdpi.com/2673-9992/37/1/9</link>
	<description>Facial palsy (FP) is a nerve disorder causing unilateral facial muscle paralysis, impacting facial symmetry and non-verbal communication. This case study describes two idiopathic FP patients treated with physiotherapy and inhibitory kinesiotape (KT) applied to the unaffected side to reduce muscle hyperactivity. The intervention aimed to improve facial symmetry and psychological well-being. Both patients showed improvements in the Sunnybrook Facial Palsy Scale and the Hospital Anxiety and Depression Scale. Despite these promising outcomes, the small sample size limits our conclusions. Further controlled studies with larger samples are needed to confirm KT&amp;amp;rsquo;s effectiveness and clarify its role in FP rehabilitation.</description>
	<pubDate>2025-08-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 9: Compensatory Muscle Activity Inhibition with Kinesiotape Application to the Unaffected Hemiface in a Person with Peripheral Facial Palsy: Two Case Reports</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/9">doi: 10.3390/msf2025037009</a></p>
	<p>Authors:
		Ana Cristina Sequeira
		Cláudia Maria Costa
		Wanda Neves
		Sofia Pinto
		Maria do Céu Nunes
		António Ramos
		Angela Maria Pereira
		Susana Almeida
		</p>
	<p>Facial palsy (FP) is a nerve disorder causing unilateral facial muscle paralysis, impacting facial symmetry and non-verbal communication. This case study describes two idiopathic FP patients treated with physiotherapy and inhibitory kinesiotape (KT) applied to the unaffected side to reduce muscle hyperactivity. The intervention aimed to improve facial symmetry and psychological well-being. Both patients showed improvements in the Sunnybrook Facial Palsy Scale and the Hospital Anxiety and Depression Scale. Despite these promising outcomes, the small sample size limits our conclusions. Further controlled studies with larger samples are needed to confirm KT&amp;amp;rsquo;s effectiveness and clarify its role in FP rehabilitation.</p>
	]]></content:encoded>

	<dc:title>Compensatory Muscle Activity Inhibition with Kinesiotape Application to the Unaffected Hemiface in a Person with Peripheral Facial Palsy: Two Case Reports</dc:title>
			<dc:creator>Ana Cristina Sequeira</dc:creator>
			<dc:creator>Cláudia Maria Costa</dc:creator>
			<dc:creator>Wanda Neves</dc:creator>
			<dc:creator>Sofia Pinto</dc:creator>
			<dc:creator>Maria do Céu Nunes</dc:creator>
			<dc:creator>António Ramos</dc:creator>
			<dc:creator>Angela Maria Pereira</dc:creator>
			<dc:creator>Susana Almeida</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037009</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-25</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-25</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>9</prism:startingPage>
		<prism:doi>10.3390/msf2025037009</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/9</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/8">

	<title>Medical Sciences Forum, Vol. 37, Pages 8: Compassion Fatigue in Portuguese Firefighters: Preliminary Results of the Compassion Fatigue Scale</title>
	<link>https://www.mdpi.com/2673-9992/37/1/8</link>
	<description>The present study had the purpose of creating and studying the psychometric properties of the Compassion Fatigue Scale (CFS) in a sample of 286 firefighters, 69% of whom were males and 78% had previous exposure to a limit situation. All participants were assessed after their informed consent through a protocol composed of a sociodemographic data section, the CFS and the Professional Quality of Life scale (ProQOL). The CFS evidenced a two-dimensional structure, Compassion Fatigue and Compassion Satisfaction, with Cronbach&amp;amp;rsquo;s alphas superior to 0.90 and correlations in the expected direction with ProQOL. Females showed higher levels of compassion fatigue than males, demonstrating that CFS can be a reliable and valid self-report measure of compassion fatigue in firefighters.</description>
	<pubDate>2025-08-25</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 8: Compassion Fatigue in Portuguese Firefighters: Preliminary Results of the Compassion Fatigue Scale</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/8">doi: 10.3390/msf2025037008</a></p>
	<p>Authors:
		Lucas Sousa
		Joana Antunes
		Bruna Dias
		Adriana Coelho
		Karolina Costa
		Andreia Conceição
		Marina Carvalho
		Carla Tomás
		Mária Viegas
		</p>
	<p>The present study had the purpose of creating and studying the psychometric properties of the Compassion Fatigue Scale (CFS) in a sample of 286 firefighters, 69% of whom were males and 78% had previous exposure to a limit situation. All participants were assessed after their informed consent through a protocol composed of a sociodemographic data section, the CFS and the Professional Quality of Life scale (ProQOL). The CFS evidenced a two-dimensional structure, Compassion Fatigue and Compassion Satisfaction, with Cronbach&amp;amp;rsquo;s alphas superior to 0.90 and correlations in the expected direction with ProQOL. Females showed higher levels of compassion fatigue than males, demonstrating that CFS can be a reliable and valid self-report measure of compassion fatigue in firefighters.</p>
	]]></content:encoded>

	<dc:title>Compassion Fatigue in Portuguese Firefighters: Preliminary Results of the Compassion Fatigue Scale</dc:title>
			<dc:creator>Lucas Sousa</dc:creator>
			<dc:creator>Joana Antunes</dc:creator>
			<dc:creator>Bruna Dias</dc:creator>
			<dc:creator>Adriana Coelho</dc:creator>
			<dc:creator>Karolina Costa</dc:creator>
			<dc:creator>Andreia Conceição</dc:creator>
			<dc:creator>Marina Carvalho</dc:creator>
			<dc:creator>Carla Tomás</dc:creator>
			<dc:creator>Mária Viegas</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037008</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-25</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-25</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>8</prism:startingPage>
		<prism:doi>10.3390/msf2025037008</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/8</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/7">

	<title>Medical Sciences Forum, Vol. 37, Pages 7: Rethinking Science Teaching for the 21st Century: A SWOT Analysis of a Multi-Strategic Model</title>
	<link>https://www.mdpi.com/2673-9992/37/1/7</link>
	<description>This work presents the Integrated Multi-Strategy Teaching (IMST) model, developed for science education to enhance autonomy, engagement, and professional competencies. Applied in a pharmacy course, IMST combines flipped classrooms, peer assessment, and scenario-based learning. A SWOT analysis based on student and faculty feedback highlights strengths in skill development and practical relevance, while noting challenges such as workload and classroom constraints. The results support the effectiveness of IMST and suggest improvements to promote broader acceptance and sustainability.</description>
	<pubDate>2025-08-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 7: Rethinking Science Teaching for the 21st Century: A SWOT Analysis of a Multi-Strategic Model</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/7">doi: 10.3390/msf2025037007</a></p>
	<p>Authors:
		Ana Isabel Fernandes
		Margarida Miranda
		</p>
	<p>This work presents the Integrated Multi-Strategy Teaching (IMST) model, developed for science education to enhance autonomy, engagement, and professional competencies. Applied in a pharmacy course, IMST combines flipped classrooms, peer assessment, and scenario-based learning. A SWOT analysis based on student and faculty feedback highlights strengths in skill development and practical relevance, while noting challenges such as workload and classroom constraints. The results support the effectiveness of IMST and suggest improvements to promote broader acceptance and sustainability.</p>
	]]></content:encoded>

	<dc:title>Rethinking Science Teaching for the 21st Century: A SWOT Analysis of a Multi-Strategic Model</dc:title>
			<dc:creator>Ana Isabel Fernandes</dc:creator>
			<dc:creator>Margarida Miranda</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037007</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-21</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-21</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>7</prism:startingPage>
		<prism:doi>10.3390/msf2025037007</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/7</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/7">

	<title>Medical Sciences Forum, Vol. 35, Pages 7: Fourier Transform Infrared Spectroscopy-Based Detection of Amoxicillin and Ampicillin for Advancing Antibiotic Monitoring with Optical Techniques</title>
	<link>https://www.mdpi.com/2673-9992/35/1/7</link>
	<description>Introduction: Amoxicillin and Ampicillin are among the most widely used antibiotics for treating bacterial infections. While traditional drug monitoring methods often face challenges relative to accuracy and analysis speed, optical-based techniques offer a promising alternative. Fourier Transform Infrared Spectroscopy (FTIR), a well-established tool, is particularly suited for this purpose. As their molecular structures and characteristic infrared absorption features are very similar, they could be difficult to differentiate using FTIR spectroscopy. Hence, chemometric analysis is important to overcome this challenge. This study introduces a novel approach to the standard methods of antibiotic detection and monitoring, leveraging the capabilities of vibrational spectroscopy and helping in antimicrobial stewardship. Attenuated Total Reflection (ATR)&amp;amp;ndash;FTIR is carried out with chemometric tools to investigate Amoxicillin and Ampicillin over different degradation processes. Principal Component Analysis (PCA) was used in the fingerprint region to detect differences between the studied antibiotics. Additionally, absorbance intensity in the fingerprint region was monitored to assess the degradation of each antibiotic over time. To achieve this, the area under the curve was calculated and subjected to inferential statistical tests for both intragroup (the degradation of the same antibiotic) and intergroup (degradation within the same time interval, comparing the two antibiotics) comparisons. All analyses were performed in OriginLab and using Python in the Google Colab and Orange environments. For the calculations of the limit of detection (LoD), the method based on the calibration curve was used. Through the experiments, it was possible to identify the fingerprints of each antibiotic and statistically separate them, despite both belonging to the same class of antibiotics, where the spectral peaks appear in the same region. For degradation, all tests were conducted with a significance level of &amp;amp;alpha; = 5%. In this investigation, our results show several quantification characteristics with a detection limit of 96.76 mM for Ampicillin and 66.01 mM for Amoxicillin using the peak intensity. This research demonstrates that FTIR spectroscopy is effective for antibiotic detection and has the potential to be further developed into a monitoring protocol.</description>
	<pubDate>2025-08-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 7: Fourier Transform Infrared Spectroscopy-Based Detection of Amoxicillin and Ampicillin for Advancing Antibiotic Monitoring with Optical Techniques</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/7">doi: 10.3390/msf2025035007</a></p>
	<p>Authors:
		Vinicius Pereira Anjos
		Maria Renata Valente Brandão Freire
		Raffaele Stasi
		Daniela Fátima Teixeira Silva
		Denise Maria Zezell
		</p>
	<p>Introduction: Amoxicillin and Ampicillin are among the most widely used antibiotics for treating bacterial infections. While traditional drug monitoring methods often face challenges relative to accuracy and analysis speed, optical-based techniques offer a promising alternative. Fourier Transform Infrared Spectroscopy (FTIR), a well-established tool, is particularly suited for this purpose. As their molecular structures and characteristic infrared absorption features are very similar, they could be difficult to differentiate using FTIR spectroscopy. Hence, chemometric analysis is important to overcome this challenge. This study introduces a novel approach to the standard methods of antibiotic detection and monitoring, leveraging the capabilities of vibrational spectroscopy and helping in antimicrobial stewardship. Attenuated Total Reflection (ATR)&amp;amp;ndash;FTIR is carried out with chemometric tools to investigate Amoxicillin and Ampicillin over different degradation processes. Principal Component Analysis (PCA) was used in the fingerprint region to detect differences between the studied antibiotics. Additionally, absorbance intensity in the fingerprint region was monitored to assess the degradation of each antibiotic over time. To achieve this, the area under the curve was calculated and subjected to inferential statistical tests for both intragroup (the degradation of the same antibiotic) and intergroup (degradation within the same time interval, comparing the two antibiotics) comparisons. All analyses were performed in OriginLab and using Python in the Google Colab and Orange environments. For the calculations of the limit of detection (LoD), the method based on the calibration curve was used. Through the experiments, it was possible to identify the fingerprints of each antibiotic and statistically separate them, despite both belonging to the same class of antibiotics, where the spectral peaks appear in the same region. For degradation, all tests were conducted with a significance level of &amp;amp;alpha; = 5%. In this investigation, our results show several quantification characteristics with a detection limit of 96.76 mM for Ampicillin and 66.01 mM for Amoxicillin using the peak intensity. This research demonstrates that FTIR spectroscopy is effective for antibiotic detection and has the potential to be further developed into a monitoring protocol.</p>
	]]></content:encoded>

	<dc:title>Fourier Transform Infrared Spectroscopy-Based Detection of Amoxicillin and Ampicillin for Advancing Antibiotic Monitoring with Optical Techniques</dc:title>
			<dc:creator>Vinicius Pereira Anjos</dc:creator>
			<dc:creator>Maria Renata Valente Brandão Freire</dc:creator>
			<dc:creator>Raffaele Stasi</dc:creator>
			<dc:creator>Daniela Fátima Teixeira Silva</dc:creator>
			<dc:creator>Denise Maria Zezell</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035007</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-21</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-21</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>7</prism:startingPage>
		<prism:doi>10.3390/msf2025035007</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/7</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/5">

	<title>Medical Sciences Forum, Vol. 37, Pages 5: The Impact of a Modular Curriculum on Veterinary Students&amp;rsquo; Quality of Life and Academic Knowledge: Proof of Concept</title>
	<link>https://www.mdpi.com/2673-9992/37/1/5</link>
	<description>This study examined quality of life and deep learning among 109 veterinary medicine students across three cohorts (2021&amp;amp;ndash;2023) in an integrated modular curriculum in Portugal. Quality of life was measured three times per academic year using the WHOQOL-BREF, whereas deep learning was assessed twice yearly via assessment tests. The results revealed consistently low scores in the psychological domain of the quality-of-life assessment and a noticeable decline in both quality of life and assessment tests during the second year. These findings highlight the need to monitor student well-being and adapt teaching strategies to sustain motivation and academic success.</description>
	<pubDate>2025-08-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 5: The Impact of a Modular Curriculum on Veterinary Students&amp;rsquo; Quality of Life and Academic Knowledge: Proof of Concept</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/5">doi: 10.3390/msf2025037005</a></p>
	<p>Authors:
		Bárbara Gonçalves
		Joana Moreira da Silva
		Maria Soares
		Rita Pequito
		Lara Alves
		Liliana Silva
		Alexandre Trindade
		Manuel Pequito
		</p>
	<p>This study examined quality of life and deep learning among 109 veterinary medicine students across three cohorts (2021&amp;amp;ndash;2023) in an integrated modular curriculum in Portugal. Quality of life was measured three times per academic year using the WHOQOL-BREF, whereas deep learning was assessed twice yearly via assessment tests. The results revealed consistently low scores in the psychological domain of the quality-of-life assessment and a noticeable decline in both quality of life and assessment tests during the second year. These findings highlight the need to monitor student well-being and adapt teaching strategies to sustain motivation and academic success.</p>
	]]></content:encoded>

	<dc:title>The Impact of a Modular Curriculum on Veterinary Students&amp;amp;rsquo; Quality of Life and Academic Knowledge: Proof of Concept</dc:title>
			<dc:creator>Bárbara Gonçalves</dc:creator>
			<dc:creator>Joana Moreira da Silva</dc:creator>
			<dc:creator>Maria Soares</dc:creator>
			<dc:creator>Rita Pequito</dc:creator>
			<dc:creator>Lara Alves</dc:creator>
			<dc:creator>Liliana Silva</dc:creator>
			<dc:creator>Alexandre Trindade</dc:creator>
			<dc:creator>Manuel Pequito</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037005</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-20</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-20</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>5</prism:startingPage>
		<prism:doi>10.3390/msf2025037005</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/5</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/6">

	<title>Medical Sciences Forum, Vol. 37, Pages 6: Efficacy of Topical Sialogogues in Xerostomia Treatment on Chronic Residents of C.H.P.L.</title>
	<link>https://www.mdpi.com/2673-9992/37/1/6</link>
	<description>Institutionalized psychiatric patients on chronic psychotropic medication are prone to xerostomia due to reduced salivary flow. This study evaluated the effectiveness of a topical sialogogue gel (Xeros Dentaid&amp;amp;reg;) in relieving drug-induced dry mouth in 81 residents at the Lisbon Psychiatric Hospital Centre (C.H.P.L.). Over 15 days, unstimulated and stimulated salivary flow rates, pH, and buffer capacity were measured before and after application. Results showed a significant increase in salivary flow (p &amp;amp;lt; 0.001) and improved subjective symptoms. Topical sialogogues may represent an accessible and effective strategy for managing xerostomia in this vulnerable population.</description>
	<pubDate>2025-08-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 6: Efficacy of Topical Sialogogues in Xerostomia Treatment on Chronic Residents of C.H.P.L.</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/6">doi: 10.3390/msf2025037006</a></p>
	<p>Authors:
		Edna Verissimo
		Cecília Rozan
		Ana Cristina Manso
		</p>
	<p>Institutionalized psychiatric patients on chronic psychotropic medication are prone to xerostomia due to reduced salivary flow. This study evaluated the effectiveness of a topical sialogogue gel (Xeros Dentaid&amp;amp;reg;) in relieving drug-induced dry mouth in 81 residents at the Lisbon Psychiatric Hospital Centre (C.H.P.L.). Over 15 days, unstimulated and stimulated salivary flow rates, pH, and buffer capacity were measured before and after application. Results showed a significant increase in salivary flow (p &amp;amp;lt; 0.001) and improved subjective symptoms. Topical sialogogues may represent an accessible and effective strategy for managing xerostomia in this vulnerable population.</p>
	]]></content:encoded>

	<dc:title>Efficacy of Topical Sialogogues in Xerostomia Treatment on Chronic Residents of C.H.P.L.</dc:title>
			<dc:creator>Edna Verissimo</dc:creator>
			<dc:creator>Cecília Rozan</dc:creator>
			<dc:creator>Ana Cristina Manso</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037006</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-20</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-20</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>6</prism:startingPage>
		<prism:doi>10.3390/msf2025037006</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/6</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/4">

	<title>Medical Sciences Forum, Vol. 37, Pages 4: Patterns of Supplement Consumption and Interaction Risks Among Polymedicated Older Adults: A Descriptive Study</title>
	<link>https://www.mdpi.com/2673-9992/37/1/4</link>
	<description>This study investigates the use of food supplements (FS) among polymedicated elderly individuals and assesses potential FS&amp;amp;ndash;drug interaction risks. A total of 98 community-dwelling older adults were surveyed and 18.4% reported FS use. FS were mostly used for musculoskeletal and cognitive support, with 71% having potential metabolic interactions via CYP enzymes or P-glycoprotein. Monthly costs reached &amp;amp;euro;55. The findings reveal a complex interaction landscape and financial burden, underscoring the need for medication reviews and health literacy efforts to ensure safer FS use in older adults. This study aligns with One Health principles by linking clinical, social, and economic aspects of aging.</description>
	<pubDate>2025-08-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 4: Patterns of Supplement Consumption and Interaction Risks Among Polymedicated Older Adults: A Descriptive Study</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/4">doi: 10.3390/msf2025037004</a></p>
	<p>Authors:
		Maria Deolinda Auxtero
		Ana Isabel Fernandes
		</p>
	<p>This study investigates the use of food supplements (FS) among polymedicated elderly individuals and assesses potential FS&amp;amp;ndash;drug interaction risks. A total of 98 community-dwelling older adults were surveyed and 18.4% reported FS use. FS were mostly used for musculoskeletal and cognitive support, with 71% having potential metabolic interactions via CYP enzymes or P-glycoprotein. Monthly costs reached &amp;amp;euro;55. The findings reveal a complex interaction landscape and financial burden, underscoring the need for medication reviews and health literacy efforts to ensure safer FS use in older adults. This study aligns with One Health principles by linking clinical, social, and economic aspects of aging.</p>
	]]></content:encoded>

	<dc:title>Patterns of Supplement Consumption and Interaction Risks Among Polymedicated Older Adults: A Descriptive Study</dc:title>
			<dc:creator>Maria Deolinda Auxtero</dc:creator>
			<dc:creator>Ana Isabel Fernandes</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037004</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-19</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-19</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>4</prism:startingPage>
		<prism:doi>10.3390/msf2025037004</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/4</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/3">

	<title>Medical Sciences Forum, Vol. 37, Pages 3: Pharmaceutical Profiling of Fentanyl Use in Portugal: Consumption Patterns and Abuse Deterrence Gaps</title>
	<link>https://www.mdpi.com/2673-9992/37/1/3</link>
	<description>Fentanyl, a potent synthetic opioid used in pain management, has seen a marked rise in outpatient use in Portugal between 2015 and 2022. During this period, consumption nearly doubled, with transdermal patches and sublingual tablets dominating the market. Rapid-onset formulations lacking abuse-deterrent features pose have heightened the risks of misuse and diversion. Despite these concerns, no abuse-deterrent fentanyl products are currently available in Portugal. These findings expose critical regulatory and pharmaceutical gaps. To mitigate public health and environmental risks, a coordinated strategy&amp;amp;mdash;encompassing prescription monitoring, education, safer formulations, and a One Health approach&amp;amp;mdash;is urgently needed to ensure responsible opioid use and stewardship.</description>
	<pubDate>2025-08-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 3: Pharmaceutical Profiling of Fentanyl Use in Portugal: Consumption Patterns and Abuse Deterrence Gaps</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/3">doi: 10.3390/msf2025037003</a></p>
	<p>Authors:
		Ana Isabel Fernandes
		</p>
	<p>Fentanyl, a potent synthetic opioid used in pain management, has seen a marked rise in outpatient use in Portugal between 2015 and 2022. During this period, consumption nearly doubled, with transdermal patches and sublingual tablets dominating the market. Rapid-onset formulations lacking abuse-deterrent features pose have heightened the risks of misuse and diversion. Despite these concerns, no abuse-deterrent fentanyl products are currently available in Portugal. These findings expose critical regulatory and pharmaceutical gaps. To mitigate public health and environmental risks, a coordinated strategy&amp;amp;mdash;encompassing prescription monitoring, education, safer formulations, and a One Health approach&amp;amp;mdash;is urgently needed to ensure responsible opioid use and stewardship.</p>
	]]></content:encoded>

	<dc:title>Pharmaceutical Profiling of Fentanyl Use in Portugal: Consumption Patterns and Abuse Deterrence Gaps</dc:title>
			<dc:creator>Ana Isabel Fernandes</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-19</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-19</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2025037003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/2">

	<title>Medical Sciences Forum, Vol. 37, Pages 2: Attitudes Toward Community Service Among Higher Health Sciences Students</title>
	<link>https://www.mdpi.com/2673-9992/37/1/2</link>
	<description>University Social Responsibility (USR) integrates academic goals with ethics, civic engagement, and sustainability. This study assessed community service attitudes among 529 higher health sciences students using the Portuguese Community Service Attitudes Scale. Although 52.9% reported prior volunteer experience, 75.2% had not participated in community service during university. An association was found between academic programme and prior involvement, particularly among Dental Medicine and Physiotherapy students. While no sex differences were observed, programme-specific trends suggest that practical training fosters stronger civic responsibility. Integrating structured, discipline-specific community service into curricula may enhance civic identity and better align education with sustainable development goals.</description>
	<pubDate>2025-08-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 2: Attitudes Toward Community Service Among Higher Health Sciences Students</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/2">doi: 10.3390/msf2025037002</a></p>
	<p>Authors:
		Sónia Vicente
		Ângela Maria Pereira
		Ana Cristina Vidal
		Cláudia Maria Costa
		</p>
	<p>University Social Responsibility (USR) integrates academic goals with ethics, civic engagement, and sustainability. This study assessed community service attitudes among 529 higher health sciences students using the Portuguese Community Service Attitudes Scale. Although 52.9% reported prior volunteer experience, 75.2% had not participated in community service during university. An association was found between academic programme and prior involvement, particularly among Dental Medicine and Physiotherapy students. While no sex differences were observed, programme-specific trends suggest that practical training fosters stronger civic responsibility. Integrating structured, discipline-specific community service into curricula may enhance civic identity and better align education with sustainable development goals.</p>
	]]></content:encoded>

	<dc:title>Attitudes Toward Community Service Among Higher Health Sciences Students</dc:title>
			<dc:creator>Sónia Vicente</dc:creator>
			<dc:creator>Ângela Maria Pereira</dc:creator>
			<dc:creator>Ana Cristina Vidal</dc:creator>
			<dc:creator>Cláudia Maria Costa</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-19</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-19</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2025037002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/37/1/1">

	<title>Medical Sciences Forum, Vol. 37, Pages 1: A One Health Perspective on the Clinical, Behavioural, and Environmental Risks of Chronic Proton Pump Inhibitor Use in Older Adults</title>
	<link>https://www.mdpi.com/2673-9992/37/1/1</link>
	<description>This study explores the clinical, behavioural, and environmental risks of chronic proton pump inhibitor (PPI) use in older adults through a One Health perspective. Among 246 participants, 32.5% were receiving PPI therapy, with 91.3% on long-term treatment, frequently lacking clear clinical justification. Polypharmacy, drug interactions, and risky lifestyle behaviours were common. Environmental review highlighted the potential persistence of PPI transformation products in water systems, raising concerns about ecological impact and antimicrobial resistance. These findings underscore the urgency of implementing deprescribing strategies, enhancing patient education, and adopting sustainable prescribing practices that align human and environmental health.</description>
	<pubDate>2025-08-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 37, Pages 1: A One Health Perspective on the Clinical, Behavioural, and Environmental Risks of Chronic Proton Pump Inhibitor Use in Older Adults</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/37/1/1">doi: 10.3390/msf2025037001</a></p>
	<p>Authors:
		Maria Deolinda Auxtero
		</p>
	<p>This study explores the clinical, behavioural, and environmental risks of chronic proton pump inhibitor (PPI) use in older adults through a One Health perspective. Among 246 participants, 32.5% were receiving PPI therapy, with 91.3% on long-term treatment, frequently lacking clear clinical justification. Polypharmacy, drug interactions, and risky lifestyle behaviours were common. Environmental review highlighted the potential persistence of PPI transformation products in water systems, raising concerns about ecological impact and antimicrobial resistance. These findings underscore the urgency of implementing deprescribing strategies, enhancing patient education, and adopting sustainable prescribing practices that align human and environmental health.</p>
	]]></content:encoded>

	<dc:title>A One Health Perspective on the Clinical, Behavioural, and Environmental Risks of Chronic Proton Pump Inhibitor Use in Older Adults</dc:title>
			<dc:creator>Maria Deolinda Auxtero</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025037001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-18</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-18</prism:publicationDate>
	<prism:volume>37</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025037001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/37/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/6">

	<title>Medical Sciences Forum, Vol. 35, Pages 6: Restoration of Antibiotic Effectiveness with P. hartigii Extract Against Multidrug-Resistant E. coli&amp;nbsp;</title>
	<link>https://www.mdpi.com/2673-9992/35/1/6</link>
	<description>Antibiotic resistance poses a critical threat to global health, largely driven by bacterial efflux pumps that expel antibiotics and reduce their efficacy. This study investigated the potential of Phellinus hartigii ethyl acetate extract (Ph-Ace) to inhibit efflux pumps and restore antibiotic activity against multidrug-resistant Escherichia coli strains. In vitro assays demonstrated that Ph-Ace effectively inhibited efflux pumps, enhancing the efficacy of resistant antibiotics. GC/MS analysis identified key components such as nonadecane and octacosane. These findings suggest Ph-Ace as a promising natural efflux pump inhibitor. Further molecular and clinical studies are required to confirm its therapeutic potential.</description>
	<pubDate>2025-08-15</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 6: Restoration of Antibiotic Effectiveness with P. hartigii Extract Against Multidrug-Resistant E. coli&amp;nbsp;</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/6">doi: 10.3390/msf2025035006</a></p>
	<p>Authors:
		Eda Altınöz
		Ilgaz Akata
		Ergin Murat Altuner
		</p>
	<p>Antibiotic resistance poses a critical threat to global health, largely driven by bacterial efflux pumps that expel antibiotics and reduce their efficacy. This study investigated the potential of Phellinus hartigii ethyl acetate extract (Ph-Ace) to inhibit efflux pumps and restore antibiotic activity against multidrug-resistant Escherichia coli strains. In vitro assays demonstrated that Ph-Ace effectively inhibited efflux pumps, enhancing the efficacy of resistant antibiotics. GC/MS analysis identified key components such as nonadecane and octacosane. These findings suggest Ph-Ace as a promising natural efflux pump inhibitor. Further molecular and clinical studies are required to confirm its therapeutic potential.</p>
	]]></content:encoded>

	<dc:title>Restoration of Antibiotic Effectiveness with P. hartigii Extract Against Multidrug-Resistant E. coli&amp;amp;nbsp;</dc:title>
			<dc:creator>Eda Altınöz</dc:creator>
			<dc:creator>Ilgaz Akata</dc:creator>
			<dc:creator>Ergin Murat Altuner</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035006</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-15</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-15</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>6</prism:startingPage>
		<prism:doi>10.3390/msf2025035006</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/6</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/5">

	<title>Medical Sciences Forum, Vol. 35, Pages 5: Enterococcus faecalis Biofilm: A Clinical and Environmental Hazard</title>
	<link>https://www.mdpi.com/2673-9992/35/1/5</link>
	<description>This review explores the biofilm architecture and drug resistance of Enterococcus faecalis in clinical and environmental settings. The biofilm in E. faecalis is a heterogeneous, three-dimensional, mushroom-like or multilayered structure, characteristically forming diplococci or short chains interspersed with water channels for nutrient exchange and waste removal. Exopolysaccharides, proteins, lipids, and extracellular DNA create a protective matrix. Persister cells within the biofilm contribute to antibiotic resistance and survival. The heterogeneous architecture of the E. faecalis biofilm contains both dense clusters and loosely packed regions that vary in thickness, ranging from 10 to 100 &amp;amp;micro;m, depending on the environmental conditions. The pathogenicity of the E. faecalis biofilm is mediated through complex interactions between genes and virulence factors such as DNA release, cytolysin, pili, secreted antigen A, and microbial surface components that recognize adhesive matrix molecules, often involving a key protein called enterococcal surface protein (Esp). Clinically, it is implicated in a range of nosocomial infections, including urinary tract infections, endocarditis, and surgical wound infections. The biofilm serves as a nidus for bacterial dissemination and as a reservoir for antimicrobial resistance. The effectiveness of first-line antibiotics (ampicillin, vancomycin, and aminoglycosides) is diminished due to reduced penetration, altered metabolism, increased tolerance, and intrinsic and acquired resistance. Alternative strategies for biofilm disruption, such as combination therapy (ampicillin with aminoglycosides), as well as newer approaches, including antimicrobial peptides, quorum-sensing inhibitors, and biofilm-disrupting agents (DNase or dispersin B), are also being explored to improve treatment outcomes. Environmentally, E. faecalis biofilms contribute to contamination in water systems, food production facilities, and healthcare environments. They persist in harsh conditions, facilitating the spread of multidrug-resistant strains and increasing the risk of transmission to humans and animals. Therefore, understanding the biofilm architecture and drug resistance is essential for developing effective strategies to mitigate their clinical and environmental impact.</description>
	<pubDate>2025-08-05</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 5: Enterococcus faecalis Biofilm: A Clinical and Environmental Hazard</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/5">doi: 10.3390/msf2025035005</a></p>
	<p>Authors:
		Bindu Sadanandan
		Kavyasree Marabanahalli Yogendraiah
		</p>
	<p>This review explores the biofilm architecture and drug resistance of Enterococcus faecalis in clinical and environmental settings. The biofilm in E. faecalis is a heterogeneous, three-dimensional, mushroom-like or multilayered structure, characteristically forming diplococci or short chains interspersed with water channels for nutrient exchange and waste removal. Exopolysaccharides, proteins, lipids, and extracellular DNA create a protective matrix. Persister cells within the biofilm contribute to antibiotic resistance and survival. The heterogeneous architecture of the E. faecalis biofilm contains both dense clusters and loosely packed regions that vary in thickness, ranging from 10 to 100 &amp;amp;micro;m, depending on the environmental conditions. The pathogenicity of the E. faecalis biofilm is mediated through complex interactions between genes and virulence factors such as DNA release, cytolysin, pili, secreted antigen A, and microbial surface components that recognize adhesive matrix molecules, often involving a key protein called enterococcal surface protein (Esp). Clinically, it is implicated in a range of nosocomial infections, including urinary tract infections, endocarditis, and surgical wound infections. The biofilm serves as a nidus for bacterial dissemination and as a reservoir for antimicrobial resistance. The effectiveness of first-line antibiotics (ampicillin, vancomycin, and aminoglycosides) is diminished due to reduced penetration, altered metabolism, increased tolerance, and intrinsic and acquired resistance. Alternative strategies for biofilm disruption, such as combination therapy (ampicillin with aminoglycosides), as well as newer approaches, including antimicrobial peptides, quorum-sensing inhibitors, and biofilm-disrupting agents (DNase or dispersin B), are also being explored to improve treatment outcomes. Environmentally, E. faecalis biofilms contribute to contamination in water systems, food production facilities, and healthcare environments. They persist in harsh conditions, facilitating the spread of multidrug-resistant strains and increasing the risk of transmission to humans and animals. Therefore, understanding the biofilm architecture and drug resistance is essential for developing effective strategies to mitigate their clinical and environmental impact.</p>
	]]></content:encoded>

	<dc:title>Enterococcus faecalis Biofilm: A Clinical and Environmental Hazard</dc:title>
			<dc:creator>Bindu Sadanandan</dc:creator>
			<dc:creator>Kavyasree Marabanahalli Yogendraiah</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035005</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-05</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-05</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>5</prism:startingPage>
		<prism:doi>10.3390/msf2025035005</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/5</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/4">

	<title>Medical Sciences Forum, Vol. 35, Pages 4: Surveillance of Antimicrobial Use in Animal Production: A Cross-Sectional Study of Kaduna Metropolis, Nigeria</title>
	<link>https://www.mdpi.com/2673-9992/35/1/4</link>
	<description>Measuring antimicrobial use (AMU) in animal production can provide useful data for monitoring AMU over time, which will promote antimicrobial resistance (AMR) reduction. This study involved the daily collation and validation of active primary drug sales and prescription data from veterinary outlets and clinics of the Kaduna metropolis. In total, 83.7% of the identified antimicrobials were in the form of oral medication, and most were registered antibiotics (52.8%). Parenteral and topical forms were also identified, with 94% also being antibiotics. The estimated AMU was 282 mg/kg population correction unit (PCU). Poultry represented the most significant population, constituting 99% (31,502,004) of the study population. The class-specific AMU was antibiotics, with 274 mg/kg PCU. The antiprotozoal AMU was 418 mg/kg PCU. The anthelminthic AMU was the highest at 576 mg/kg PCU. This study has provided useful and practical information on the trends in antimicrobial use in animals, with poultry being the most important animal population involved in AMU and oxytetracycline being the most abused antibiotic in animal production. Antimicrobial stewardship (AMS) should be targeted at poultry populations, with an emphasis on reducing antibiotic use/consumption.</description>
	<pubDate>2025-08-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 4: Surveillance of Antimicrobial Use in Animal Production: A Cross-Sectional Study of Kaduna Metropolis, Nigeria</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/4">doi: 10.3390/msf2025035004</a></p>
	<p>Authors:
		Aliyu Abdulkadir
		Marvelous Oluwashina Ajayi
		Halima Abubakar Kusfa
		</p>
	<p>Measuring antimicrobial use (AMU) in animal production can provide useful data for monitoring AMU over time, which will promote antimicrobial resistance (AMR) reduction. This study involved the daily collation and validation of active primary drug sales and prescription data from veterinary outlets and clinics of the Kaduna metropolis. In total, 83.7% of the identified antimicrobials were in the form of oral medication, and most were registered antibiotics (52.8%). Parenteral and topical forms were also identified, with 94% also being antibiotics. The estimated AMU was 282 mg/kg population correction unit (PCU). Poultry represented the most significant population, constituting 99% (31,502,004) of the study population. The class-specific AMU was antibiotics, with 274 mg/kg PCU. The antiprotozoal AMU was 418 mg/kg PCU. The anthelminthic AMU was the highest at 576 mg/kg PCU. This study has provided useful and practical information on the trends in antimicrobial use in animals, with poultry being the most important animal population involved in AMU and oxytetracycline being the most abused antibiotic in animal production. Antimicrobial stewardship (AMS) should be targeted at poultry populations, with an emphasis on reducing antibiotic use/consumption.</p>
	]]></content:encoded>

	<dc:title>Surveillance of Antimicrobial Use in Animal Production: A Cross-Sectional Study of Kaduna Metropolis, Nigeria</dc:title>
			<dc:creator>Aliyu Abdulkadir</dc:creator>
			<dc:creator>Marvelous Oluwashina Ajayi</dc:creator>
			<dc:creator>Halima Abubakar Kusfa</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035004</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-08-04</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-08-04</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>4</prism:startingPage>
		<prism:doi>10.3390/msf2025035004</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/4</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/33/1/5">

	<title>Medical Sciences Forum, Vol. 33, Pages 5: Monitoring the Health of Our Oceans: From the Sea Surface to the Seafloor</title>
	<link>https://www.mdpi.com/2673-9992/33/1/5</link>
	<description>Overfishing represents one of the most alarming threats to marine conservation in the Mediterranean Sea. In particular, deep-sea trawl fishing can severely damage marine habitats that may take decades to recover due to their slow growth rates. Hence, monitoring the health and subsistence of deep-sea ecosystems in fishing hotspots is vital to understand the impacts of deep-sea fishing. This paper presents a methodological study to prepare an expedition in Sardinian (Italy) deep waters. The methodology is composed of three sections: first, it offers a comparative analysis of the proper technological mix to identify fishing hotspots pre-expedition; second, it simulates an in situ expedition to monitor the state of deep-sea ecosystems in proximity of the fishing hotspots identified; and third, it offers recommendations for data analysis and management post-expedition. This study offers a replicable methodology for advancing knowledge on the state of deep-sea ecosystems affected by trawl fishing.</description>
	<pubDate>2025-07-30</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 33, Pages 5: Monitoring the Health of Our Oceans: From the Sea Surface to the Seafloor</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/33/1/5">doi: 10.3390/msf2025033005</a></p>
	<p>Authors:
		Carol Maione
		</p>
	<p>Overfishing represents one of the most alarming threats to marine conservation in the Mediterranean Sea. In particular, deep-sea trawl fishing can severely damage marine habitats that may take decades to recover due to their slow growth rates. Hence, monitoring the health and subsistence of deep-sea ecosystems in fishing hotspots is vital to understand the impacts of deep-sea fishing. This paper presents a methodological study to prepare an expedition in Sardinian (Italy) deep waters. The methodology is composed of three sections: first, it offers a comparative analysis of the proper technological mix to identify fishing hotspots pre-expedition; second, it simulates an in situ expedition to monitor the state of deep-sea ecosystems in proximity of the fishing hotspots identified; and third, it offers recommendations for data analysis and management post-expedition. This study offers a replicable methodology for advancing knowledge on the state of deep-sea ecosystems affected by trawl fishing.</p>
	]]></content:encoded>

	<dc:title>Monitoring the Health of Our Oceans: From the Sea Surface to the Seafloor</dc:title>
			<dc:creator>Carol Maione</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025033005</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-07-30</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-07-30</prism:publicationDate>
	<prism:volume>33</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>5</prism:startingPage>
		<prism:doi>10.3390/msf2025033005</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/33/1/5</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/3">

	<title>Medical Sciences Forum, Vol. 35, Pages 3: RhsP2 Protein as a New Antibacterial Toxin Targeting RNA</title>
	<link>https://www.mdpi.com/2673-9992/35/1/3</link>
	<description>Many bacteria, such as Pseudomonas aeruginosa, have encoded many toxins like RhsP2 that target non-coding RNAs (ncRNAs) in a similar mechanism to ART components; bacterial RNA loses its function of amino acid translation. A virtual screening approach was used to investigate RhsP2, which targets 16s rRNAs and then disrupts the translation of bacterial amino acids to proteins. Rifamycin is the bioreference as it forms a stable complex with the bacterial RNA in its active sites. Using different docking software can determine the best predicted conformations between RhsP2/16S and rRNA, and analyzing the docking score for both Affinity Binding and the root mean square deviation (RMSD) of particle coordinates helps choose the most appropriate drugs by using tools such as bioinformatics platforms and databases.</description>
	<pubDate>2025-07-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 3: RhsP2 Protein as a New Antibacterial Toxin Targeting RNA</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/3">doi: 10.3390/msf2025035003</a></p>
	<p>Authors:
		Tamara Nami Haj Marza
		</p>
	<p>Many bacteria, such as Pseudomonas aeruginosa, have encoded many toxins like RhsP2 that target non-coding RNAs (ncRNAs) in a similar mechanism to ART components; bacterial RNA loses its function of amino acid translation. A virtual screening approach was used to investigate RhsP2, which targets 16s rRNAs and then disrupts the translation of bacterial amino acids to proteins. Rifamycin is the bioreference as it forms a stable complex with the bacterial RNA in its active sites. Using different docking software can determine the best predicted conformations between RhsP2/16S and rRNA, and analyzing the docking score for both Affinity Binding and the root mean square deviation (RMSD) of particle coordinates helps choose the most appropriate drugs by using tools such as bioinformatics platforms and databases.</p>
	]]></content:encoded>

	<dc:title>RhsP2 Protein as a New Antibacterial Toxin Targeting RNA</dc:title>
			<dc:creator>Tamara Nami Haj Marza</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-07-24</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-07-24</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2025035003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/33/1/4">

	<title>Medical Sciences Forum, Vol. 33, Pages 4: From Sea to Plate: The Plastic Pollution Problem in the Food Chain</title>
	<link>https://www.mdpi.com/2673-9992/33/1/4</link>
	<description>The rising concern over plastic pollution is not only related to pollution in marine and terrestrial habitats but also effects humans. This study analyzes the trophic transfer of microplastics throughout the food chain, with an emphasis on the effects on human health. It provides a review of 12 articles analyzing the microplastic intake by humans via ingestion of fish and environmental exposure. In particular, the reviewed studies focused on microplastic ingestion by fish and animals intended for human consumption, the distribution of microplastics in human tissues, and human blood. The results of this analysis can extend our understanding of microplastic transfer in the human body, with implications for future research.</description>
	<pubDate>2025-07-15</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 33, Pages 4: From Sea to Plate: The Plastic Pollution Problem in the Food Chain</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/33/1/4">doi: 10.3390/msf2025033004</a></p>
	<p>Authors:
		Carolyne Shealy
		Gabriela Fernandez
		Domenico Vito
		Carol Maione
		</p>
	<p>The rising concern over plastic pollution is not only related to pollution in marine and terrestrial habitats but also effects humans. This study analyzes the trophic transfer of microplastics throughout the food chain, with an emphasis on the effects on human health. It provides a review of 12 articles analyzing the microplastic intake by humans via ingestion of fish and environmental exposure. In particular, the reviewed studies focused on microplastic ingestion by fish and animals intended for human consumption, the distribution of microplastics in human tissues, and human blood. The results of this analysis can extend our understanding of microplastic transfer in the human body, with implications for future research.</p>
	]]></content:encoded>

	<dc:title>From Sea to Plate: The Plastic Pollution Problem in the Food Chain</dc:title>
			<dc:creator>Carolyne Shealy</dc:creator>
			<dc:creator>Gabriela Fernandez</dc:creator>
			<dc:creator>Domenico Vito</dc:creator>
			<dc:creator>Carol Maione</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025033004</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-07-15</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-07-15</prism:publicationDate>
	<prism:volume>33</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>4</prism:startingPage>
		<prism:doi>10.3390/msf2025033004</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/33/1/4</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/36/1/1">

	<title>Medical Sciences Forum, Vol. 36, Pages 1: Abstracts of the X Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 10)</title>
	<link>https://www.mdpi.com/2673-9992/36/1/1</link>
	<description>The Spanish Group for Cancer Immuno-Biotherapies (G&amp;amp;Eacute;TICA) held the X Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 10) from 14 to 16 March 2024, in Seville (Spain). FIT Cancer is the largest meeting uniquely focused on cancer immunotherapy in Spain and brings together clinicians and researchers, with expertise in the field of cancer immunology and immunotherapy. Here, we present abstracts submitted by G&amp;amp;Eacute;TICA&amp;amp;rsquo;s members to the X Forum on Translational Immunology and Cancer Immunotherapy, which were divided into three topics: cell-based immunotherapies, novel therapeutic targets and strategies and clinical scenarios and potential biomarkers.</description>
	<pubDate>2025-07-10</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 36, Pages 1: Abstracts of the X Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 10)</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/36/1/1">doi: 10.3390/msf2025036001</a></p>
	<p>Authors:
		Francisco Aya
		Luis de la Cruz
		Delvys Rodríguez-Abreu
		Luis Álvarez-Vallina
		Manel Juan
		Antonio José Conde-Moreno
		Elisabeth Pérez-Ruiz
		Xabier Mielgo
		Ana Arance
		</p>
	<p>The Spanish Group for Cancer Immuno-Biotherapies (G&amp;amp;Eacute;TICA) held the X Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 10) from 14 to 16 March 2024, in Seville (Spain). FIT Cancer is the largest meeting uniquely focused on cancer immunotherapy in Spain and brings together clinicians and researchers, with expertise in the field of cancer immunology and immunotherapy. Here, we present abstracts submitted by G&amp;amp;Eacute;TICA&amp;amp;rsquo;s members to the X Forum on Translational Immunology and Cancer Immunotherapy, which were divided into three topics: cell-based immunotherapies, novel therapeutic targets and strategies and clinical scenarios and potential biomarkers.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the X Forum on Translational Immunology and Cancer Immunotherapy (FIT Cancer 10)</dc:title>
			<dc:creator>Francisco Aya</dc:creator>
			<dc:creator>Luis de la Cruz</dc:creator>
			<dc:creator>Delvys Rodríguez-Abreu</dc:creator>
			<dc:creator>Luis Álvarez-Vallina</dc:creator>
			<dc:creator>Manel Juan</dc:creator>
			<dc:creator>Antonio José Conde-Moreno</dc:creator>
			<dc:creator>Elisabeth Pérez-Ruiz</dc:creator>
			<dc:creator>Xabier Mielgo</dc:creator>
			<dc:creator>Ana Arance</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025036001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-07-10</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-07-10</prism:publicationDate>
	<prism:volume>36</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025036001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/36/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/33/1/3">

	<title>Medical Sciences Forum, Vol. 33, Pages 3: Mapping Public Sentiment: A Data-Driven Analysis of COVID-19 Discourse on Social Media in Italy</title>
	<link>https://www.mdpi.com/2673-9992/33/1/3</link>
	<description>This study provides a detailed analysis of COVID-19-related social media discourse in Italy, using 535,886 tweets from 10 major cities between 30 August 2020 and 8 June 2021. The tweets were translated from Italian to English for analysis. A multifaceted methodology was employed: Latent Dirichlet Allocation (LDA) identified 20 key themes; sentiment analysis, using TextBlob, Flair, and TweetNLP, and emotion recognition using TweetNLP, revealed the emotional tone of the discourse, with 453 tweets unanimously positive across all algorithms. TextBlob was used for lexical analysis to rank the most salient positive and negative terms. The results indicated that positive sentiments centered on hope, safety measures, and vaccination progress, while negative sentiments focused on fear, death, and quarantine frustrations. This research offers valuable insights for public health officials, enabling tailored messaging, real-time strategy monitoring, and agile policymaking during the pandemic, with implications for future health crises.</description>
	<pubDate>2025-07-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 33, Pages 3: Mapping Public Sentiment: A Data-Driven Analysis of COVID-19 Discourse on Social Media in Italy</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/33/1/3">doi: 10.3390/msf2025033003</a></p>
	<p>Authors:
		Gabriela Fernandez
		Siddharth Suresh-Babu
		Domenico Vito
		</p>
	<p>This study provides a detailed analysis of COVID-19-related social media discourse in Italy, using 535,886 tweets from 10 major cities between 30 August 2020 and 8 June 2021. The tweets were translated from Italian to English for analysis. A multifaceted methodology was employed: Latent Dirichlet Allocation (LDA) identified 20 key themes; sentiment analysis, using TextBlob, Flair, and TweetNLP, and emotion recognition using TweetNLP, revealed the emotional tone of the discourse, with 453 tweets unanimously positive across all algorithms. TextBlob was used for lexical analysis to rank the most salient positive and negative terms. The results indicated that positive sentiments centered on hope, safety measures, and vaccination progress, while negative sentiments focused on fear, death, and quarantine frustrations. This research offers valuable insights for public health officials, enabling tailored messaging, real-time strategy monitoring, and agile policymaking during the pandemic, with implications for future health crises.</p>
	]]></content:encoded>

	<dc:title>Mapping Public Sentiment: A Data-Driven Analysis of COVID-19 Discourse on Social Media in Italy</dc:title>
			<dc:creator>Gabriela Fernandez</dc:creator>
			<dc:creator>Siddharth Suresh-Babu</dc:creator>
			<dc:creator>Domenico Vito</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025033003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-07-08</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-07-08</prism:publicationDate>
	<prism:volume>33</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2025033003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/33/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/34/1/3">

	<title>Medical Sciences Forum, Vol. 34, Pages 3: Molecular Docking Study of Natural Compounds Targeting the &amp;beta;2-Adrenergic Receptor (&amp;beta;2-AR)</title>
	<link>https://www.mdpi.com/2673-9992/34/1/3</link>
	<description>G-protein-coupled receptors (GPCRs) are vital transmembrane proteins that regulate a wide range of physiological processes by transmitting extracellular signals into intracellular responses. Among them, the &amp;amp;beta;2-adrenergic receptor (&amp;amp;beta;2-AR) plays a central role in bronchodilation, smooth muscle relaxation, and cardiovascular modulation, making it a key therapeutic target for diseases such as asthma, chronic obstructive pulmonary disease (COPD), and hypertension. This study explores the potential of natural bioactive compounds like ephedrine, quercetin, catechin, and resveratrol as alternative ligands for &amp;amp;beta;2-AR through molecular docking analysis. Using AutoDock 4.6, these compounds were docked with the binding site of the &amp;amp;beta;2-AR (PDB ID: 2RH1), and their binding affinities and interaction map were evaluated. Results showed that all compounds exhibited favorable binding energies and stable interactions with key receptor residues, with quercetin demonstrating the highest affinity. The findings suggest that these natural compounds may serve as promising leads for the development of safer, plant-derived modulators of &amp;amp;beta;2-AR, supporting the role of computational approaches in natural product-based drug discovery. However, as docking cannot determine functional activity, these findings should be interpreted as preliminary and require experimental validation.</description>
	<pubDate>2025-07-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 34, Pages 3: Molecular Docking Study of Natural Compounds Targeting the &amp;beta;2-Adrenergic Receptor (&amp;beta;2-AR)</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/34/1/3">doi: 10.3390/msf2025034003</a></p>
	<p>Authors:
		Sepideh Jafari
		Joanna Bojarska
		</p>
	<p>G-protein-coupled receptors (GPCRs) are vital transmembrane proteins that regulate a wide range of physiological processes by transmitting extracellular signals into intracellular responses. Among them, the &amp;amp;beta;2-adrenergic receptor (&amp;amp;beta;2-AR) plays a central role in bronchodilation, smooth muscle relaxation, and cardiovascular modulation, making it a key therapeutic target for diseases such as asthma, chronic obstructive pulmonary disease (COPD), and hypertension. This study explores the potential of natural bioactive compounds like ephedrine, quercetin, catechin, and resveratrol as alternative ligands for &amp;amp;beta;2-AR through molecular docking analysis. Using AutoDock 4.6, these compounds were docked with the binding site of the &amp;amp;beta;2-AR (PDB ID: 2RH1), and their binding affinities and interaction map were evaluated. Results showed that all compounds exhibited favorable binding energies and stable interactions with key receptor residues, with quercetin demonstrating the highest affinity. The findings suggest that these natural compounds may serve as promising leads for the development of safer, plant-derived modulators of &amp;amp;beta;2-AR, supporting the role of computational approaches in natural product-based drug discovery. However, as docking cannot determine functional activity, these findings should be interpreted as preliminary and require experimental validation.</p>
	]]></content:encoded>

	<dc:title>Molecular Docking Study of Natural Compounds Targeting the &amp;amp;beta;2-Adrenergic Receptor (&amp;amp;beta;2-AR)</dc:title>
			<dc:creator>Sepideh Jafari</dc:creator>
			<dc:creator>Joanna Bojarska</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025034003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-07-08</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-07-08</prism:publicationDate>
	<prism:volume>34</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2025034003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/34/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/32/1/5">

	<title>Medical Sciences Forum, Vol. 32, Pages 5: Leveraging Digital Health for Pandemic Response: Reliable Telemonitoring and Personalized Patient Care</title>
	<link>https://www.mdpi.com/2673-9992/32/1/5</link>
	<description>The COVID-19 pandemic exposed the urgent need for scalable, reliable telemedicine tools to manage mild cases remotely and avoid overburdening healthcare systems. This study evaluates StepCare, a remote monitoring medical device, during the first pandemic wave at a single center in Spain. Among 35 patients monitored, StepCare showed high clinical reliability, aligning with physician assessments in 90.4% of cases. Patients and clinicians reported excellent usability and satisfaction. The system improved workflow efficiency, reducing triage time by 25% and associated costs by 84%. These results highlight StepCare&amp;amp;rsquo;s value as a scalable, patient-centered solution for remote care during health crises.</description>
	<pubDate>2025-07-08</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 32, Pages 5: Leveraging Digital Health for Pandemic Response: Reliable Telemonitoring and Personalized Patient Care</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/32/1/5">doi: 10.3390/msf2025032005</a></p>
	<p>Authors:
		Maria Montserrat Pérez García
		Ainhoa Berasategi Artieda
		Amaia Mendizabal Olaizola
		Idoya Lizaso Vaquero
		Francisco Diaz Tore
		Macarena Sevilla
		Ainhoa Bastarrika
		Ainhoa Ariceta
		Darya Chyzhyk
		Maider Alberich
		Manuel Millet Sampedro
		</p>
	<p>The COVID-19 pandemic exposed the urgent need for scalable, reliable telemedicine tools to manage mild cases remotely and avoid overburdening healthcare systems. This study evaluates StepCare, a remote monitoring medical device, during the first pandemic wave at a single center in Spain. Among 35 patients monitored, StepCare showed high clinical reliability, aligning with physician assessments in 90.4% of cases. Patients and clinicians reported excellent usability and satisfaction. The system improved workflow efficiency, reducing triage time by 25% and associated costs by 84%. These results highlight StepCare&amp;amp;rsquo;s value as a scalable, patient-centered solution for remote care during health crises.</p>
	]]></content:encoded>

	<dc:title>Leveraging Digital Health for Pandemic Response: Reliable Telemonitoring and Personalized Patient Care</dc:title>
			<dc:creator>Maria Montserrat Pérez García</dc:creator>
			<dc:creator>Ainhoa Berasategi Artieda</dc:creator>
			<dc:creator>Amaia Mendizabal Olaizola</dc:creator>
			<dc:creator>Idoya Lizaso Vaquero</dc:creator>
			<dc:creator>Francisco Diaz Tore</dc:creator>
			<dc:creator>Macarena Sevilla</dc:creator>
			<dc:creator>Ainhoa Bastarrika</dc:creator>
			<dc:creator>Ainhoa Ariceta</dc:creator>
			<dc:creator>Darya Chyzhyk</dc:creator>
			<dc:creator>Maider Alberich</dc:creator>
			<dc:creator>Manuel Millet Sampedro</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025032005</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-07-08</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-07-08</prism:publicationDate>
	<prism:volume>32</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>5</prism:startingPage>
		<prism:doi>10.3390/msf2025032005</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/32/1/5</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/2">

	<title>Medical Sciences Forum, Vol. 35, Pages 2: Antimicrobial Resistance and Virulence in Escherichia coli from Broiler Production Unit: Genetic Insights for One Health</title>
	<link>https://www.mdpi.com/2673-9992/35/1/2</link>
	<description>The overuse of antibiotics in livestock contributes to antimicrobial resistance and zoonotic risk. This study investigated 19 Escherichia coli isolates from broiler feces (Savinor, Portugal), characterizing resistance genes, virulence factors, integrases, and phylogenetic groups by PCR. Most isolates carried ampC, tetA, blaCTX-M, and qnrS; all harbored fimA, and six had int1. Phylogroup A predominated. Resistance was mainly found in commensal groups, highlighting adaptation to poultry environments. The findings underscore the need for regional antimicrobial resistance monitoring and One Health strategies. Stewardship, biosecurity, and alternative measures are vital to mitigate antimicrobial resistance spread and zoonotic potential.</description>
	<pubDate>2025-07-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 2: Antimicrobial Resistance and Virulence in Escherichia coli from Broiler Production Unit: Genetic Insights for One Health</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/2">doi: 10.3390/msf2025035002</a></p>
	<p>Authors:
		Jessica Ribeiro
		Vanessa Silva
		Gilberto Igrejas
		Sandrina A. Heleno
		Filipa S. Reis
		Patrícia Poeta
		</p>
	<p>The overuse of antibiotics in livestock contributes to antimicrobial resistance and zoonotic risk. This study investigated 19 Escherichia coli isolates from broiler feces (Savinor, Portugal), characterizing resistance genes, virulence factors, integrases, and phylogenetic groups by PCR. Most isolates carried ampC, tetA, blaCTX-M, and qnrS; all harbored fimA, and six had int1. Phylogroup A predominated. Resistance was mainly found in commensal groups, highlighting adaptation to poultry environments. The findings underscore the need for regional antimicrobial resistance monitoring and One Health strategies. Stewardship, biosecurity, and alternative measures are vital to mitigate antimicrobial resistance spread and zoonotic potential.</p>
	]]></content:encoded>

	<dc:title>Antimicrobial Resistance and Virulence in Escherichia coli from Broiler Production Unit: Genetic Insights for One Health</dc:title>
			<dc:creator>Jessica Ribeiro</dc:creator>
			<dc:creator>Vanessa Silva</dc:creator>
			<dc:creator>Gilberto Igrejas</dc:creator>
			<dc:creator>Sandrina A. Heleno</dc:creator>
			<dc:creator>Filipa S. Reis</dc:creator>
			<dc:creator>Patrícia Poeta</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-07-07</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-07-07</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2025035002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/35/1/1">

	<title>Medical Sciences Forum, Vol. 35, Pages 1: Abstracts of the 4th International Electronic Conference on Antibiotics</title>
	<link>https://www.mdpi.com/2673-9992/35/1/1</link>
	<description>The 4th International Electronic Conference on Antibiotics (ECA2025) was an online conference held on 21&amp;amp;ndash;23 May 2025, organized by the MDPI journal Antibiotics. This event aims to bring together researchers and scholars to discuss a wide range of topics covering the aim and scope of Antibiotics. We envision this conference as a highly interactive forum open to diverse interaction between its participants. It serves as a platform covering a broad range of topics, publishing papers on all aspects of antibiotics and encompassing the general fields of biochemistry, chemistry, genetics, microbiology, and pharmacology.</description>
	<pubDate>2025-07-02</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 35, Pages 1: Abstracts of the 4th International Electronic Conference on Antibiotics</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/35/1/1">doi: 10.3390/msf2025035001</a></p>
	<p>Authors:
		Manuel Simões
		Marc Maresca
		</p>
	<p>The 4th International Electronic Conference on Antibiotics (ECA2025) was an online conference held on 21&amp;amp;ndash;23 May 2025, organized by the MDPI journal Antibiotics. This event aims to bring together researchers and scholars to discuss a wide range of topics covering the aim and scope of Antibiotics. We envision this conference as a highly interactive forum open to diverse interaction between its participants. It serves as a platform covering a broad range of topics, publishing papers on all aspects of antibiotics and encompassing the general fields of biochemistry, chemistry, genetics, microbiology, and pharmacology.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 4th International Electronic Conference on Antibiotics</dc:title>
			<dc:creator>Manuel Simões</dc:creator>
			<dc:creator>Marc Maresca</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025035001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-07-02</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-07-02</prism:publicationDate>
	<prism:volume>35</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025035001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/35/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/32/1/4">

	<title>Medical Sciences Forum, Vol. 32, Pages 4: Advancements in Nanotechnology for Orthopedic Applications: A Comprehensive Overview of Nanomaterials in Bone Tissue Engineering and Implant Innovation</title>
	<link>https://www.mdpi.com/2673-9992/32/1/4</link>
	<description>Orthopedic implant technology has historically seen difficulties in attaining long-term stability and biological integration, leading to complications such as implant loosening, wear debris production, and heightened infection risk. Nanotechnology provides a revolutionary method for addressing these constraints through the introduction of materials characterized by exceptional biocompatibility, durability, and integration potential. Nanomaterials (NMs), characterized by distinctive surface topographies and elevated surface area-to-volume ratios, facilitate improved osseointegration and provide regulated medication release, thereby creating a localized therapeutic milieu surrounding the implant site. To overcome the long-standing constraints of conventional implants, such as poor osseointegration, low mechanical fixation, immunological rejection, and implant-related infections, nanotechnology is causing a revolution in the field of orthopedic research. NMs are ideally suited for orthopedic applications due to their exceptional features, including increased tribology, wear resistance, prolonged drug administration, and excellent tissue regeneration. Because of their nanoscale size, they can imitate the hierarchical structure of real bone, which in turn encourages the proliferation of cells, lowers the risk of infection, and helps with the mending of bone fractures. This article will investigate the wide-ranging possibilities of nanostructured ceramics, polymers, metals, and carbon materials in bone tissue engineering, diagnostics, and the treatment of implant-related infections, bone malignancies, and bone healing. In addition, this paper will provide a basic overview of the most recent discoveries in nanotechnology driving the future of translational orthopedic research. It will also highlight safety evaluations and regulatory requirements for orthopedic devices.</description>
	<pubDate>2025-06-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 32, Pages 4: Advancements in Nanotechnology for Orthopedic Applications: A Comprehensive Overview of Nanomaterials in Bone Tissue Engineering and Implant Innovation</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/32/1/4">doi: 10.3390/msf2025032004</a></p>
	<p>Authors:
		Newton Neogi
		Kristi Priya Choudhury
		Sabbir Hossain
		Ibrahim Hossain
		</p>
	<p>Orthopedic implant technology has historically seen difficulties in attaining long-term stability and biological integration, leading to complications such as implant loosening, wear debris production, and heightened infection risk. Nanotechnology provides a revolutionary method for addressing these constraints through the introduction of materials characterized by exceptional biocompatibility, durability, and integration potential. Nanomaterials (NMs), characterized by distinctive surface topographies and elevated surface area-to-volume ratios, facilitate improved osseointegration and provide regulated medication release, thereby creating a localized therapeutic milieu surrounding the implant site. To overcome the long-standing constraints of conventional implants, such as poor osseointegration, low mechanical fixation, immunological rejection, and implant-related infections, nanotechnology is causing a revolution in the field of orthopedic research. NMs are ideally suited for orthopedic applications due to their exceptional features, including increased tribology, wear resistance, prolonged drug administration, and excellent tissue regeneration. Because of their nanoscale size, they can imitate the hierarchical structure of real bone, which in turn encourages the proliferation of cells, lowers the risk of infection, and helps with the mending of bone fractures. This article will investigate the wide-ranging possibilities of nanostructured ceramics, polymers, metals, and carbon materials in bone tissue engineering, diagnostics, and the treatment of implant-related infections, bone malignancies, and bone healing. In addition, this paper will provide a basic overview of the most recent discoveries in nanotechnology driving the future of translational orthopedic research. It will also highlight safety evaluations and regulatory requirements for orthopedic devices.</p>
	]]></content:encoded>

	<dc:title>Advancements in Nanotechnology for Orthopedic Applications: A Comprehensive Overview of Nanomaterials in Bone Tissue Engineering and Implant Innovation</dc:title>
			<dc:creator>Newton Neogi</dc:creator>
			<dc:creator>Kristi Priya Choudhury</dc:creator>
			<dc:creator>Sabbir Hossain</dc:creator>
			<dc:creator>Ibrahim Hossain</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025032004</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-06-26</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-06-26</prism:publicationDate>
	<prism:volume>32</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>4</prism:startingPage>
		<prism:doi>10.3390/msf2025032004</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/32/1/4</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/32/1/3">

	<title>Medical Sciences Forum, Vol. 32, Pages 3: Improving Bone Protection Provision for Patients with Fragility Fractures</title>
	<link>https://www.mdpi.com/2673-9992/32/1/3</link>
	<description>Osteoporosis therapy is a crucial component of fragility fracture patients&amp;amp;rsquo; care. A Quality Improvement Project (QIP) was undertaken to review and improve such bone protection practice within a busy UK hospital orthopaedic department. Full-loop audit cycles, totalling 216 patients, were conducted before and after the implementation of a single-page checklist. This intervention significantly increased consultant-led osteoporosis plans by 37%, enhanced bone-sparing treatment administration by 20%, and eliminated unsafe prescriptions. Provision timeliness was not affected, but the communication of correct discharge information was significantly improved by 27%, and staff surveys showed the checklist was well-received, easy-to-use, and educational. Hopefully this will encourage other orthogeriatric teams to utilise a similarly effective and simple QI strategy.</description>
	<pubDate>2025-06-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 32, Pages 3: Improving Bone Protection Provision for Patients with Fragility Fractures</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/32/1/3">doi: 10.3390/msf2025032003</a></p>
	<p>Authors:
		Aaron Goldberg
		</p>
	<p>Osteoporosis therapy is a crucial component of fragility fracture patients&amp;amp;rsquo; care. A Quality Improvement Project (QIP) was undertaken to review and improve such bone protection practice within a busy UK hospital orthopaedic department. Full-loop audit cycles, totalling 216 patients, were conducted before and after the implementation of a single-page checklist. This intervention significantly increased consultant-led osteoporosis plans by 37%, enhanced bone-sparing treatment administration by 20%, and eliminated unsafe prescriptions. Provision timeliness was not affected, but the communication of correct discharge information was significantly improved by 27%, and staff surveys showed the checklist was well-received, easy-to-use, and educational. Hopefully this will encourage other orthogeriatric teams to utilise a similarly effective and simple QI strategy.</p>
	]]></content:encoded>

	<dc:title>Improving Bone Protection Provision for Patients with Fragility Fractures</dc:title>
			<dc:creator>Aaron Goldberg</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025032003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-06-20</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-06-20</prism:publicationDate>
	<prism:volume>32</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2025032003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/32/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/34/1/2">

	<title>Medical Sciences Forum, Vol. 34, Pages 2: In Silico Evaluation of Diketopiperazine (DPK) Derivatives as Potential Inhibitors for G-Protein-Coupled Receptors (GPCRs)</title>
	<link>https://www.mdpi.com/2673-9992/34/1/2</link>
	<description>G-protein-coupled receptors (GPCRs) are a group of various membrane proteins that mediate essential physiological processes by translating extracellular signals into intracellular responses. The &amp;amp;beta;2-Adrenergic Receptor (&amp;amp;beta;2-AR), a key GPCR, plays a critical role in smooth muscle relaxation, bronchodilation, and cardiovascular function, making it an important therapeutic target for diseases such as asthma and hypertension. Diketopiperazines (DPKs), as cyclic peptides, have shown promise as scaffolds for inhibiting protein interactions and modulating receptor activity, offering a potential alternative to traditional small-molecule inhibitors with reduced side effects. In this study, five DPK derivatives were selected from the PubChem database and evaluated for their binding affinity to the 3D structure of &amp;amp;beta;2-AR (PDB ID = 2RH1) through molecular docking studies using AutoDock 4.6 and MGLTools. The binding energy and hydrogen bond formation of each compound were evaluated to determine their interaction efficiency. Among the compounds, tryptophan-proline diketopiperazine (compound 3) exhibited the highest binding affinity with a binding energy of &amp;amp;minus;5.89 kcal/mol. This enhanced interaction is attributed to the aromatic nature of tryptophan, which promotes strong &amp;amp;pi;-&amp;amp;pi; stacking interactions, and the rigidity of proline, which optimally fits within the receptor&amp;amp;rsquo;s binding pocket. Hydrophobic interactions further stabilized the complex. These findings highlight compound 3 as a promising &amp;amp;beta;2-AR modulator, providing valuable insights for the design of peptide-based inhibitors targeting &amp;amp;beta;2-AR-related pathologies.</description>
	<pubDate>2025-06-19</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 34, Pages 2: In Silico Evaluation of Diketopiperazine (DPK) Derivatives as Potential Inhibitors for G-Protein-Coupled Receptors (GPCRs)</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/34/1/2">doi: 10.3390/msf2025034002</a></p>
	<p>Authors:
		Sepideh Jafari
		Joanna Bojarska
		</p>
	<p>G-protein-coupled receptors (GPCRs) are a group of various membrane proteins that mediate essential physiological processes by translating extracellular signals into intracellular responses. The &amp;amp;beta;2-Adrenergic Receptor (&amp;amp;beta;2-AR), a key GPCR, plays a critical role in smooth muscle relaxation, bronchodilation, and cardiovascular function, making it an important therapeutic target for diseases such as asthma and hypertension. Diketopiperazines (DPKs), as cyclic peptides, have shown promise as scaffolds for inhibiting protein interactions and modulating receptor activity, offering a potential alternative to traditional small-molecule inhibitors with reduced side effects. In this study, five DPK derivatives were selected from the PubChem database and evaluated for their binding affinity to the 3D structure of &amp;amp;beta;2-AR (PDB ID = 2RH1) through molecular docking studies using AutoDock 4.6 and MGLTools. The binding energy and hydrogen bond formation of each compound were evaluated to determine their interaction efficiency. Among the compounds, tryptophan-proline diketopiperazine (compound 3) exhibited the highest binding affinity with a binding energy of &amp;amp;minus;5.89 kcal/mol. This enhanced interaction is attributed to the aromatic nature of tryptophan, which promotes strong &amp;amp;pi;-&amp;amp;pi; stacking interactions, and the rigidity of proline, which optimally fits within the receptor&amp;amp;rsquo;s binding pocket. Hydrophobic interactions further stabilized the complex. These findings highlight compound 3 as a promising &amp;amp;beta;2-AR modulator, providing valuable insights for the design of peptide-based inhibitors targeting &amp;amp;beta;2-AR-related pathologies.</p>
	]]></content:encoded>

	<dc:title>In Silico Evaluation of Diketopiperazine (DPK) Derivatives as Potential Inhibitors for G-Protein-Coupled Receptors (GPCRs)</dc:title>
			<dc:creator>Sepideh Jafari</dc:creator>
			<dc:creator>Joanna Bojarska</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025034002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-06-19</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-06-19</prism:publicationDate>
	<prism:volume>34</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2025034002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/34/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/34/1/1">

	<title>Medical Sciences Forum, Vol. 34, Pages 1: Abstracts of the 3rd International Electronic Conference on Biomedicines</title>
	<link>https://www.mdpi.com/2673-9992/34/1/1</link>
	<description>The 3rd International Electronic Conference on Biomedicines (ECB 2025) was an online event held from 12 to 15 May 2025, by the journal Biomedicines MDPI. The goal of this conference was to enable scientists to present their latest research in the field of biomedicines, especially on the discovery and characterization of new therapeutic targets in the era of precise medicine, and to engage in discussions with the scientific community worldwide. Recent advances in biomedical research have provided an advanced insight into the biological background of human disease, setting the groundwork for the development of new therapeutic strategies. The agenda of the conference included, but was not limited to, the following topics: insulin resistance or hyperinsulinemia; immunotherapy and adverse effects; the tumor microenvironment; the immune system, tumor immunology, and autoimmune disease; biomedicine in cardiovascular diseases; diabetes, obesity, and metabolic diseases; gene therapy and gene editing; rare diseases; and molecular mechanisms of neurodegeneration.</description>
	<pubDate>2025-06-13</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 34, Pages 1: Abstracts of the 3rd International Electronic Conference on Biomedicines</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/34/1/1">doi: 10.3390/msf2025034001</a></p>
	<p>Authors:
		Felipe Fregni
		Allan Stensballe
		Georgia Levidou
		Serafino Fazio
		</p>
	<p>The 3rd International Electronic Conference on Biomedicines (ECB 2025) was an online event held from 12 to 15 May 2025, by the journal Biomedicines MDPI. The goal of this conference was to enable scientists to present their latest research in the field of biomedicines, especially on the discovery and characterization of new therapeutic targets in the era of precise medicine, and to engage in discussions with the scientific community worldwide. Recent advances in biomedical research have provided an advanced insight into the biological background of human disease, setting the groundwork for the development of new therapeutic strategies. The agenda of the conference included, but was not limited to, the following topics: insulin resistance or hyperinsulinemia; immunotherapy and adverse effects; the tumor microenvironment; the immune system, tumor immunology, and autoimmune disease; biomedicine in cardiovascular diseases; diabetes, obesity, and metabolic diseases; gene therapy and gene editing; rare diseases; and molecular mechanisms of neurodegeneration.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 3rd International Electronic Conference on Biomedicines</dc:title>
			<dc:creator>Felipe Fregni</dc:creator>
			<dc:creator>Allan Stensballe</dc:creator>
			<dc:creator>Georgia Levidou</dc:creator>
			<dc:creator>Serafino Fazio</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025034001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-06-13</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-06-13</prism:publicationDate>
	<prism:volume>34</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025034001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/34/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/32/1/2">

	<title>Medical Sciences Forum, Vol. 32, Pages 2: Impact of Propensity Score-Adjusted Targeted Intervention on Survival Outcomes Among Patients with HIV: A Clinical Trial Analysis</title>
	<link>https://www.mdpi.com/2673-9992/32/1/2</link>
	<description>Background: This study investigates the survival outcomes of individuals with HIV receiving different treatment regimens compared to a control group. Utilizing a cohort dataset with demographic and clinical information, this research aims to assess the impact of various factors, including age, education, and travel time, on survival while controlling for confounding effects using propensity score adjustment. Methods: A total of 380 patients with HIV were included in this study, categorized into an intervention group receiving a specific treatment regimen and a control group. The primary outcome measured was the time to death or censoring. Survival analysis was performed using the Cox proportional hazards model, adjusted for potential confounders, including treatment (intervention and control), age, education, travel time, and gestational age at enrollment. Propensity scores were also incorporated to adjust for treatment selection bias. Results: The Cox model revealed a significant protective effect of the intervention on survival (hazard ratio (HR) = 0.583, p = 0.045), indicating that the treatment improved survival outcomes compared to the control group. After adjusting for propensity scores, the relationship between the intervention and survival remained significant (HR = 0.631, p = 0.106), suggesting the robustness of the treatment&amp;amp;rsquo;s effect even after accounting for confounding variables. Other covariates, such as age, education, and travel time, did not show significant independent effects on survival, likely due to their correlation with the treatment variable. Conclusions: This study highlights the crucial role of the intervention in enhancing survival among individuals with HIV. The use of propensity score adjustment improves the validity of these findings by mitigating confounding bias in observational data. These results highlight the importance of ART (antiretroviral therapy) in HIV management and demonstrate the utility of statistical methods like propensity scores in clinical research. Further studies with diverse populations and advanced methodologies are recommended to validate these findings across different settings.</description>
	<pubDate>2025-06-04</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 32, Pages 2: Impact of Propensity Score-Adjusted Targeted Intervention on Survival Outcomes Among Patients with HIV: A Clinical Trial Analysis</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/32/1/2">doi: 10.3390/msf2025032002</a></p>
	<p>Authors:
		Ibrahim Abubakar Sadiq
		Abubakar Usman
		Jibril Yahaya Kajuru
		Yahaya Zakari
		Sani Ibrahim Doguwa
		Idris Zubairu Sadiq
		Aliyu Ismail Ishaq
		</p>
	<p>Background: This study investigates the survival outcomes of individuals with HIV receiving different treatment regimens compared to a control group. Utilizing a cohort dataset with demographic and clinical information, this research aims to assess the impact of various factors, including age, education, and travel time, on survival while controlling for confounding effects using propensity score adjustment. Methods: A total of 380 patients with HIV were included in this study, categorized into an intervention group receiving a specific treatment regimen and a control group. The primary outcome measured was the time to death or censoring. Survival analysis was performed using the Cox proportional hazards model, adjusted for potential confounders, including treatment (intervention and control), age, education, travel time, and gestational age at enrollment. Propensity scores were also incorporated to adjust for treatment selection bias. Results: The Cox model revealed a significant protective effect of the intervention on survival (hazard ratio (HR) = 0.583, p = 0.045), indicating that the treatment improved survival outcomes compared to the control group. After adjusting for propensity scores, the relationship between the intervention and survival remained significant (HR = 0.631, p = 0.106), suggesting the robustness of the treatment&amp;amp;rsquo;s effect even after accounting for confounding variables. Other covariates, such as age, education, and travel time, did not show significant independent effects on survival, likely due to their correlation with the treatment variable. Conclusions: This study highlights the crucial role of the intervention in enhancing survival among individuals with HIV. The use of propensity score adjustment improves the validity of these findings by mitigating confounding bias in observational data. These results highlight the importance of ART (antiretroviral therapy) in HIV management and demonstrate the utility of statistical methods like propensity scores in clinical research. Further studies with diverse populations and advanced methodologies are recommended to validate these findings across different settings.</p>
	]]></content:encoded>

	<dc:title>Impact of Propensity Score-Adjusted Targeted Intervention on Survival Outcomes Among Patients with HIV: A Clinical Trial Analysis</dc:title>
			<dc:creator>Ibrahim Abubakar Sadiq</dc:creator>
			<dc:creator>Abubakar Usman</dc:creator>
			<dc:creator>Jibril Yahaya Kajuru</dc:creator>
			<dc:creator>Yahaya Zakari</dc:creator>
			<dc:creator>Sani Ibrahim Doguwa</dc:creator>
			<dc:creator>Idris Zubairu Sadiq</dc:creator>
			<dc:creator>Aliyu Ismail Ishaq</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025032002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-06-04</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-06-04</prism:publicationDate>
	<prism:volume>32</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2025032002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/32/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/33/1/2">

	<title>Medical Sciences Forum, Vol. 33, Pages 2: The Association of the Global Climate Crisis with Environmental Risks and the Impact of Heat Stress on Occupational Safety, Health, and Hygiene</title>
	<link>https://www.mdpi.com/2673-9992/33/1/2</link>
	<description>The relationship between the global climate crisis, which is associated with environmental risks, and occupational hygiene has not been extensively studied. This study develops a framework for identifying how climate change and the climate crisis could impact the workplace environment, workers, and occupational morbidity, mortality, and injury. A framework is used in this paper that is based on a review of the scientific literature published from 2014 to 2024, addressing climate risks, their interaction with occupational hazards, and their effects on the workforce. Eight categories of climate-related hazards are identified: increasingly high temperatures, dust and air pollution, sun and cosmic ultraviolet exposure, pandemics and infectious diseases, diseases transmitted by insects and changes in ecosystems, industrial occupational diseases, changes and crises in the built environment, and extreme weather events. Policies need to consider the gaps in the possibility of interactions between known hazards and new conditions and the productivity of workers, especially those who are most at risk of heat-related illnesses.</description>
	<pubDate>2025-05-21</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 33, Pages 2: The Association of the Global Climate Crisis with Environmental Risks and the Impact of Heat Stress on Occupational Safety, Health, and Hygiene</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/33/1/2">doi: 10.3390/msf2025033002</a></p>
	<p>Authors:
		Ioannis Adamopoulos
		Niki Syrou
		George Mpourazanis
		Theodoros C. Constantinidis
		George Dounias
		</p>
	<p>The relationship between the global climate crisis, which is associated with environmental risks, and occupational hygiene has not been extensively studied. This study develops a framework for identifying how climate change and the climate crisis could impact the workplace environment, workers, and occupational morbidity, mortality, and injury. A framework is used in this paper that is based on a review of the scientific literature published from 2014 to 2024, addressing climate risks, their interaction with occupational hazards, and their effects on the workforce. Eight categories of climate-related hazards are identified: increasingly high temperatures, dust and air pollution, sun and cosmic ultraviolet exposure, pandemics and infectious diseases, diseases transmitted by insects and changes in ecosystems, industrial occupational diseases, changes and crises in the built environment, and extreme weather events. Policies need to consider the gaps in the possibility of interactions between known hazards and new conditions and the productivity of workers, especially those who are most at risk of heat-related illnesses.</p>
	]]></content:encoded>

	<dc:title>The Association of the Global Climate Crisis with Environmental Risks and the Impact of Heat Stress on Occupational Safety, Health, and Hygiene</dc:title>
			<dc:creator>Ioannis Adamopoulos</dc:creator>
			<dc:creator>Niki Syrou</dc:creator>
			<dc:creator>George Mpourazanis</dc:creator>
			<dc:creator>Theodoros C. Constantinidis</dc:creator>
			<dc:creator>George Dounias</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025033002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-05-21</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-05-21</prism:publicationDate>
	<prism:volume>33</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2025033002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/33/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/30/1/1">

	<title>Medical Sciences Forum, Vol. 30, Pages 1: Abstracts of the 2nd International Electronic Conference on Vaccines (IECV 2024), 27&amp;ndash;29 November 2024</title>
	<link>https://www.mdpi.com/2673-9992/30/1/1</link>
	<description>The 2nd International Electronic Conference on Vaccines (IECV 2024) took place online from 27 to 29 November 2024. This conference report is a collection of abstracts from six different sessions of IECV 2024.</description>
	<pubDate>2025-04-17</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 30, Pages 1: Abstracts of the 2nd International Electronic Conference on Vaccines (IECV 2024), 27&amp;ndash;29 November 2024</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/30/1/1">doi: 10.3390/msf2025030001</a></p>
	<p>Authors:
		Sara Louise Cosby
		</p>
	<p>The 2nd International Electronic Conference on Vaccines (IECV 2024) took place online from 27 to 29 November 2024. This conference report is a collection of abstracts from six different sessions of IECV 2024.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 2nd International Electronic Conference on Vaccines (IECV 2024), 27&amp;amp;ndash;29 November 2024</dc:title>
			<dc:creator>Sara Louise Cosby</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025030001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-04-17</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-04-17</prism:publicationDate>
	<prism:volume>30</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025030001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/30/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/33/1/1">

	<title>Medical Sciences Forum, Vol. 33, Pages 1: Climate Change Risks and Impacts on Public Health Correlated with Air Pollution&amp;mdash;African Dust in South Europe</title>
	<link>https://www.mdpi.com/2673-9992/33/1/1</link>
	<description>Climate change poses a significant risk to the environment and public health, leading to extreme weather patterns, rising sea levels, and loss of biodiversity. The relationship between air pollution from African dust and climate change demonstrates its critical role in trapping heat in the atmosphere, resulting in heat-related illnesses, heart problems, and respiratory issues. This research points to the detrimental effects of pollutants such as smog, dust, acid rain, and ozone depletion on ecosystems, highlighting the importance of using geographically weighted regression modeling and the MODIS-NDVI analysis to address air pollution. Particulate Matter (PM2.5&amp;amp;ndash;10) and ozone levels can have negative impacts on respiratory and cardiovascular health. Proactive steps, such as implementing clean energy technologies and enforcing stricter pollution regulations, are necessary to protect public health. Acting is crucial to addressing these global challenges and creating a cleaner, healthier future for future generations, underscoring the need for climate justice commitment.</description>
	<pubDate>2025-04-16</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 33, Pages 1: Climate Change Risks and Impacts on Public Health Correlated with Air Pollution&amp;mdash;African Dust in South Europe</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/33/1/1">doi: 10.3390/msf2025033001</a></p>
	<p>Authors:
		Ioannis Adamopoulos
		Niki Syrou
		Domenico Vito
		</p>
	<p>Climate change poses a significant risk to the environment and public health, leading to extreme weather patterns, rising sea levels, and loss of biodiversity. The relationship between air pollution from African dust and climate change demonstrates its critical role in trapping heat in the atmosphere, resulting in heat-related illnesses, heart problems, and respiratory issues. This research points to the detrimental effects of pollutants such as smog, dust, acid rain, and ozone depletion on ecosystems, highlighting the importance of using geographically weighted regression modeling and the MODIS-NDVI analysis to address air pollution. Particulate Matter (PM2.5&amp;amp;ndash;10) and ozone levels can have negative impacts on respiratory and cardiovascular health. Proactive steps, such as implementing clean energy technologies and enforcing stricter pollution regulations, are necessary to protect public health. Acting is crucial to addressing these global challenges and creating a cleaner, healthier future for future generations, underscoring the need for climate justice commitment.</p>
	]]></content:encoded>

	<dc:title>Climate Change Risks and Impacts on Public Health Correlated with Air Pollution&amp;amp;mdash;African Dust in South Europe</dc:title>
			<dc:creator>Ioannis Adamopoulos</dc:creator>
			<dc:creator>Niki Syrou</dc:creator>
			<dc:creator>Domenico Vito</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025033001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-04-16</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-04-16</prism:publicationDate>
	<prism:volume>33</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025033001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/33/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/32/1/1">

	<title>Medical Sciences Forum, Vol. 32, Pages 1: Abstracts of 1st International Online Conference on Clinical Reports</title>
	<link>https://www.mdpi.com/2673-9992/32/1/1</link>
	<description>The 1st International Online Conference on Clinical Reports (IOCCR 2025) was held online on 19&amp;amp;ndash;20 March 2025, organized by the open access MDPI journal Reports (ISSN: 2571-841X; IF: 0.8). This conference offered a platform for doctors, experts, and medical-related practitioners in the field of medical cases, images, and videos in human medicine to engage in an exchange of ideas and share cutting-edge research findings. The conference encompassed diverse facets of clinical medicine, including, but not limited to, the following: Disaster/Climate Change Medicine, Cancer, Cardiovascular Diseases, Oral Diseases, and Orthopedic Surgery.</description>
	<pubDate>2025-04-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 32, Pages 1: Abstracts of 1st International Online Conference on Clinical Reports</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/32/1/1">doi: 10.3390/msf2025032001</a></p>
	<p>Authors:
		Toshio Hattori
		</p>
	<p>The 1st International Online Conference on Clinical Reports (IOCCR 2025) was held online on 19&amp;amp;ndash;20 March 2025, organized by the open access MDPI journal Reports (ISSN: 2571-841X; IF: 0.8). This conference offered a platform for doctors, experts, and medical-related practitioners in the field of medical cases, images, and videos in human medicine to engage in an exchange of ideas and share cutting-edge research findings. The conference encompassed diverse facets of clinical medicine, including, but not limited to, the following: Disaster/Climate Change Medicine, Cancer, Cardiovascular Diseases, Oral Diseases, and Orthopedic Surgery.</p>
	]]></content:encoded>

	<dc:title>Abstracts of 1st International Online Conference on Clinical Reports</dc:title>
			<dc:creator>Toshio Hattori</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025032001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-04-14</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-04-14</prism:publicationDate>
	<prism:volume>32</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025032001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/32/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/31/1/1">

	<title>Medical Sciences Forum, Vol. 31, Pages 1: Abstracts from the 72nd Congress of the ESCVS, the European Society of CardioVascular and Endovascular Surgery</title>
	<link>https://www.mdpi.com/2673-9992/31/1/1</link>
	<description>The 72nd Annual International Congress of the European Society for Cardiovascular and Endovascular Surgery (ESCVS) 2024 in Istanbul, Turkey, marks a significant milestone in the advancement of cardiovascular surgery. As the main event in the cardiovascular surgery community calendar, this congress serves as a platform for leading experts, clinicians, and researchers to exchange information on the latest innovations, research results, and clinical procedures. This dedicated supplement to Proceedings provides a curated collection of abstracts presented at the congress, highlighting breakthrough contributions and fostering collaboration across the European and global cardiovascular surgery communities. The topics presented in this supplement represent a wide range of innovative advances in the fields of both cardiovascular and endovascular surgery. These include novel and minimally invasive surgical techniques, technological innovations, updates to clinical recommendations and guidelines, and new therapeutic strategies and procedures. Through the knowledge conveyed in these abstracts, the congress aims to advance the continuous evolution of patient care and outcomes in cardiac and vascular surgery. By showcasing the vibrant research and collaborative spirit of the ESCVS, this supplement provides valuable insights into the future directions of the field, emphasizing the importance of interdisciplinary approaches and innovation in addressing the complexities of cardiovascular disease. As cardiovascular care continues to evolve, the research and discussions presented at this congress will play a critical role in shaping the next generation of cardiac and vascular surgeons, promoting better patient outcomes, and improving the overall quality of cardiovascular health in Europe and worldwide.</description>
	<pubDate>2025-04-03</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 31, Pages 1: Abstracts from the 72nd Congress of the ESCVS, the European Society of CardioVascular and Endovascular Surgery</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/31/1/1">doi: 10.3390/msf2025031001</a></p>
	<p>Authors:
		Ergun Demirsoy
		Matthias Thielmann
		</p>
	<p>The 72nd Annual International Congress of the European Society for Cardiovascular and Endovascular Surgery (ESCVS) 2024 in Istanbul, Turkey, marks a significant milestone in the advancement of cardiovascular surgery. As the main event in the cardiovascular surgery community calendar, this congress serves as a platform for leading experts, clinicians, and researchers to exchange information on the latest innovations, research results, and clinical procedures. This dedicated supplement to Proceedings provides a curated collection of abstracts presented at the congress, highlighting breakthrough contributions and fostering collaboration across the European and global cardiovascular surgery communities. The topics presented in this supplement represent a wide range of innovative advances in the fields of both cardiovascular and endovascular surgery. These include novel and minimally invasive surgical techniques, technological innovations, updates to clinical recommendations and guidelines, and new therapeutic strategies and procedures. Through the knowledge conveyed in these abstracts, the congress aims to advance the continuous evolution of patient care and outcomes in cardiac and vascular surgery. By showcasing the vibrant research and collaborative spirit of the ESCVS, this supplement provides valuable insights into the future directions of the field, emphasizing the importance of interdisciplinary approaches and innovation in addressing the complexities of cardiovascular disease. As cardiovascular care continues to evolve, the research and discussions presented at this congress will play a critical role in shaping the next generation of cardiac and vascular surgeons, promoting better patient outcomes, and improving the overall quality of cardiovascular health in Europe and worldwide.</p>
	]]></content:encoded>

	<dc:title>Abstracts from the 72nd Congress of the ESCVS, the European Society of CardioVascular and Endovascular Surgery</dc:title>
			<dc:creator>Ergun Demirsoy</dc:creator>
			<dc:creator>Matthias Thielmann</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025031001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-04-03</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-04-03</prism:publicationDate>
	<prism:volume>31</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025031001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/31/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/29/1/1">

	<title>Medical Sciences Forum, Vol. 29, Pages 1: Eco-Friendly Antimicrobial Strategies to Fight Chronic Wound Infections Associated with Multidrug-Resistant Pathogens for the Development of Innovative Medical Systems (SCIAMI)</title>
	<link>https://www.mdpi.com/2673-9992/29/1/1</link>
	<description>The SCIAMI International Workshop was held in Chieti, Italy, at University G. d&amp;amp;rsquo;Annunzio, Chieti-Pescara, from 7 to 8 June 2024. It was organized by Simonetta D&amp;amp;rsquo;Ercole and was funded by the European Union&amp;amp;ndash;Next Generation EU, &amp;amp;ldquo;MUR-Fondo Promozione e Sviluppo&amp;amp;ndash;UdA, SCIAMI, Eco-friendly antimicrobial Strategies to fight Chronic wound Infections Associated with Multidrug resistant pathogens for the development of Innovative medical systems&amp;amp;rdquo;. This conference report is an abstract collection from different sessions of SCIAMI.</description>
	<pubDate>2025-03-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 29, Pages 1: Eco-Friendly Antimicrobial Strategies to Fight Chronic Wound Infections Associated with Multidrug-Resistant Pathogens for the Development of Innovative Medical Systems (SCIAMI)</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/29/1/1">doi: 10.3390/msf2025029001</a></p>
	<p>Authors:
		Simonetta D’Ercole
		</p>
	<p>The SCIAMI International Workshop was held in Chieti, Italy, at University G. d&amp;amp;rsquo;Annunzio, Chieti-Pescara, from 7 to 8 June 2024. It was organized by Simonetta D&amp;amp;rsquo;Ercole and was funded by the European Union&amp;amp;ndash;Next Generation EU, &amp;amp;ldquo;MUR-Fondo Promozione e Sviluppo&amp;amp;ndash;UdA, SCIAMI, Eco-friendly antimicrobial Strategies to fight Chronic wound Infections Associated with Multidrug resistant pathogens for the development of Innovative medical systems&amp;amp;rdquo;. This conference report is an abstract collection from different sessions of SCIAMI.</p>
	]]></content:encoded>

	<dc:title>Eco-Friendly Antimicrobial Strategies to Fight Chronic Wound Infections Associated with Multidrug-Resistant Pathogens for the Development of Innovative Medical Systems (SCIAMI)</dc:title>
			<dc:creator>Simonetta D’Ercole</dc:creator>
		<dc:identifier>doi: 10.3390/msf2025029001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-03-20</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-03-20</prism:publicationDate>
	<prism:volume>29</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2025029001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/29/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/28/1/2">

	<title>Medical Sciences Forum, Vol. 28, Pages 2: Modeling Electrical Potential in Multi-Dendritic Neurons Using Bessel Functions</title>
	<link>https://www.mdpi.com/2673-9992/28/1/2</link>
	<description>Understanding the distribution of electrical potential within neurons is critical for advancing our comprehension of neuronal signaling and communication. Neurons, the fundamental units of the nervous system, rely on complex electrochemical processes to transmit information. The intricate structure of neurons, especially those with multiple dendrites, plays a crucial role in how these electrical signals are generated, propagated, and integrated. Despite significant progress in neuroscience, accurately modeling the electrical potential within neurons with elaborate dendritic architectures remains a challenge. This article introduces a novel approach to modeling the electrical potential in multi-dendritic neurons using Bessel functions, which offers a more precise and detailed representation of these processes. The proposed method involves solving the electric potential diffusion equation in cylindrical coordinates, a mathematical framework that naturally aligns with the geometry of dendrites. The radial and axial components of the solution are expressed using Bessel functions and sinusoidal functions, respectively. Bessel functions are particularly well-suited for this purpose due to their ability to describe waveforms in cylindrical systems, making them ideal for capturing the spatial variations in electrical potential within the cylindrical shape of dendrites. By leveraging this mathematical approach, we obtain a complete representation of the potential distribution across the neuron, from the soma (cell body) through the dendrites to the synaptic terminals. This model accurately captures the spatial variations of electrical potential in different regions of the neuron, including areas with complex dendritic arborizations, which are branching structures that significantly influence the neuron&amp;amp;rsquo;s electrical characteristics. Simulation results underscore the effectiveness of this approach in reproducing realistic neuronal behavior. The model successfully mimics the way electrical signals propagate and interact within dendritic structures, providing crucial insights into the underlying mechanisms of signal integration and transmission in neurons.</description>
	<pubDate>2025-03-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 28, Pages 2: Modeling Electrical Potential in Multi-Dendritic Neurons Using Bessel Functions</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/28/1/2">doi: 10.3390/msf2024028002</a></p>
	<p>Authors:
		Kaouther Selmi
		Souhaila Khalfallah
		Kais Bouallegue
		</p>
	<p>Understanding the distribution of electrical potential within neurons is critical for advancing our comprehension of neuronal signaling and communication. Neurons, the fundamental units of the nervous system, rely on complex electrochemical processes to transmit information. The intricate structure of neurons, especially those with multiple dendrites, plays a crucial role in how these electrical signals are generated, propagated, and integrated. Despite significant progress in neuroscience, accurately modeling the electrical potential within neurons with elaborate dendritic architectures remains a challenge. This article introduces a novel approach to modeling the electrical potential in multi-dendritic neurons using Bessel functions, which offers a more precise and detailed representation of these processes. The proposed method involves solving the electric potential diffusion equation in cylindrical coordinates, a mathematical framework that naturally aligns with the geometry of dendrites. The radial and axial components of the solution are expressed using Bessel functions and sinusoidal functions, respectively. Bessel functions are particularly well-suited for this purpose due to their ability to describe waveforms in cylindrical systems, making them ideal for capturing the spatial variations in electrical potential within the cylindrical shape of dendrites. By leveraging this mathematical approach, we obtain a complete representation of the potential distribution across the neuron, from the soma (cell body) through the dendrites to the synaptic terminals. This model accurately captures the spatial variations of electrical potential in different regions of the neuron, including areas with complex dendritic arborizations, which are branching structures that significantly influence the neuron&amp;amp;rsquo;s electrical characteristics. Simulation results underscore the effectiveness of this approach in reproducing realistic neuronal behavior. The model successfully mimics the way electrical signals propagate and interact within dendritic structures, providing crucial insights into the underlying mechanisms of signal integration and transmission in neurons.</p>
	]]></content:encoded>

	<dc:title>Modeling Electrical Potential in Multi-Dendritic Neurons Using Bessel Functions</dc:title>
			<dc:creator>Kaouther Selmi</dc:creator>
			<dc:creator>Souhaila Khalfallah</dc:creator>
			<dc:creator>Kais Bouallegue</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024028002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2025-03-20</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2025-03-20</prism:publicationDate>
	<prism:volume>28</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2024028002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/28/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/25/1/16">

	<title>Medical Sciences Forum, Vol. 25, Pages 16: Statement of Peer Review</title>
	<link>https://www.mdpi.com/2673-9992/25/1/16</link>
	<description>In submitting conference proceedings to Medical Sciences Forum, the volume editors of the proceedings certify to the publisher that all papers published in this volume have been subjected to peer review administered by the volume editors [...]</description>
	<pubDate>2024-12-24</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 25, Pages 16: Statement of Peer Review</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/25/1/16">doi: 10.3390/msf2024025016</a></p>
	<p>Authors:
		Margherita Ferrante
		Gea Oliveri Conti
		</p>
	<p>In submitting conference proceedings to Medical Sciences Forum, the volume editors of the proceedings certify to the publisher that all papers published in this volume have been subjected to peer review administered by the volume editors [...]</p>
	]]></content:encoded>

	<dc:title>Statement of Peer Review</dc:title>
			<dc:creator>Margherita Ferrante</dc:creator>
			<dc:creator>Gea Oliveri Conti</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024025016</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-12-24</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-12-24</prism:publicationDate>
	<prism:volume>25</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Editorial</prism:section>
	<prism:startingPage>16</prism:startingPage>
		<prism:doi>10.3390/msf2024025016</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/25/1/16</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/25/1/15">

	<title>Medical Sciences Forum, Vol. 25, Pages 15: How Eco-Anxiety Is Affected by Community Health Status and Climate Justice Determinants: An Exploratory Study in Young Population</title>
	<link>https://www.mdpi.com/2673-9992/25/1/15</link>
	<description>The climate crisis, combined with the COVID-19 lockdown measures, exacerbated pre-existing psychological conditions among young people experiencing climate anxiety due to a lack of information and a diffuse sense of powerlessness. The current study aimed to find correlations between the health status of a community, the environmental determinants among youths, and how these affect their vision of climate change and their mental health. An exploratory survey was conducted among people aged between 18 and 33 years old from three continents, with a focus on emotional states related to natural disasters occurring in their regions. The online survey consisted of six questions. The pilot phase results showed that more females from India experienced stressful situations related to climate change, and that respondents aged between 18 and 20 years old were more informed about eco-anxiety. Given its growing frequency among young adults, further studies should be conducted to address the problem and create alternatives and coping mechanisms such as climate action.</description>
	<pubDate>2024-12-23</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 25, Pages 15: How Eco-Anxiety Is Affected by Community Health Status and Climate Justice Determinants: An Exploratory Study in Young Population</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/25/1/15">doi: 10.3390/msf2024025015</a></p>
	<p>Authors:
		Melissa Jimenez Gomez Tagle
		Domenico Vito
		</p>
	<p>The climate crisis, combined with the COVID-19 lockdown measures, exacerbated pre-existing psychological conditions among young people experiencing climate anxiety due to a lack of information and a diffuse sense of powerlessness. The current study aimed to find correlations between the health status of a community, the environmental determinants among youths, and how these affect their vision of climate change and their mental health. An exploratory survey was conducted among people aged between 18 and 33 years old from three continents, with a focus on emotional states related to natural disasters occurring in their regions. The online survey consisted of six questions. The pilot phase results showed that more females from India experienced stressful situations related to climate change, and that respondents aged between 18 and 20 years old were more informed about eco-anxiety. Given its growing frequency among young adults, further studies should be conducted to address the problem and create alternatives and coping mechanisms such as climate action.</p>
	]]></content:encoded>

	<dc:title>How Eco-Anxiety Is Affected by Community Health Status and Climate Justice Determinants: An Exploratory Study in Young Population</dc:title>
			<dc:creator>Melissa Jimenez Gomez Tagle</dc:creator>
			<dc:creator>Domenico Vito</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024025015</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-12-23</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-12-23</prism:publicationDate>
	<prism:volume>25</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>15</prism:startingPage>
		<prism:doi>10.3390/msf2024025015</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/25/1/15</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/25/1/14">

	<title>Medical Sciences Forum, Vol. 25, Pages 14: Monitoring the Effects of Transboundary Water Pollution in Imperial Beach, California</title>
	<link>https://www.mdpi.com/2673-9992/25/1/14</link>
	<description>Transboundary water pollution is a major global challenge as its movement and impacts remain unsurveyed. Monitoring pollution along international borders can reveal some of the pathways by which sewage and chemicals enter water bodies, and can hence advance the implementation of measures to prevent leakages and discharges into international waters. In this paper, we surveyed the impacts of sewage pollution and chemicals along the U.S.&amp;amp;ndash;Mexico international border, using Imperial Beach (California) as a main case study. Pollution was primarily attributed to the inflow of contaminated waters from the neighboring city of Tijuana (Mexico), where a malfunctioning wastewater treatment plant and a lack of sewage pipes being upgraded have caused direct leakage and toxic discharges into the Tijuana River. Reported effects from water pollution at the Tijuana River estuary in Imperial Beach include frequent beach closure, damages to coastal ecosystems, negative impacts on the fishery industry, and several effects on the health of beach users and surfers. Hence, the situation requires urgent measures oriented at coastal management at the mouth of the Tijuana River as well as the consistent monitoring and reporting of human health effects linked to beach uses.</description>
	<pubDate>2024-12-12</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 25, Pages 14: Monitoring the Effects of Transboundary Water Pollution in Imperial Beach, California</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/25/1/14">doi: 10.3390/msf2024025014</a></p>
	<p>Authors:
		Carol Maione
		Domenico Vito
		Gabriela Fernandez
		</p>
	<p>Transboundary water pollution is a major global challenge as its movement and impacts remain unsurveyed. Monitoring pollution along international borders can reveal some of the pathways by which sewage and chemicals enter water bodies, and can hence advance the implementation of measures to prevent leakages and discharges into international waters. In this paper, we surveyed the impacts of sewage pollution and chemicals along the U.S.&amp;amp;ndash;Mexico international border, using Imperial Beach (California) as a main case study. Pollution was primarily attributed to the inflow of contaminated waters from the neighboring city of Tijuana (Mexico), where a malfunctioning wastewater treatment plant and a lack of sewage pipes being upgraded have caused direct leakage and toxic discharges into the Tijuana River. Reported effects from water pollution at the Tijuana River estuary in Imperial Beach include frequent beach closure, damages to coastal ecosystems, negative impacts on the fishery industry, and several effects on the health of beach users and surfers. Hence, the situation requires urgent measures oriented at coastal management at the mouth of the Tijuana River as well as the consistent monitoring and reporting of human health effects linked to beach uses.</p>
	]]></content:encoded>

	<dc:title>Monitoring the Effects of Transboundary Water Pollution in Imperial Beach, California</dc:title>
			<dc:creator>Carol Maione</dc:creator>
			<dc:creator>Domenico Vito</dc:creator>
			<dc:creator>Gabriela Fernandez</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024025014</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-12-12</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-12-12</prism:publicationDate>
	<prism:volume>25</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>14</prism:startingPage>
		<prism:doi>10.3390/msf2024025014</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/25/1/14</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/28/1/1">

	<title>Medical Sciences Forum, Vol. 28, Pages 1: Abstracts of the 2nd International Electronic Conference on Clinical Medicine (ECCM 2024)</title>
	<link>https://www.mdpi.com/2673-9992/28/1/1</link>
	<description>The 2nd International Electronic Conference on Clinical Medicine: Chronic Diseases&amp;amp;mdash;Current State and Future Trends (ECCM 2024) was organized by MDPI and MDPI Journal of Clinical Medicine and took place online from 13 to 15 November 2024. This conference report is an abstract collection from different sessions of ECCM 2024.</description>
	<pubDate>2024-11-22</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 28, Pages 1: Abstracts of the 2nd International Electronic Conference on Clinical Medicine (ECCM 2024)</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/28/1/1">doi: 10.3390/msf2024028001</a></p>
	<p>Authors:
		Emmanuel Andrès
		Kent Doi
		</p>
	<p>The 2nd International Electronic Conference on Clinical Medicine: Chronic Diseases&amp;amp;mdash;Current State and Future Trends (ECCM 2024) was organized by MDPI and MDPI Journal of Clinical Medicine and took place online from 13 to 15 November 2024. This conference report is an abstract collection from different sessions of ECCM 2024.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 2nd International Electronic Conference on Clinical Medicine (ECCM 2024)</dc:title>
			<dc:creator>Emmanuel Andrès</dc:creator>
			<dc:creator>Kent Doi</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024028001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-11-22</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-11-22</prism:publicationDate>
	<prism:volume>28</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2024028001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/28/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/25/1/13">

	<title>Medical Sciences Forum, Vol. 25, Pages 13: A Machine Learning-Based Risk Prediction Model During Pregnancy in Low-Resource Settings</title>
	<link>https://www.mdpi.com/2673-9992/25/1/13</link>
	<description>Maternal health is a serious concern for many nations due to a lack of appropriate healthcare facilities, healthcare staff, and late diagnoses of life-threatening diseases. Pregnant women suffer with numerous challenges during the pregnancy and childbirth. Non-communicable diseases, a lack of nutrition in diets, and unawareness of the risks associated with pregnancy are the primary reasons for these challenges. Sometimes these reasons become a direct cause of maternal mortality as well. Awareness of the risks and early detection may contribute to a reduction in maternal deaths during pregnancy and childbirth. Various ICTs have been incorporated into the healthcare industry to diagnose the issue as quickly as is feasible and an appropriate remedy can be initiated to treat diseases. Machine Learning (ML) techniques have the potential to predict the probable risk factors for timely interventions; however, challenge arises when the data are limited and unstructured. The Decision Tree (DT), Naive Bayes (NB), Logistic Regression (LR), Support Vector Machine (SVM), K-Nearest Neighbors (KNN), and Linear Discriminant Analysis (LDA) algorithms, with 10-fold cross validation, are used in this study. The dataset utilized in this study included both the present and past medical histories and important vitals of pregnant women. With a test score of 98.8%, the Decision Tree (DT) algorithm outperformed other algorithms, according to the results. Based on the predicted result, pregnant women can consult with medical specialists for their consultation to reduce the potential difficulties in the near future.</description>
	<pubDate>2024-11-18</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 25, Pages 13: A Machine Learning-Based Risk Prediction Model During Pregnancy in Low-Resource Settings</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/25/1/13">doi: 10.3390/msf2024025013</a></p>
	<p>Authors:
		Kapil Tomar
		Chandra Mani Sharma
		Tanisha Prasad
		Vijayaraghavan M. Chariar
		</p>
	<p>Maternal health is a serious concern for many nations due to a lack of appropriate healthcare facilities, healthcare staff, and late diagnoses of life-threatening diseases. Pregnant women suffer with numerous challenges during the pregnancy and childbirth. Non-communicable diseases, a lack of nutrition in diets, and unawareness of the risks associated with pregnancy are the primary reasons for these challenges. Sometimes these reasons become a direct cause of maternal mortality as well. Awareness of the risks and early detection may contribute to a reduction in maternal deaths during pregnancy and childbirth. Various ICTs have been incorporated into the healthcare industry to diagnose the issue as quickly as is feasible and an appropriate remedy can be initiated to treat diseases. Machine Learning (ML) techniques have the potential to predict the probable risk factors for timely interventions; however, challenge arises when the data are limited and unstructured. The Decision Tree (DT), Naive Bayes (NB), Logistic Regression (LR), Support Vector Machine (SVM), K-Nearest Neighbors (KNN), and Linear Discriminant Analysis (LDA) algorithms, with 10-fold cross validation, are used in this study. The dataset utilized in this study included both the present and past medical histories and important vitals of pregnant women. With a test score of 98.8%, the Decision Tree (DT) algorithm outperformed other algorithms, according to the results. Based on the predicted result, pregnant women can consult with medical specialists for their consultation to reduce the potential difficulties in the near future.</p>
	]]></content:encoded>

	<dc:title>A Machine Learning-Based Risk Prediction Model During Pregnancy in Low-Resource Settings</dc:title>
			<dc:creator>Kapil Tomar</dc:creator>
			<dc:creator>Chandra Mani Sharma</dc:creator>
			<dc:creator>Tanisha Prasad</dc:creator>
			<dc:creator>Vijayaraghavan M. Chariar</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024025013</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-11-18</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-11-18</prism:publicationDate>
	<prism:volume>25</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>13</prism:startingPage>
		<prism:doi>10.3390/msf2024025013</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/25/1/13</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/23/1/10">

	<title>Medical Sciences Forum, Vol. 23, Pages 10: Nutritional Protein Value of Flours via LC-MS/MS Analysis</title>
	<link>https://www.mdpi.com/2673-9992/23/1/10</link>
	<description>The growth of the world&amp;amp;rsquo;s population and the reduction in the average annual global individual carbon footprint are current issues. With the aim of assessing nutritional protein values, we developed a sensitive analytical methodology for the identification and quantification of amino acids. Strategies have been developed to reduce sample complexity and improve detection for analysis by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). The method is suitable for the purpose and is a useful tool for protein value assessment, according to the Food and Agriculture Organization of the United Nations.</description>
	<pubDate>2024-09-20</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 23, Pages 10: Nutritional Protein Value of Flours via LC-MS/MS Analysis</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/23/1/10">doi: 10.3390/msf2023023010</a></p>
	<p>Authors:
		Maria João Nunes
		Catarina V. Esteves
		Mário Diniz
		João Paulo Noronha
		Luis C. Branco
		</p>
	<p>The growth of the world&amp;amp;rsquo;s population and the reduction in the average annual global individual carbon footprint are current issues. With the aim of assessing nutritional protein values, we developed a sensitive analytical methodology for the identification and quantification of amino acids. Strategies have been developed to reduce sample complexity and improve detection for analysis by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). The method is suitable for the purpose and is a useful tool for protein value assessment, according to the Food and Agriculture Organization of the United Nations.</p>
	]]></content:encoded>

	<dc:title>Nutritional Protein Value of Flours via LC-MS/MS Analysis</dc:title>
			<dc:creator>Maria João Nunes</dc:creator>
			<dc:creator>Catarina V. Esteves</dc:creator>
			<dc:creator>Mário Diniz</dc:creator>
			<dc:creator>João Paulo Noronha</dc:creator>
			<dc:creator>Luis C. Branco</dc:creator>
		<dc:identifier>doi: 10.3390/msf2023023010</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-09-20</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-09-20</prism:publicationDate>
	<prism:volume>23</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>10</prism:startingPage>
		<prism:doi>10.3390/msf2023023010</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/23/1/10</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/25/1/12">

	<title>Medical Sciences Forum, Vol. 25, Pages 12: The Epidemiology of Hepatitis in the Marche Region (Italy): A Notification System over a Decade (2012&amp;ndash;2021)</title>
	<link>https://www.mdpi.com/2673-9992/25/1/12</link>
	<description>The World Health Organization has highlighted the substantial impact of viral hepatitis on individuals, healthcare systems, and economies worldwide. This study&amp;amp;rsquo;s objective is to monitor disease notifications to assess their trends. Data from infectious disease notifications detected in the Marche Region (Italy) were analyzed and entered into the Nuovo Sistema Informativo Sanitario portal between 1 January 2012 and 31 December 2021. In this period, there were 399 confirmed reports, of which 47.9% were for hepatitis A, 26.8% were for hepatitis B, 7% were for hepatitis C, and 18.3% were for hepatitis E; 67.4% of the afflicted individuals were male, and the average age was 43.5 years old. The year with the highest peak was 2017, accounting for 18% of the reports, while the year with the lowest number was 2020, followed by 2021, accounting for 3.8% and 4.5%, respectively. Effective surveillance systems are key to combating the spread of hepatitis and reducing its impact, although they have been affected by the SARS-CoV-2 pandemic, with many cases remaining undetected.</description>
	<pubDate>2024-08-29</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 25, Pages 12: The Epidemiology of Hepatitis in the Marche Region (Italy): A Notification System over a Decade (2012&amp;ndash;2021)</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/25/1/12">doi: 10.3390/msf2024025012</a></p>
	<p>Authors:
		Cosimo Damiano Giorgio Mangino
		Corinna Fortunato
		Love Chibuzor Ilochonwu
		Andrea Mazzacchera
		Davide Mengarelli detto Rinaldini
		Giulia Mercante
		Andrea Paladini
		Fabio Filippetti
		</p>
	<p>The World Health Organization has highlighted the substantial impact of viral hepatitis on individuals, healthcare systems, and economies worldwide. This study&amp;amp;rsquo;s objective is to monitor disease notifications to assess their trends. Data from infectious disease notifications detected in the Marche Region (Italy) were analyzed and entered into the Nuovo Sistema Informativo Sanitario portal between 1 January 2012 and 31 December 2021. In this period, there were 399 confirmed reports, of which 47.9% were for hepatitis A, 26.8% were for hepatitis B, 7% were for hepatitis C, and 18.3% were for hepatitis E; 67.4% of the afflicted individuals were male, and the average age was 43.5 years old. The year with the highest peak was 2017, accounting for 18% of the reports, while the year with the lowest number was 2020, followed by 2021, accounting for 3.8% and 4.5%, respectively. Effective surveillance systems are key to combating the spread of hepatitis and reducing its impact, although they have been affected by the SARS-CoV-2 pandemic, with many cases remaining undetected.</p>
	]]></content:encoded>

	<dc:title>The Epidemiology of Hepatitis in the Marche Region (Italy): A Notification System over a Decade (2012&amp;amp;ndash;2021)</dc:title>
			<dc:creator>Cosimo Damiano Giorgio Mangino</dc:creator>
			<dc:creator>Corinna Fortunato</dc:creator>
			<dc:creator>Love Chibuzor Ilochonwu</dc:creator>
			<dc:creator>Andrea Mazzacchera</dc:creator>
			<dc:creator>Davide Mengarelli detto Rinaldini</dc:creator>
			<dc:creator>Giulia Mercante</dc:creator>
			<dc:creator>Andrea Paladini</dc:creator>
			<dc:creator>Fabio Filippetti</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024025012</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-08-29</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-08-29</prism:publicationDate>
	<prism:volume>25</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>12</prism:startingPage>
		<prism:doi>10.3390/msf2024025012</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/25/1/12</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/27/1/3">

	<title>Medical Sciences Forum, Vol. 27, Pages 3: Abstracts of the 2023 Autumn Meeting of the British Society for Cardiovascular Research</title>
	<link>https://www.mdpi.com/2673-9992/27/1/3</link>
	<description>The Autumn Meeting of the British Society for Cardiovascular Research in 2023 was organized by Carolyn Carr, Lisa Heather and Claudia Montes Aparicio at Wadham College at the University of Oxford and was the 50th Anniversary Meeting of the Society. The theme of the meeting was &amp;amp;ldquo;The impact of dysregulated metabolism on cardiovascular function&amp;amp;rdquo; and included an early career symposium on &amp;amp;ldquo;Life in academia and beyond&amp;amp;rdquo;. The Annual Bernard and Joan Marshall Distinguished Investigator Lecture was given by Professor Doug Lewandowski on &amp;amp;ldquo;Metabolic flux in the driver&amp;amp;rsquo;s seat during cardiac health and disease&amp;amp;rdquo;. This paper presents the abstracts selected for oral and poster presentation.</description>
	<pubDate>2024-08-28</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 27, Pages 3: Abstracts of the 2023 Autumn Meeting of the British Society for Cardiovascular Research</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/27/1/3">doi: 10.3390/msf2024027003</a></p>
	<p>Authors:
		Carolyn Carr
		</p>
	<p>The Autumn Meeting of the British Society for Cardiovascular Research in 2023 was organized by Carolyn Carr, Lisa Heather and Claudia Montes Aparicio at Wadham College at the University of Oxford and was the 50th Anniversary Meeting of the Society. The theme of the meeting was &amp;amp;ldquo;The impact of dysregulated metabolism on cardiovascular function&amp;amp;rdquo; and included an early career symposium on &amp;amp;ldquo;Life in academia and beyond&amp;amp;rdquo;. The Annual Bernard and Joan Marshall Distinguished Investigator Lecture was given by Professor Doug Lewandowski on &amp;amp;ldquo;Metabolic flux in the driver&amp;amp;rsquo;s seat during cardiac health and disease&amp;amp;rdquo;. This paper presents the abstracts selected for oral and poster presentation.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 2023 Autumn Meeting of the British Society for Cardiovascular Research</dc:title>
			<dc:creator>Carolyn Carr</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024027003</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-08-28</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-08-28</prism:publicationDate>
	<prism:volume>27</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>3</prism:startingPage>
		<prism:doi>10.3390/msf2024027003</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/27/1/3</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/27/1/2">

	<title>Medical Sciences Forum, Vol. 27, Pages 2: Abstracts of the 2022 Autumn Meeting of the British Society for Cardiovascular Research</title>
	<link>https://www.mdpi.com/2673-9992/27/1/2</link>
	<description>The Autumn Meeting of the British Society for Cardiovascular Research in 2022 was organized by David Grieve, Lauren Kerrigan, Claire Tonry and Chris Watson and held at the Wellcome-Wolfson Institute for Experimental Medicine, Queen&amp;amp;rsquo;s University Belfast. The theme of the meeting was &amp;amp;lsquo;Cardiac remodeling&amp;amp;mdash;basic mechanisms to clinical management&amp;amp;rsquo; and included an early career symposium. The Annual Bernard and Joan Marshall Distinguished Investigator Lecture was given by Professor Merry Lindsey on &amp;amp;lsquo;Extracellular matrix remodeling in heart failure&amp;amp;rsquo;. This paper presents the abstracts selected for oral and poster presentation.</description>
	<pubDate>2024-08-26</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 27, Pages 2: Abstracts of the 2022 Autumn Meeting of the British Society for Cardiovascular Research</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/27/1/2">doi: 10.3390/msf2024027002</a></p>
	<p>Authors:
		Carolyn Carr
		</p>
	<p>The Autumn Meeting of the British Society for Cardiovascular Research in 2022 was organized by David Grieve, Lauren Kerrigan, Claire Tonry and Chris Watson and held at the Wellcome-Wolfson Institute for Experimental Medicine, Queen&amp;amp;rsquo;s University Belfast. The theme of the meeting was &amp;amp;lsquo;Cardiac remodeling&amp;amp;mdash;basic mechanisms to clinical management&amp;amp;rsquo; and included an early career symposium. The Annual Bernard and Joan Marshall Distinguished Investigator Lecture was given by Professor Merry Lindsey on &amp;amp;lsquo;Extracellular matrix remodeling in heart failure&amp;amp;rsquo;. This paper presents the abstracts selected for oral and poster presentation.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 2022 Autumn Meeting of the British Society for Cardiovascular Research</dc:title>
			<dc:creator>Carolyn Carr</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024027002</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-08-26</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-08-26</prism:publicationDate>
	<prism:volume>27</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>2</prism:startingPage>
		<prism:doi>10.3390/msf2024027002</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/27/1/2</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/27/1/1">

	<title>Medical Sciences Forum, Vol. 27, Pages 1: Abstracts of the 2021 Autumn Meeting of the British Society for Cardiovascular Research</title>
	<link>https://www.mdpi.com/2673-9992/27/1/1</link>
	<description>The Autumn Meeting of the British Society for Cardiovascular Research in 2021 was a virtual meeting organised by Andrew Bond, Anita Thomas, Elisa Avolio, Michele Carrabba, Raimondo Ascione, and Paolo Madeddu of the Bristol Medical School. The theme of the meeting was &amp;amp;lsquo;Tissue engineering and regenerative medicine in cardiovascular disease&amp;amp;rsquo; and included an early career symposium. The Annual Bernard and Joan Marshall Distinguished Investigator Lecture was given by Professor Toshiharu Shinoka. This paper presents the abstracts selected for oral and poster presentations.</description>
	<pubDate>2024-08-23</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 27, Pages 1: Abstracts of the 2021 Autumn Meeting of the British Society for Cardiovascular Research</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/27/1/1">doi: 10.3390/msf2024027001</a></p>
	<p>Authors:
		Carolyn Carr
		</p>
	<p>The Autumn Meeting of the British Society for Cardiovascular Research in 2021 was a virtual meeting organised by Andrew Bond, Anita Thomas, Elisa Avolio, Michele Carrabba, Raimondo Ascione, and Paolo Madeddu of the Bristol Medical School. The theme of the meeting was &amp;amp;lsquo;Tissue engineering and regenerative medicine in cardiovascular disease&amp;amp;rsquo; and included an early career symposium. The Annual Bernard and Joan Marshall Distinguished Investigator Lecture was given by Professor Toshiharu Shinoka. This paper presents the abstracts selected for oral and poster presentations.</p>
	]]></content:encoded>

	<dc:title>Abstracts of the 2021 Autumn Meeting of the British Society for Cardiovascular Research</dc:title>
			<dc:creator>Carolyn Carr</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024027001</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-08-23</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-08-23</prism:publicationDate>
	<prism:volume>27</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Conference Report</prism:section>
	<prism:startingPage>1</prism:startingPage>
		<prism:doi>10.3390/msf2024027001</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/27/1/1</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/24/1/21">

	<title>Medical Sciences Forum, Vol. 24, Pages 21: Preface: The 3rd International Electronic Conference on Antibiotics</title>
	<link>https://www.mdpi.com/2673-9992/24/1/21</link>
	<description>This volume presents a collection of contributions at the 3rd International Electronic Conference on Antibiotics held on 1&amp;amp;ndash;15 December 2023 [...]</description>
	<pubDate>2024-08-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 24, Pages 21: Preface: The 3rd International Electronic Conference on Antibiotics</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/24/1/21">doi: 10.3390/msf2024024021</a></p>
	<p>Authors:
		Marc Maresca
		</p>
	<p>This volume presents a collection of contributions at the 3rd International Electronic Conference on Antibiotics held on 1&amp;amp;ndash;15 December 2023 [...]</p>
	]]></content:encoded>

	<dc:title>Preface: The 3rd International Electronic Conference on Antibiotics</dc:title>
			<dc:creator>Marc Maresca</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024024021</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-08-14</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-08-14</prism:publicationDate>
	<prism:volume>24</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Editorial</prism:section>
	<prism:startingPage>21</prism:startingPage>
		<prism:doi>10.3390/msf2024024021</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/24/1/21</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/24/1/20">

	<title>Medical Sciences Forum, Vol. 24, Pages 20: Statement of Peer Review</title>
	<link>https://www.mdpi.com/2673-9992/24/1/20</link>
	<description>In submitting conference proceedings to Medical Sciences Forum, the volume editors of the proceedings certify to the publisher that all papers published in this volume have been subjected to peer review administered by the volume editors [...]</description>
	<pubDate>2024-08-14</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 24, Pages 20: Statement of Peer Review</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/24/1/20">doi: 10.3390/msf2024024020</a></p>
	<p>Authors:
		Marc Maresca
		</p>
	<p>In submitting conference proceedings to Medical Sciences Forum, the volume editors of the proceedings certify to the publisher that all papers published in this volume have been subjected to peer review administered by the volume editors [...]</p>
	]]></content:encoded>

	<dc:title>Statement of Peer Review</dc:title>
			<dc:creator>Marc Maresca</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024024020</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-08-14</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-08-14</prism:publicationDate>
	<prism:volume>24</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Editorial</prism:section>
	<prism:startingPage>20</prism:startingPage>
		<prism:doi>10.3390/msf2024024020</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/24/1/20</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
        <item rdf:about="https://www.mdpi.com/2673-9992/25/1/11">

	<title>Medical Sciences Forum, Vol. 25, Pages 11: Promoting Sustainable Agriculture: Impacts of Innovative Soil Management Approaches on Human Health and Ecosystems</title>
	<link>https://www.mdpi.com/2673-9992/25/1/11</link>
	<description>Soil use and its proper management are key elements of sustainable development. However, given the complexity of the issue, it is necessary to address it using an interdisciplinary approach. The proposed work aims to analyze the consequences, in terms of damage assessment, of two different soil management systems of a cereal crop through the use of Life Cycle Assessment (LCA) methodology. One system follows a traditional approach and the other utilizes a Decision Support System (DSS). The long-term impacts on human health, ecosystems, and resource availability are calculated by employing the ReCiPe 2016 endpoint method. The results show notable reductions in resource use and environmental impacts with DSS, with a 41% decrease in damage to human health, a 24% reduction in ecosystem damage, and a 23% reduction in resource use. Hence, implementing new technologies and new management strategies in agriculture can lead to more sustainable management choices and can avoid long-term burdens compared to a traditional approach.</description>
	<pubDate>2024-08-07</pubDate>

	<content:encoded><![CDATA[
	<p><b>Medical Sciences Forum, Vol. 25, Pages 11: Promoting Sustainable Agriculture: Impacts of Innovative Soil Management Approaches on Human Health and Ecosystems</b></p>
	<p>Medical Sciences Forum <a href="https://www.mdpi.com/2673-9992/25/1/11">doi: 10.3390/msf2024025011</a></p>
	<p>Authors:
		Maria Vittoria Di Loreto
		Simone Grasso
		Francesco Lodato
		Giorgio Pennazza
		Luca Vollero
		Marco Santonico
		</p>
	<p>Soil use and its proper management are key elements of sustainable development. However, given the complexity of the issue, it is necessary to address it using an interdisciplinary approach. The proposed work aims to analyze the consequences, in terms of damage assessment, of two different soil management systems of a cereal crop through the use of Life Cycle Assessment (LCA) methodology. One system follows a traditional approach and the other utilizes a Decision Support System (DSS). The long-term impacts on human health, ecosystems, and resource availability are calculated by employing the ReCiPe 2016 endpoint method. The results show notable reductions in resource use and environmental impacts with DSS, with a 41% decrease in damage to human health, a 24% reduction in ecosystem damage, and a 23% reduction in resource use. Hence, implementing new technologies and new management strategies in agriculture can lead to more sustainable management choices and can avoid long-term burdens compared to a traditional approach.</p>
	]]></content:encoded>

	<dc:title>Promoting Sustainable Agriculture: Impacts of Innovative Soil Management Approaches on Human Health and Ecosystems</dc:title>
			<dc:creator>Maria Vittoria Di Loreto</dc:creator>
			<dc:creator>Simone Grasso</dc:creator>
			<dc:creator>Francesco Lodato</dc:creator>
			<dc:creator>Giorgio Pennazza</dc:creator>
			<dc:creator>Luca Vollero</dc:creator>
			<dc:creator>Marco Santonico</dc:creator>
		<dc:identifier>doi: 10.3390/msf2024025011</dc:identifier>
	<dc:source>Medical Sciences Forum</dc:source>
	<dc:date>2024-08-07</dc:date>

	<prism:publicationName>Medical Sciences Forum</prism:publicationName>
	<prism:publicationDate>2024-08-07</prism:publicationDate>
	<prism:volume>25</prism:volume>
	<prism:number>1</prism:number>
	<prism:section>Proceeding Paper</prism:section>
	<prism:startingPage>11</prism:startingPage>
		<prism:doi>10.3390/msf2024025011</prism:doi>
	<prism:url>https://www.mdpi.com/2673-9992/25/1/11</prism:url>
	
	<cc:license rdf:resource="CC BY 4.0"/>
</item>
    
<cc:License rdf:about="https://creativecommons.org/licenses/by/4.0/">
	<cc:permits rdf:resource="https://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="https://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="https://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
